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ABSTRACT 
The burgeoning knowledge in genetics implies that genetic services (including clinical and 
counselling) will be in increasing demand in the future.  
This study investigated South African doctors’ genetic education, knowledge and attitudes 
towards genetic services and examined whether these factors affect referral to genetic 
services. Several studies have indicated that health professionals have poor understanding 
of genetics and genetic conditions, and this lack of insight extends to knowledge of genetic 
services and how and when to access them, so that those who would benefit from services 
might not gain access to them because they are not referred by their doctors (Delikurt et al., 
2015).  
METHODS 
A questionnaire was developed based on published research and questions relating to the 
aims of the project.  Forty one questions were asked, covering referral patterns, 
demographics, education, knowledge and attitudes to genetic services and genetic 
counselling.  
The sample population consisted of 140 GPs attending a family practitioners’ conference. 
Fifty one responses were received.  
Results were analysed using descriptive statistics and content analysis of open ended 
questions. 
RESULTS 
Results show that 52.9% of general practitioners have referred to genetics in the past, 92.2% 
think they will refer in future and only 49% know how to access genetic services. Doctors 
who knew how to access genetic services were more likely to have previously referred 
patients to these services. Almost half the doctors who had not used genetic services 
previously felt that genetic services were difficult to access and several attributed this to 
their lack of knowledge.  
Doctors who had the most education were more likely to have previously referred patients 
to genetic services. Doctors indicated that they would like more education on basic genetics, 
common genetic conditions and genetic services via forums such as conferences, CME 
activities and online resources. 
More than half of the doctors rated themselves as “not confident” in their genetic 
knowledge. Down syndrome was the most commonly seen genetic condition in practice, 
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followed by cystic fibrosis and breast cancer. More than 80% of respondents did not know 
about direct-to-consumer testing, but 46% thought they might be approached to interpret 
the results of a direct-to-consumer test in future. Doctors showed poor understanding of the 
ethics of testing minors for genetic conditions. 
Genetic services and genetic counselling were seen as indispensable by 66.7% and 74.5% of 
doctors respectively.  
CONCLUSIONS 
Overall, doctors’ knowledge of genetics seems poor and most of them indicate they would 
like more education on basic genetic concepts, referral guidelines for genetic services and 
how to access genetic services, which agrees with the amount of education being the most 
important factor relating to previous referral to genetic services. 
This study will provide guidance for awareness and education programmes, and inform the 
future development of genetic services in South Africa. 
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1 LITERATURE REVIEW 
The literature for the review was selected by searching the Google Scholar database using 
the terms: [genetic counselling referral OR doctor OR specialist]; Articles excluding patents. 
An alert was created, and abstracts of relevant articles were read to determine whether or 
not they would add to the literature already selected. Full articles were downloaded when 
the abstract indicated that they would be relevant. 
1.1 Introduction 
Genetic services have existed in South Africa since the 1970’s and strong policies have been 
created for their development. However, the expansion of these services has stagnated since 
the 1990’s, when the Human immunodeficiency virus/Acquired Immunodeficiency 
syndrome (HIV/AIDS) epidemic diverted resources from genetic services into primary health 
care. Improved care for HIV patients has controlled the epidemic and the infant mortality 
rate (IMR) has decreased. Demographics in South Africa indicate that genetic services are 
now essential, and proper use of these services could further reduce the IMR through 
appropriate management of congenital conditions, but there are still very few funded posts 
for medical geneticists, genetic counsellors and medical genetic scientists (who work in 
laboratories) in the public and private sector (Nippert et al., 2013). While public health policy 
may be the main reason for the lack of posts, use of genetic services by medical doctors 
working in primary care is of interest. This study was designed to research whether primary 
care doctors are using genetic services (or would like to use them) and see them as a valuable 
addition to their practice. 
The exponential growth of genomics and molecular biology in the past two decades, 
including the Human Genome Project, advances in sequencing and information technology, 
has resulted in almost daily reports of breakthroughs in genetics (Burke et al., 2010). This 
increase in knowledge could lead to opportunities for improving public health by improving 
early detection, implementing more effective prevention programmes and targeting 
personalised treatment. These developments will allow improved use of resources by health 
professionals (Kurlan & Ford, 2015) e.g. better screening of populations ensuring that 
treatments get to people who will benefit, new treatments and genetic testing options. 
Consensus among delegates at a Public Health Genomics meeting held in Suffolk, UK, (Burke 
et al., 2010) was that “…health professionals had to engage with the genomics agenda and 
to recognise its potential for disease prevention and health improvement.”  
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However, the rate of expansion of genetic knowledge makes it difficult for medical doctors 
to keep up to date without continuing education and better use of genetic services will only 
happen if doctors know how and when to refer patients to these services. There is little 
known about how doctors working outside genetics use genetic services and what factors 
are associated with referral to genetic services. Several studies have indicated that health 
professionals have poor understanding of genetics and genetic conditions, and this lack of 
insight extends to knowledge of genetic services and how and when to access them, so that 
those who would benefit from services might not gain access to them because they are not 
referred by their doctors (Delikurt et al., 2015).  
This descriptive survey-based study attempts to describe how medical doctors working in 
general practice in South Africa understand and use genetic knowledge and genetic services. 
The study will also investigate what factors have been associated with previous referral to 
genetic services, and whether the doctors think they may refer in future. Finally, the survey 
served as an educational tool to raise awareness about genetics and genetic services 
amongst the group of doctors participating in the survey. 
1.2 Health care services in South Africa 
Health care services in South Africa are inequitable (Benatar, 2004 cited in Greenberg et al., 
2012). There are disparities in medical services between the nine provinces, which 
implement government programmes and policies at their own discretion and according to 
their individual needs (Greenberg et al., 2012). Access to medical services is compounded by 
social dynamics. The country is positioned between first world and third world development, 
with a rural population of 18.8 million (GeoHive, 2015), nine official languages and several 
different cultures. 
A large number of poor and indigent people are seen in the state sector, where fees are 
charged according to income, so that the poorest patients are treated for free and wealthier 
patients pay according to their means. Primary care occurs in district based clinics and more 
specialised care (including genetic services) requires referral to secondary, tertiary and 
quaternary state hospitals which may not be easily accessible by these patients. In contrast, 
a smaller and wealthier proportion has medical aid insurance which pays professionals 
working in private care (Greenberg et al., 2012). Private patients will usually consult a general 
practitioner (GP) or family physician for primary care, and rely on these doctors for referral 
into specialised services if necessary. Private patients can also be seen in state hospitals and 
their medical aid will be billed accordingly. Since there are currently no medical geneticists 
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working in private practice and only a few genetic counsellors working privately part time, 
private patients are generally also referred to state genetic services for consultations with 
medical geneticists.   
1.3 The importance of genetic services in health care 
Genetic services comprise medical geneticists, genetic counsellors, genetic nurses and 
medical scientists working as a collaborative team. Together, these professionals provide 
comprehensive health services for individuals and families affected by genetic and congenital 
conditions.  
While genetic services are available in South Africa, budget constraints mean the focus is on 
primary health care, including antenatal care, childbirth and early childhood care. Tertiary 
services, including genetic services, are not given prominence in local health settings and the 
development of South Africa’s genetic services is hampered by the lack of genetic posts and 
limited investment in new laboratory technology and equipment (Kromberg & Krause, 2013).  
In a small study in which doctors responded to a survey on genetic testing, they indicated 
that there were too few genetic counsellors and medical geneticists in South Africa (Vogel et 
al., 2011). 
The emphasis on common diseases is appropriate, but rare diseases, of which 70% are 
inherited or congenital, are collectively a great burden on individual families and society as 
a whole and are often associated with lifelong special needs (Nippert et al., 2013). At least 1 
in every 15 births in South Africa is estimated to be affected by a congenital disorder 
(Malherbe, Christianson & Aldous, 2015). This means that over 18 000 new cases should be 
reported every year, but in 2012 only just over 2000 cases were reported - an  under-
reporting of 88% (Malherbe, Christianson & Aldous, 2015). Between 2008 and 2010, the 
reported percentage of under-5 year old deaths due to congenital and genetic disorders 
doubled from 4% to 8%, which is similar to figures reported in India (3% to 7%) and the 
Philippines (6% to 10%). This increase can be attributed to a reduction in deaths from 
infectious diseases and malnutrition, yet it is still believed that “poor universal clinical 
diagnostic services and inadequate surveillance and reporting systems” leads to under-
reporting of deaths due to congenital anomalies (Nippert et al., 2013).  
The burden of genetic conditions as a proportion of morbidity becomes relevant when the 
IMR reduces to below 40 in 1000 live births (Malherbe, Christianson & Aldous, 2015). In 
South Africa, with the improved access of the population to antiretroviral therapy, the IMR 
in 2014 was 33.5 per 1000 births (Malherbe, Christianson & Aldous, 2015).   
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Up to 70% of congenital diseases can be prevented, treated, or reduced in severity through 
genetic services, including prenatal screening and, for example, through the introduction of 
folic acid supplementation reducing the incidence of neural tube defects, but attending 
doctors need to recognise these conditions and know where to refer patients in order for 
this potential to be realised. Genetic services are also becoming more important with 
increased understanding of genetic contributions to common diseases such as cancer, 
cardiovascular disease, diabetes and dementia (Riesgraf et al., 2014).  
1.2.1 Genetic services in South Africa 
Genetic services in which medical geneticists and genetic counsellors work as a collaborative 
team were first officially offered in South Africa in 1974, when 15 publicly funded genetic 
nurse positions were established in centres across the country (Jenkins, 1990; Greenberg et 
al., 2012). As early as 1982, Op’t Hof stated that facilities in South Africa were too limited to 
provide genetic counselling to all prospective couples with indications such as family history, 
a child with a genetic disorder or malformation, intellectual disability, metabolic disease, 
disorders of sex development, history of miscarriages or stillbirths, teratogens and 
consanguinity. While all of these indications and psychosocial issues remain relevant today, 
the options for patients have been profoundly increased and now include carrier testing, 
preimplantation genetic diagnosis, non-invasive prenatal testing, prenatal diagnosis and next 
generation sequencing. Recently, debates around the “three-parent embryo” (for 
mitochondrial conditions) and “embryo editing” (using gene editing technologies to repair 
or alter mutated genes) have added even more complexity to the field of genetics (Albertini, 
2015). 
The first masters’ programme in genetic counselling in South Africa was introduced in the 
late 1980’s (Greenberg et al., 2012). The number of genetics posts increased gradually 
through the late 1990’s and early 2000’s (Kromberg, Sizer & Christianson, 2013) until by 2008 
there were five genetic services centres in South Africa. However, the HIV/AIDS and 
tuberculosis epidemics redirected funds and support from genetic services and thwarted 
efforts to implement policy guidelines (Kromberg, Wessels & Krause, 2013), so that 
infrastructure for primary care counselling remains undeveloped (Nippert et al., 2013).  
The GenTEE report comments that there are currently sufficient genetic training 
programmes in South Africa to train staff for medical genetic services. However, “the 
national and provincial health departments lack(ing) the will, commitment and finances to 
support this training and make posts available for those trained” (Nippert et al., 2013). 
5 
 
Diagnoses of genetic conditions need to be confirmed by skilled professionals and laboratory 
services and there is currently a lack of both of these in South Africa, despite policy guidelines 
published by the National Department of Health in 2004 recommending 20 medical 
geneticists and 80 genetic counsellors to be in posts by 2010 (Malherbe, Christianson & 
Aldous, 2015). At present, there are 8 medical geneticists and 30 genetic counsellors 
registered with the Health Professionals Council of South Africa (HPCSA) (HPCSA, 2015). 
However, only a maximum of 18 of the listed genetic counsellors are currently practising (J. 
Greenberg, pers. comm., 2015). 
In the developing countries mentioned in the GenTEE report (Argentina, Brazil, China, Egypt, 
India, Oman, the Philippines and South Africa) (Nippert et al., 2013), the lack of sufficient 
medical genetic services probably contributes to a lack of awareness by GPs about the 
availability and utility of these services, and thus there are fewer referrals to these services. 
Despite this, the WHO states that: “Cuba, Brazil, India, China and South Africa are countries 
that offer excellent examples of the utilisation of genetic technology and serves to address 
the health needs of their populations….” (WHO, 2008).  
1.2.2 Access to genetic services in South Africa 
Fairly comprehensive genetic services offering clinical, counselling and laboratory genetic 
services as well as academic training and outreach clinics are available in the public health 
system in the larger cities of Cape Town, Bloemfontein and Johannesburg, with a limited 
service available in Durban. These services are linked to the academic centres of the 
universities of Cape Town, Free State, Stellenbosch, KwaZulu Natal and Witwatersrand 
(Greenberg et al., 2012) and are available through referral from other hospitals and clinics.  
Rural communities are served through outreach visits, but these are insufficient for the 
needs of the large rural population in South Africa. Access to all forms of healthcare in rural 
areas is significantly more difficult than in urban areas due mainly to distance between clinics 
and lack of money for transport, and this is true of genetic services too. The limited 
accessibility and scope of health care facilities in rural areas has an impact on how rural 
doctors feel about genetics and genetic services. However, the fact that patients in rural 
areas are more reliant on primary care doctors for referral to genetic services means that it 
is even more important for these physicians to have the knowledge to be able to refer to 
genetic services when necessary (Marathe et al., 2015). 
A small number of wealthier patients can be seen in the private sector, where several genetic 
counsellors have small practices with the support of academic centres (HPCSA, 2015, 
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Kromberg, Wessels & Krause, 2013). However, at a meeting of Genetic Counselling South 
Africa (GCSA) in 2011, counsellors in private practice reported that they were not very busy. 
This does seem to be improving slowly with more awareness by some doctors, particularly 
after efforts are made to include genetics education in professional meetings (pers. comm., 
Frieda Loubser, 2015). 
Bidondo et al. (2015) suggested several strategies for addressing birth defects from the 
public health perspective in Argentina, a developing country with many similarities to South 
Africa. Among these were to address the perception that, due to the need for technology, 
research and genomics, medical genetics is a service for highly developed countries only, 
and, secondly, to develop genetic training programmes for health professionals at all levels 
with an emphasis on primary care. Similarly to South Africa, Argentina has insufficient 
genetic services available for the population and services are unevenly spread through the 
population and among different disorders e.g. in South Africa special services exist for neural 
tubes defects but not for Down syndrome (Nippert et al., 2013). A suggestion to attach 
trained genetic counsellors to groups of GPs or specialist clinics in towns and cities which 
currently have no genetic services would help to raise awareness of genetics and the unique 
skills that genetic counsellors possess by both the medical professionals and the lay public 
(Greenberg et al., 2012). 
1.4 Referral to genetic services by doctors 
According to the WHO in 2008, a functioning public health care system requires an 
appropriate referral system to specialised services (e.g. genetic services) if needed. 
Consequently, patients in South Africa are unable to access genetic services directly, as these 
services are found in the tertiary healthcare sector. A GP’s ability to recognise genetic 
conditions and refer to appropriate specialists is thus crucial and requires basic knowledge 
of genetic conditions as well as the benefits and availability of genetic services (Marathe et 
al., 2015).  However, in South Africa, there is little use of genetic services by medical 
professionals working outside academic hospitals, and patients who would benefit from 
these services might not gain access to them because they are not referred by their doctors 
(Greenberg et al., 2012). 
Despite the fact that up to 15% of a GP’s consultations are said to involve genetic conditions 
(Hopkins, 2007), several studies worldwide have shown that a large number of GPs have 
never referred patients to genetic services and that there are several barriers to referral. The 
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most commonly cited reason for not referring patients to genetic services is lack of 
knowledge, both of conditions and of availability of services. 
In a survey in the Netherlands, Baars, Henneman & ten Kate (2005) found many doctors did 
not refer patients for genetic counselling due to a lack of knowledge about genetics and 
genetic testing. A previous study (Aalfs et al., 2003) in the Netherlands indicated that 29% of 
GPs had never referred a patient for genetic counselling. Of the remainder, 40% of referrals 
had been initiated by the patient. Similarly, Claybrook et al. (2010), found that only half of 
oncologists surveyed in Indiana had referred patients with colorectal cancer to genetic 
services. Reasons cited for not referring patients included lack of appropriate patients, lack 
of information about genetic services and lack of knowledge about which patients should be 
referred. These studies are further supported by a recent investigation in Columbia, where 
doctors working in genetic clinics reported that education and training in genetics in medical 
schools were inadequate, and that medical practitioners did not know enough to be able to 
refer appropriately to a genetic service (Rodas-Perez et al., 2015). This report also cited 
absence of training in communication skills and the influence of religious beliefs as barriers 
to referral by some colleagues. Tan & Fitzgerald (2014) working in Australia, surveyed GPs 
and specialists on their referrals to genetic services for Lynch syndrome (hereditary colon 
cancer) and found three main barriers: 1) the clinical knowledge of the physicians, including 
which patients are eligible for services and lack of time and skills to collect family histories; 
2) the patients’ experiences, interest in genetic services and knowledge of family history and 
3) organizational issues including cost and access to services, referral guidelines and referral 
pathways. These authors suggested developing supportive tools for physicians.   
The same factors were recognised in a review of nine studies (Delikurt et al., 2015), mostly 
from America but including Australia and the Netherlands, which described six barriers to 
referral to genetic services by non-genetic healthcare professionals:  
i) lack of awareness of patient risk factors,  
ii) failure to obtain family history,  
iii) lack of knowledge of genetics and genetic conditions,  
iv) lack of awareness of genetic services,  
v) inadequate coordination of referral, 
vi) lack of genetics workforce.  
Another recent review (Mikat-Stevens, Larson & Tarini, 2014) classified barriers across four 
themes:  
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i) knowledge and skills,  
ii) ethical, legal and social implications (e.g. genetic discrimination),  
iii) healthcare systems  
iv) scientific evidence.  
This review also mentioned patient anxiety and lack of time as barriers to referral.  
In South Africa, Kromberg, Sizer & Christianson (2013) included financial, geographical, 
cultural and political barriers in the list. However, geographical and financial barriers do not 
necessarily stop people from travelling to use genetic services if they know that they need 
them and where to find them, and this information would usually be offered by their primary 
care providers. Furthermore, most genetic services clinics offer an outreach programme for 
rural areas (J. Greenberg, pers. comm. 2012). Geographical and financial barriers to use of 
genetic services are also mentioned in a study in Columbia where genetic services are not 
covered by health insurance (Rodas-Perez et al., 2015). 
Sometimes, patients are more aware of their need for genetic services than doctors. In 2010, 
the National Society of Genetic Counsellors (NSGC) in America (quoted in Riesgraf et al., 
2014), claimed that about 50% of genetic counselling clients are self-referred. This implies 
that doctors do not always recognise when a client should be referred to genetic services 
and the system of referral to state services, via tertiary institutions, may not be optimal at 
this point for patient needs. In another example from Pakistan, 53% of couples self-referred 
for prenatal genetic counselling and only 44% were referred by their doctors (Afroze & Jehan, 
2014). The self-referrals were mostly seeking information on family history or risks for future 
pregnancies. The authors attributed the lack of referral to unawareness by doctors and lack 
of service integration. Once again, genetic education for doctors is proposed as part of the 
solution.  
In South Africa, the general public’s lack of knowledge about genetic services, as well as 
cultural beliefs regarding genetic conditions, create further barriers to the use of these 
services and self-referrals are less frequent (Kromberg, Sizer & Christianson, 2013). 
Anecdotal evidence collected by the author suggests that even people with tertiary 
education do not understand what genetic counselling entails. Once they are better 
informed, many of them say that they themselves, or someone that they know, could have 
used the service. Again, anecdotally, the few people that the author has met who have used 
counselling services have struggled to find them in the private sector and usually their 
medical service providers have been unable to help them to locate a genetic counsellor. This 
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observation is also mentioned in Doyle et al.’s 2015 paper where it was mentioned that 
“genetic counsellors are a less visible, less explicit component ….simply because, being a 
relatively new profession, there are not enough practising genetic counsellors to be able to 
demonstrate broad utility.” This is further borne out by Delikurt et al. (2015) who 
summarised barriers to individual use of genetic services as lack of awareness of personal 
risk, lack of knowledge and/or awareness of medical history of family members and lack of 
knowledge of genetic services. 
The importance of raising awareness of genetics by doctors was illustrated in a survey done 
at a conference on genetic testing in South Africa. While fewer than 50% of these doctors 
had requested a genetic test previously, more than 75% indicated that they intended doing 
so after the conference (Vogel et al., 2011).  
1.5 Medical doctors’ knowledge of genetics  
Adequate knowledge of genetic conditions is necessary for diagnosis and/or appropriate 
referral to genetic services by doctors. Furthermore, while specialised genetic services are 
essential for complete care, genetic and genomic information is increasingly being used 
across healthcare disciplines and thus all health professionals should have a basic working 
knowledge of genetics (Seven et al., 2015). 
It has been suggested that many GPs are “confidently incompetent” (they do not know what 
they do not know) in their knowledge of genetics (Hapgood et al., 2002, cited in Hopkins, 
2007). However, many other studies have shown that GPs feel they lack the skills and 
knowledge to deal with patient queries about genetic conditions in practice and are thus fully 
aware of their incompetence in genetics (Aalfs et al., 2003; Barbero et al., 2003; Bernhard et 
al., 2005; de Abrew, Dissanayake & Korf, 2014; Klitzman et al., 2013; Marathe et al., 2015; 
Rodas-Perez et al., 2015; Trivers et al., 2011). These studies have been conducted worldwide 
on health professionals’ knowledge of genetic conditions, with most indicating that their 
knowledge of genetics is very limited, is perceived as not clinically relevant and does not 
cover the complex psychosocial and ethical issues raised by genetic conditions, and that this 
impacts on the quality of care of patients (de Abrew, Dissanayake & Korf, 2014).  
For example, in the USA in 2013, Klitzman et al. (2013) found that, of 220 physicians 
surveyed, 73.7% and 87.1% respectively rated their knowledge of genetics and genetic 
testing as very or somewhat poor. These figures have remained static over the last decade. 
GPs in the Netherlands also felt that their level of genetic knowledge was limited (Aalfs et 
al., 2003). Barbero et al. (2003) found that health professionals in Argentina had little 
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knowledge of medical genetics. In Maryland, USA  only 10% of obstetric patients with at least 
one indication for genetic counselling were referred to genetic counselling clinics and 
insufficient information was given to the patients on what to expect from the counselling 
service (Bernhard et al., 2005). Another study in the United States found that doctors 
inaccurately estimated risk for BRCA1/2 mutations and thus referred too many low risk and 
too few high risk patients to genetic services (Trivers et al., 2011). Van Wyk (2008) found 
similar gaps in Johannesburg GPs’ understanding of cancer genetics. Finally, research in 
Tasmania showed that GPs managing genetic cardiac disease are reliant on information from 
cardiologists for information on the condition itself, as well as whether or not to refer 
patients for genetic counselling (Marathe et al., 2015).  
In contrast, Wonkam, Njamnshi & Angwafo (2006) and Abdolahi et al. (2014) found that 
doctors in Cameroon and Iran respectively demonstrate an adequate level of clinical genetic 
knowledge and the need for genetic services although doctors in Cameroon are largely 
unaware of DNA diagnostic tests. 
Despite the majority of studies described above recounting a self-reported lack of knowledge 
on genetics by medical doctors, Kumar & Gantley (1999) reported that GPs felt that they 
would be able to integrate genetic technology into their work with little adaptation. 
However, at the same time, many studies show that doctors themselves feel that they need 
better training in genetic conditions, how to access genetic services and when to refer 
patients to services (Baars, Henneman & ten Kate, 2005; Tan & Fitzgerald, 2014; Tan, Spurdle 
& Obermair, 2014). 
1.6 Doctors’ education in genetics 
Knowledge and education are inextricably linked, and many of the studies investigating the 
genetic knowledge of doctors recommend that improved education of doctors in genetics is 
the major factor that will influence better understanding and awareness of genetics, and 
more appropriate use of genetic services (Baars, Henneman & ten Kate, 2005; de Abrew, 
Dissanayake & Korf, 2014; Klitzman et al., 2013; Rodas-Perez et al., 2015; Tan & Fitzgerald, 
2014; Tan, Spurdle & Obermair, 2014; Trivers et al., 2011; Wonkam, Njamnshi & Angwafo, 
2006). Greenberg et al. (2012), discussing the challenges faced by the genetic counselling 
profession in South Africa, indicate that education is key to both medical and lay people using 
services. They state: “If the health professionals were better informed, they would refer a 
wider range of patients, more people would benefit…..and counsellors could expand their 
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expertise…” i.e. Better understanding of genetic conditions would lead to more demand for 
services.   
More and better structured training in genetics is required at medical schools, as many GPs 
feel that their genetic education has been insufficient even though they recognise the 
importance of genetics for their work (Burke et al., 2009; Rodas-Perez et al., 2015). 
Furthermore, with the amount of genetic knowledge increasing at such a fast rate (Burke et 
al., 2010), it would be impossible for undergraduate training to provide sufficient genetic 
education for medical doctors, and this education should be supplemented by continuing 
medical education (CME) or continuing professional development (CPD) once these doctors 
are practising. South African doctors are obliged by the HPCSA to maintain their professional 
status through obtaining CME points and this is an ideal platform for improving their 
understanding of genetics (Pather, 2006). Postgraduate education in genetics is also 
important as even medical specialities recognise that they are limited in their knowledge, 
awareness and understanding of genetics (Pather, 2006; Rodas-Perez et al., 2015).  
Even prior to the completion of the Human Genome Project, Hunter et al. (1998) commented 
that genetic education about services, conditions, testing and implications for the patient 
and family would become very important in the future with the expansion of genetic 
knowledge, for both patients and clinicians. This need for “genetically literate” doctors has 
been emphasized by several authors (Feero et al., 2014 cited in  de Abrew, Dissanayake & 
Korf, 2014; Wonkam, Njamnshi & Angwafo, 2006) discussing how medical education needs 
to adapt to the rapid rate of knowledge acquisition, especially as more genetic testing 
becomes available. 
In South Africa, basic training of health care professionals, particularly nurses, occurs from 
primary health care level through to tertiary settings, while other medical professionals such 
as physiotherapists, occupational therapists and medical doctors receive limited 
undergraduate teaching, with only four medical schools (University of Cape Town, University 
of the Witwatersrand, University of the Orange Free State and University of Stellenbosch) 
employing medical geneticists and integrating medical genetics into undergraduate student 
curricula (Nippert et al., 2013). Limited medical genetics is also taught at three other 
universities, but teaching is usually done by non-genetic specialists such as paediatricians. 
The GenTEE report assumes that this unsatisfactory undergraduate medical training results 
means that most physicians in South Africa “do not recognize the genetic basis of diseases 
of their patients, do not know how to refer to genetic services, if available, and do not give 
due importance to genetic counselling” (Nippert et al., 2013). 
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A review group in the UK identified several desired outcomes for training of undergraduate 
doctors in genetics (Burke et al., 2009). These were: 
i) the ability to identify patients with genetic conditions, with 
understanding of inheritance patterns and basic genetics; 
ii) the ability to manage patients with genetic conditions; 
iii) the ability to appropriately refer patients with genetic conditions; 
iv) the ability to access information on genetics 
v) the ability to understand the uses and limitations  of different genetic 
tests, and ethical issues associated with genetic testing; 
vi) the ability to discuss genetic information with patients. 
This group also identified 17 genetic conditions that doctors should be able to identify and 
manage. These included chromosomal conditions (e.g. Down syndrome), common single 
gene disorders (e.g. haemophilia,) common disorders with a genetic component (e.g. 
Alzheimer’s disease) and familial cancers. Core competencies in genetics for nurses have also 
been described and they include outcomes i), iii), v) and vi) above and add the skills of taking 
family histories and drawing pedigrees, which would be valuable for doctors too (Seven et 
al., 2015). 
Recently, a group in Texas implemented a medical genetics programme for their paediatric 
residents, since they felt that genetic training had been deficient in primary care residents. 
This programme had three main outcomes, indicating the effectiveness of a well-structured 
educational programme (Nguyen et al., 2015):  
i) learning opportunities were provided in a variety of settings, and the trainees said 
it was “the most educational rotation” that they experienced;  
ii)  an increase in trainee confidence and clinical competence;   
iii) increased awareness and appreciation for multidisciplinary relationships, in 
particular for genetic counsellors. 
 
1.7 Family doctors as gatekeepers for genetic services 
Family physicians (or GPs) provide comprehensive, holistic care for patients of all ages with 
all conditions (Hopkins, 2007; Abdolahi et al., 2014) and are often the first point of screening 
for early signs of serious conditions. The relationship of a family physician with a family, as 
well as their continued involvement in patient care and long-term management of chronic 
and complicated conditions means that these clinicians are familiar with health history and 
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healthcare needs in families (Hopkins, 2007) and may be able to identify individuals and 
families for whom genetic testing could be helpful (Burke et al., 2009) e.g. detecting single 
gene disorders such as hypercholesterolaemia or inherited cardiomyopathies could identify 
asymptomatic family members who would benefit from prophylactic treatment. However, 
in the public health system in South Africa, particularly in the Community Health Clinics, the 
role of a GP in continuing health care is less apparent as doctors often rotate duties (Masters, 
2010). Up to 15% of GP consultations are believed to involve genetics, but this may be an 
underestimate when including queries such as stature, familial baldness, family history of 
cancer and drug responses (Hopkins, 2007).  
A directed family history is the first important tool for screening for genetic conditions, and 
family physicians are in the unique position of being able to take a comprehensive family 
history which could indicate referral to genetic services. However, these doctors do not have 
the time or the knowledge for comprehensive genetic consultations and counselling during 
their short contact times with patients. Recommendations for primary care geneticists, that 
could reduce the load on overloaded tertiary centres, have been made in the United 
Kingdom, but this has not been accepted as a viable option as support structures and 
evidence for cost savings are not available (Hopkins, 2007). Similarly, by the 1990s, the 
National Department of Health in South Africa had realised the need for more widespread 
genetic services and set up policy guidelines which supported trying to offer medical genetic 
services including counselling services to the public through primary care but these policies 
have also not been implemented (Nippert et al., 2013). 
Since South Africa is a developing and diverse country, its genetic services requirements may 
differ from those of developed countries, but studies done in Johannesburg (Kromberg & 
Berkowitz, 1986) and in Queensland (Kromberg, Parkes & Taylor, 2006) found that GPs were 
the second largest referral source of clients to genetic services and recommended further 
genetic education for them. 
1.7 Unique roles and skills of genetic counsellors 
A study in Columbia (Rodas-Perez et al., 2015) found that doctors working in medical genetics 
did not believe that other health professionals could work as genetic counsellors, 
emphasising the specialist nature of this field. However, as far as this researcher can 
ascertain, no studies have been done in South Africa on what medical doctors working 
outside of genetics understand about the roles of genetic counsellors and how they can 
improve delivery of health services.  
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Genetic counselling is a relatively new profession, first practiced in the 1970s (Harper, 2010) 
and gradually gaining in popularity since then. Genetic counsellors’ roles have evolved since 
1971, and they now see clients in many different areas (Uhlmann, Schuette & Yashar, 2009). 
Initially, they were supportive of paediatric geneticists and helped with family histories, 
researching genetic conditions, explaining genetic concepts to families and supporting 
families emotionally. Nowadays, while the traditional skills are still very important, genetic 
counsellors also work in a variety of clinical settings, including paediatrics, neurogenetics and 
cancer genetics, and in diverse fields like pharmacogenomics (looking at individual variations 
in drug response), bioinformatics, diagnostic laboratories (advising on appropriate use of 
genetic tests), research development, and public health and policy settings, often as part of 
a multidisciplinary team in specialist units in these diverse settings (Doyle et al., 2015; Skirton 
et al., 2014). 
Fulfilling these roles requires a unique set of skills, all of which are not usually part of a 
doctor’s skills (Doyle et al., 2015), and which Uhlmann, Schuette & Yashar (2009) classed into 
four domains:  
i) communication skills (written and verbal);  
ii) critical thinking skills (evaluating and presenting risks through analysing 
information);  
iii) interpersonal, counselling and psychosocial assessment skills;  
iv) professional and ethical values.  
A review by Skirton et al. (2014) suggested that genetic counsellors undertake a significant 
workload in direct patient care and there should be more use of genetic counsellors in 
countries where they are underutilised.  
In South Africa, genetic counsellors play several other roles beyond counselling (Kromberg, 
Wessels & Krause, 2013). These include teaching, research, marketing, public engagement 
and administration. Counsellors themselves suggested that more marketing of the 
profession is needed, more education should be provided and more referrals sought in order 
for the profession to grow and reach its potential (Kromberg, Wessels & Krause, 2013).  
1.8 Medical genetics in the future 
New technologies such as next generation sequencing and CRISPR (clustered regularly 
interspaced short palindromic repeats), as well as the field of pharmacogenomics and the 
increasing recognition of personalised healthcare, are all easily accessible to the public 
through the internet and, increasingly, social media (Riesgraf et al., 2014). 
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Pharmacogenomics, particularly, is a field that will have impact on general practice in future, 
as more and more drug metabolism pathways are associated with single nucleotide 
polymorphisms (SNPs), with implications for drug dosage regimens (Walter & Emory, 2012). 
As the public becomes more aware of these advances, there will be a greater need for genetic 
services to help the public to understand their utility, creating the need for public health 
genomics policies and for medical doctors to be able to answer queries about genomics from 
their patients. The Bellagio statement (Boccia & Zimmern, 2015) defined public health 
genomics as “the responsible and effective translation of genome-based knowledge and 
technologies into public policy and health services for the benefit of population health.” 
Whereas previously, cost and time meant that only one gene could be tested at a time, the 
advent of massively parallel rapid gene sequencing means that many genes can be 
sequenced at one time, at much reduced cost. At present, sequencing is of limited clinical 
utility because of the uncertain implications of the many variants of unknown significance 
being discovered. However, as this information begins to complement clinical knowledge, 
future integration into clinical practice is probably inevitable (Vassy et al., 2015). Since June 
2013, when Angelina Jolie disclosed her BRCA 1 positive status, and when the United States 
Supreme Court ruled that genes could not be patented (Borzekowski et al., 2013), public 
awareness and demand for genetic testing has been vastly increased, especially in the First 
World. A study done in America  found that referrals for BRCA testing increased by 85% 
following the release of Jolie’s results, with an increase of 107% in the number of identified 
BRCA1/2 carriers, which implied that the referrals were appropriately identified. The authors 
identified the challenge of meeting increased demand for genetic services including 
screening, counselling, testing and preventive surgery (Raphael et al., 2015). While it is 
recommended that multigene panel testing is accompanied by genetic counselling to explain 
the nature of variants of unknown significance and the implications of the testing itself, in 
reality the consumer-driven nature of the testing and the fact that testing is offered direct 
to the consumer via the internet means that these ethical issues are not often covered and 
the value of these tests in improving risk assessment, early detection and prevention, 
particularly in oncology, has not been realised. Kurlan & Ford (2015) recommend research 
on the effectiveness of clinician-patient communication and healthcare delivery systems 
required for panel testing, with an emphasis on access and ethics and Klitzman et al. (2013) 
stated that it is crucial to understand knowledge, attitudes and practices of doctors regarding 
genetic testing as it becomes more extensive and increasingly available. 
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In 1960, only 700 inherited conditions were recognised, by 1980, 3000 single gene disorders 
were categorised (Op’t Hof, 1982) and now over 10 000 disease causing genes are listed in 
the gene card database (Weizmann Institute of Science, 2014). In the near future, the ready 
availability of genomic sequencing will mean that, in order to fulfil the imperative to “do no 
harm”, multigene panels will need to be carefully selected and tailored to each patient 
(Kurlan & Ford, 2015), so that patients without risk factors aren’t screened unnecessarily, 
patients understand what is being tested, and so that they receive the necessary advice 
about screening and prevention strategies.  
Adding to the availability of clinically useful genetic tests, a range of direct-to-consumer 
(DTC) genetic tests can now be purchased online via the Internet. Some of these tests offer 
health-related products including susceptibility testing for common diseases such as cancers 
and diabetes, as well as pharmacogenomics testing. Some of these tests are available 
without consultation with a physician, although all recommend pre- and post-test genetic 
counselling, and some are only available through a medical doctor. In a review article 
(Goldsmith et al., 2013) up to 65% of primary care doctors were not aware of DTC testing, 
and up to 85% did not feel qualified to interpret the results of a DTC test. This article also 
mentioned the need for improved education of doctors, not only in genetics but also in 
personal genomics. 
The current genetic workforce is understaffed, even in developed countries such as the USA, 
and Kurlan & Ford (2015), commenting on the availability of multigene panels, recommend 
a “social investment” in training for genomics and social medicine, both of genetic 
counsellors and clinicians so that recommended referral to expert clinicians for test 
selection, pre- and post-test counselling can occur “whenever possible.”  
1.9 Motivation for research 
The idea for this study was borne out of frustration with the lack of genetic counselling posts 
in South Africa. Several studies have indicated that health professionals have poor 
understanding of genetics and genetic conditions, and this lack of insight extends to 
knowledge of genetic services and how and when to access them, and means that people 
may not be referred appropriately to genetic services (Delikurt et al., 2015). No previous 
studies have addressed these issues in South Africa.  
Several studies worldwide (e.g. Aalfs et al., 2003; Baars, Henneman & ten Kate, 2005; 
Barbero et al., 2003; Claybrook et al., 2010; Freedman et al., 2003; Hunter et al., 1998; 
Klitzman et al., 2013) and two in South Africa (van Wyk, 2008; Vogel et al., 2011) have 
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evaluated doctors’ knowledge and attitudes1 to aspects of genetics. This study will cover a 
broader range of doctors’ genetic knowledge and education and also investigate their 
opinions on genetic services in an attempt to understand what factors affect use of genetic 
services by doctors in South Africa.  
In achieving this goal, it is hoped that awareness of genetic counselling and genetic services 
is raised among doctors. By addressing issues identified in the study, genetic services could 
respond to non-genetic doctors’ needs and referral to genetic services could become more 
frequent. Ultimately, this knowledge could be used to gain insight into how genetics can be 
integrated into medical care by doctors.  
The information obtained here could also be used to develop new academic curricula for 
basic and clinical genetics at medical schools, as well as a CPD programme for further 
genetics education of doctors. 
Finally, the answers obtained from doctors to the survey may encourage the South African 
Department of Health to implement the policy guidelines that are currently being updated 
for the broadening of genetic services in South Africa.  
However, the study is limited by small numbers and will be cautious in extrapolating findings 
to the general GP or family practitioner population. Further research will be needed to verify 
findings. 
1.9.1 Aims 
The aim of this study was to assess general practitioners’ knowledge and attitudes towards 
genetics and genetic services in South Africa, and to understand what factors play a role in 
referral to genetic services. 
1.9.2   Objectives 
1. To determine whether doctors have referred previously to genetic services and 
whether they intend to do so in future.  
2. To determine what factors relate to doctors’ use of genetic services.  
                                                          
1 The word “attitudes” as used in this dissertation refers to the doctor’s opinions towards aspects of 
genetics, genetic services and genomics.  This study does not explore attitudes from a psychological 
or social science perspective. 
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3. To investigate how much genetics education doctors have received in undergraduate 
studies and as postgraduates, the form of this education and what sort of education 
they would like in future. 
4. To explore what doctors know about genetics, genetic conditions, genomics, and 
ethical issues of testing children. 
5. To explore doctors’ understanding of the value of genetic services.  
6. To explore doctors’ opinions about the roles of genetic counsellors.  
7. To investigate what doctors think they need from genetic services in South Africa. 
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2 METHODS 
The major research questions asked in this study were: 
1. What do doctors know about genetics and genetic services in South Africa? 
2. What factors affect doctors’ referral to genetic services in South Africa?  
The study attempts to explore these factors by asking several open-ended questions to 
inform the quantitative answers obtained from the survey. 
This chapter describes the participants and methods used to conduct this research. It 
includes design, participants, instrumentation, ethics considerations and data analysis of the 
study. 
2.1 Study design 
This descriptive cross-sectional survey uses a structured questionnaire with closed- and 
open-ended questions. This type of survey is described by Sandelowski (2000: 337) as 
“especially amenable to obtaining straight and largely unadorned (i.e., minimally theorized 
or otherwise transformed…) answers to questions of special relevance to practitioners and 
policy makers” and is thus well suited to this study which seeks to understand what GPs  
know about genetics and genetic services, what factors are associated with the use of genetic 
services by GPs in South Africa, and how the use of these services by GPs could be improved. 
The advantages of this type of study include greater validity of data and ensuring that 
questions are answered from different perspectives (Sandelowski, 2000).  
The quantitative component of this study provided possible associations between referral 
patterns, demographics, education and knowledge of the participants. However, the 
information gained from quantitative surveys is constrained by what has not been asked as 
all variables are not known (Kearns, 1992). The addition of open-ended questions to describe 
the answers to quantitative questions seeks to include some of these unknown variables. 
Qualitative methods are designed to answer questions from the perspective of the subjects 
experiencing a particular phenomenon (Vaismoradi, Turenen & Bondas, 2013), and in this 
study, open ended questions were asked to attempt to understand doctors’ attitudes to 
genetics and to inform the quantitative answers by asking doctors to explain their responses.  
2.2 Study participants 
The 5-day annual University of Cape Town Division of Family Medicine Conference of General 
Practitioners, was held from 19 to 23 January in 2015 at the River Club in Cape Town, and is 
open to all doctors in South Africa. A wide range of interested physicians are invited to attend 
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every year (www.uct.ac.za/calendar/events). The 2015 Programme included 
Ophthalmology, Pharmaco-Therapeutics, Bioethics (which included talks about genetics), a 
section on the Future of Medicine, talks on Cardiology, Rheumatology, Gynaecology, 
Geriatrics and Dermatology, thus doctors practising in a variety of fields as well as general 
practice were expected to attend the conference. Doctors could choose which sessions to 
attend, but most were present for the whole conference. 
The sample was chosen for convenience as this was an easy method of obtaining a relatively 
large and diverse group of GPs in one area at one time. Since all doctors could attend and 
would obtain CME points for attendance, the sample was assumed to be reasonably 
representative despite its small size relative to the larger population of doctors practicing in 
South Africa. In this study, the term “family doctors” will indicate both general practitioners 
(GPs) and family physicians. In South Africa, family physicians are required to hold a MBChB 
and a MMed in Family Medicine whereas GPs only need a MBChB in order to practise. 
However, this study is mainly concerned with physicians (also called clinicians or doctors) 
working in primary health care, whether they are qualified as family physicians or as GPs and 
since the conference stipulated “General Practitioners” in its title, it could be assumed the 
doctors were working as GPs. General practitioners work in a wide range of areas, from 
private to public, urban to rural (Masters, 2010). The participating doctors came from 
different regions in South Africa and two indicated that they practised in other countries 
(Zimbabwe and Ireland) as well as doing limited work in South Africa. 
The study population was considered appropriate for answering the research question, as 
GPs are commonly involved in primary care and are the most likely health professionals to 
identify conditions in their patients requiring referral to specialist services, including 
genetics.  
As an incentive to participate, they were offered the chance to be included in a lucky draw 
for a two night stay in a holiday flat in Cape Town.  
2.3 Research instrumentation  
The research instrument was a structured questionnaire generated on Google Forms, which 
allowed an Internet-based survey to be available, as well as a printed survey to be distributed 
at the conference. The internet survey was used by one respondent in the pilot study. 
Data was collected using the self-administered structured survey that was designed to 
investigate GPs’ genetic education, knowledge of genetics, and attitudes to genetic services, 
as well as demographic factors and how these issues relate to patient referral patterns to 
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genetic services. Survey content was informed by a review of current published literature on 
knowledge and attitudes of doctors to genetics and genetic services, as well as by questions 
that would help to answer the research question.  Several questions were adapted from 
previously published papers and these are cited below (section 2.3.2). 
The language of the survey was English, and this was appropriate as the conference was 
conducted in English, most medical information is available in English and it could be 
assumed that conference delegates were proficient enough in English to complete the survey 
instrument. 
Christensen et al. (2013) listed the following advantages of self-administered, structured 
surveys:  
i) self-administered questionnaires are cost- and time-effective, as large numbers 
of responses can be obtained without expending time on individual face-to-face 
or telephonic interviews. However, face-to face interviews are known to have 
higher response rates, possibly due to the motivating physical presence of an 
interviewer. This was offset in this case by the economic and time restraints of 
this project, which had to be completed in a few months with a limited budget. 
While lower levels of non-response are considered to be an indicator of quality, 
it is not known what bias is introduced by non-respondents to surveys; 
ii) answers to self-administered surveys tend to be of higher quality than answers 
from face-to-face interviews, particularly with sensitive questions, due to the 
phenomenon of social desirability bias. In this survey, respondents were more 
likely to be honest about their assessment of their own knowledge of genetics 
and whether or not they thought genetic services are valuable, if they believed 
that their answers were anonymous, particularly if their knowledge was thought 
to be inadequate or if they held negative stances about genetic services. Factual 
answers tend to show no difference between self-administered and face-to-face 
survey modes.  
iii) paper based surveys also allow respondents to be more free in their answers and 
to add comments wherever they feel it is appropriate, thus allowing participants 
to comment on aspects about which they feel strongly and allowing for a richer 
analysis of the content; 
iv) individuals with higher education levels have been associated with an increase 
in response rate to all modes of surveys. The participants in this survey were all 
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medical doctors attending an English conference, so it was expected that they 
were all highly educated. 
Further advantages to using the paper-based survey was the ease of distribution at the 
conference. This format and venue also made it more likely that respondents would answer 
from their own knowledge and not try to search online or through other medical references 
for correct answers to knowledge questions. This survey could be distributed to future 
cohorts without influencing the quality of the data collected. 
Disadvantages of self-administered questionnaires include:   
i) a lower response rate, both to the overall survey and to individual items in a 
questionnaire, probably due to the lack of interviewer motivation;  
ii) visualisation of items of scale may influence responders to choose less extreme 
answers than they would if they were asked face-to-face;  
iii) as mentioned above it is also well known that there is an inherent bias in all 
modes of survey, because it is not known what factors differ between non-
respondent and respondent characteristics; 
iv) since time available is restricted, recall bias can be a problem with all types of  
surveys, particularly self-administered surveys, as there is no way of prompting 
memory with probing questions as is sometimes done in face-to-face or 
telephone interviews. However, only three questions in this survey relied on 
recall – two on use of genetic services, and one on conditions seen in practice 
(Christensen et al., 2013). 
2.3.1 Information sheet and informed consent  (Appendix A) 
An information sheet and informed consent form were attached to the front of the 
questionnaire (Appendix A). The information sheet explained the purpose of the survey, that 
it consisted of 41 questions that would take less than 20 minutes to complete, and asked the 
doctors to complete the questionnaire as fully as possible. It also mentioned that we were 
interested in the doctors’ working knowledge of genetics, as well as their exposure to 
genetics and experience in practice. Contact details of the researcher and supervisor were 
included on the cover page, which the respondents were encouraged to remove and keep. 
It also described the lucky draw.  
The informed consent sheet requested participants to sign consent to fill in the survey and 
asked them to email the researcher if they wanted access to the online version of the 
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questionnaire. Furthermore, there was a section asking respondents to indicate whether or 
not they would like feedback on the study results.  
2.3.2 Questionnaire  
The final survey consisted of five sections containing 41 questions altogether (Appendix B). 
Questions were asked in various forms, including questions with multiple choice answers, 
ranked answers using a Likert scale and short answer questions, allowing the collection of 
both qualitative and quantitative data.  
The sections were as follows: 
Section 1 consisted of three initial questions relating to patient referral to genetic services. 
The questions asked whether the doctor had previously referred patients to genetic services, 
whether they thought they would refer to genetic services in future, and whether they knew 
how to access genetic services in South Africa. 
Section 2 contained eight demographic questions. Demographic information included field 
of practice, age, educational qualifications and year of graduation, gender, location of 
practice, years in practice and specific fields of interest. Questions in this section were 
informed by previously published literature (Baars, Henneman & ten Kate, 2005; Klitzman et 
al., 2013; Tan, Spurdle & Obermair, 2014). 
Section 3 asked questions on education and knowledge. The four questions on education 
included amount and form of genetics education during undergraduate studies and since 
graduation. The sub-section on knowledge comprised 12 questions. These were:  
i) A Likert scale of self-reported confidence in knowledge of genetics on a scale of 1 to 
5 from not confident to very confident. The Likert scale is used as a measure of 
attitude (Boone & Boone, 2012);    
ii) A table asking doctors to fill in genetic conditions that they had seen in their practice, 
and then answer questions on mode of inheritance, whether or not a genetic test is 
available and whether or not the condition would have a significant impact on life. 
This question was adapted from a similar question by Wonkam, Njamnshi & Angwafo 
(2006).  
iii) A table pre-populated with 10 inherited and congenital conditions and asking about 
the doctors’ experience with the conditions, the availability of metabolic, genetic, 
carrier and predictive testing, and whether or not other family members are at risk). 
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This question was adapted from similar questions in papers published by Baars, 
Henneman & ten Kate (2005) and Seven, et al. (2015).  
iv) A checklist question on how prenatal conditions are diagnosed.  
v) A series of four questions on inherited breast cancer.  
vi) To assess knowledge of genomics and new technologies, three questions were asked 
about DTC testing.  
vii) A multiple choice question on the ethics of testing children under the age of 18 was 
included in this section.  
Section 4 asked 14 questions about genetic services and included several open-ended 
questions which targeted general practitioners’ perceptions of and attitudes to genetic 
services. Questions in this section included: 
i) which medical professionals should refer to genetic services; 
ii) roles of genetic counsellors; 
iii) three questions adapted from Wonkam, Njamnshi & Angwafo (2006) about the 
value of genetic services and genetic counselling; 
iv) a question about further genetic education needs;  
v) two questions about access to genetic services; 
vi) a question on what needs doctors have from genetic services  
Three questions were asked about doctors’ knowledge and attitudes about genomics in 
Section 5. These included:  
i) an open-ended question asking what the respondent would do if a patient 
approached them with results from a DTC genetic test;   
ii) how we can make genomics more accessible to clinicians in South Africa; 
iii) whether pharmacogenomics will have an impact on prescribing medications in 
future. 
The last question in the questionnaire was an open-ended question asking whether the 
genetics section on the last day of the conference had changed the respondents’ answers in 
any way. 
2.3.3 Pilot study 
Prior to the conference, a pilot draft of the survey was sent to 10 family doctors practising in 
Cape Town. Five paper surveys were delivered to a local family practice and five internet 
surveys were sent to doctors involved in problem based learning facilitation at the University 
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of Cape Town Faculty of Health Sciences. Only two replies were received, one paper survey 
from the family practice and one internet survey from a problem based learning facilitator. 
The following changes were made to the questionnaire:  
i. Typesetting errors were amended;   
ii. Question 15 was duplicated in the pilot questionnaire. The duplicate question was 
removed and all questions after 15 were re-numbered; 
iii. Originally, question 17 asked doctors to list 5 genetic conditions they had seen in 
practice and then refer back to these conditions to answer a series of questions 
about each. This question was tabulated in the final questionnaire as a more practical 
way to answer this question. 
iv. Similarly, in the pilot survey, question 18 was a series of 10 (18 a. to j.) checkbox 
questions asking “What experience have you had with (name of condition)?” with 9 
possible answers. This was also tabulated for practicality. 
v. The final question to be answered after the genetics session at the conference was 
not included in the pilot survey. 
2.4 Ethical considerations 
Ethics approval was obtained from the UCT Human Research Ethics Committee (HREC/REF:  
812/2014) before starting data collection. An information sheet and consent form were 
attached to the front of the survey (Appendix A). Participants signed consent to participate 
in the survey. Since they are medical doctors, it was expected that the participants had a high 
level of reading comprehension and that they understood the information sheet and consent 
form. The participants were reassured that all collected data would remain anonymous. The 
informed consent page and request to participate in the lucky draw was removed and kept 
separately to the questionnaires before analysing the data, so that the data remained 
anonymous.  
2.4.1 Data safety and monitoring 
All written data generated was kept in a locked cabinet to be destroyed after the project’s 
completion. The data was only made available to the researcher and the supervisors. Names 
were removed as soon as questionnaires and interviews were returned. Participants’ 
anonymity was assured by ascribing a code to each questionnaire and removing all 
identifying information.  
A separate list of names and contact details was kept for the prize draw and destroyed after 
the winner was announced. 
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A separate list of names was kept of participating doctors who wanted feedback after 
completion of the study. 
2.5 Data collection 
Paper questionnaires were handed out to each doctor attending the conference and the 
doctors were reminded of the invitation to complete the questionnaires each morning. Ten 
doctors did not accept questionnaires. Two other surveys were distributed at the 
conference, which limited time available for completion of the questionnaire. 
Surveys were distributed to delegates over the five days of the conference. The participants 
could choose to answer the questionnaire at any time between the beginning of the 
conference (19 Jan 2015) and 30 April 2015, but only one respondent completed the 
questionnaire after the conference and returned it to the researcher by email. Although all 
participants were offered the opportunity to complete the questionnaire on the internet, no 
one used this method. A further 50  surveys of the 140 distributed were completed and 
returned by hand during the conference for a 36.4% response rate, which was similar to the 
response rate of 36.7% quoted by Wonkam, Njamnshi & Angwafo (2006) but lower than the 
reported response rate to mail  surveys of physicians in America of between 50 and 59% 
(Asch, Jedzriewski & Christakis,1997). The response rate was, however, much higher than 
the 15.2% response rate to a mail survey of GPs in South Africa (Masters, 2010). 
This low number of responses could theoretically lead to increased response bias, but studies 
done on response bias in paediatricians in America have shown very low rates of response 
bias compared to patients and the whole population (Cull et al., 2005).  
Not all surveys were completed fully, but sufficient information was obtained from each 
questionnaire that all were included in data analysis. 
The responses were captured into the google docs’ survey instrument and a response form 
similar to an Excel form was generated. 
2.6 Data analysis 
The raw data generated from the questionnaires was analysed using descriptive statistics, 
content analysis and chi-squared association analysis. Descriptive statistics were used for 
quantitative analysis, to summarise the data numerically. Themes were identified from open-
ended questions and the numbers of statements relating to those themes were reported. In 
this way, underlying reasons for basic quantitative observations could be determined, 
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providing a deeper understanding of the results than would have been obtained from pure 
statistical analysis. 
Data was organised into tables and charts for easy comparison and figures were presented 
both as frequencies and percentages, which were rounded off to the nearest 0.1%. 
Several questions contained a text box next to the answer “Other”, in which comments could 
be made. These comments were noted and content analysed for further insight into the 
answers supplied by multiple choice or checklist questions. 
In the analysis of the results, several questions were not presented in the order of the 
questionnaire, as some answers were found to be more relevant to other sections. The 
question asking why doctors hadn’t previously used genetic services was moved to the first 
section on referral patterns of doctors, as the answers were applicable to this segment. A 
question on what sort of further education on genetics, if any, the doctors would like, was 
allocated to the section on Education. The question asking what the respondents think about 
their knowledge of genetics was later allocated to the section on Knowledge, and analysed 
to inform the respondents’ self-assessment on their knowledge of genetics. The genomics 
questions were also later allocated to the Knowledge section. 
2.6.1 Referral patterns of doctors to genetic services 
Descriptive statistics were used to quantitatively describe referral to genetic services in the 
past and predicted referral in future, and this was linked to later answers to an open-ended 
question on why some doctors had not used genetic services previously.  
2.6.2 Demographics  
Demographics of the sample were analysed using descriptive statistics. 
2.6.3 Doctor’s genetic education and knowledge of genetics  
Education and knowledge of doctors were both analysed using descriptive statistics, with 
individual answers being informed by content analysis of open-ended questions. 
Answers to the questions on genetics knowledge (questions 17, 18, 19, 20, 21, 22, 23, 24, 25, 
26 and 27) were scored as below. Answers given by doctors were discussed with other 
genetic counsellors and also by consulting Firth, Hurst & Hall (2005) and Gene Reviews. 
Question 17: A table of conditions doctors recalled seeing in practice. Each condition noted 
was given a score out of three, one for correctly identifying a genetic condition, one for 
correctly identifying the mode of inheritance and one for correctly identifying whether or 
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not a genetic test is available. No marks were allocated for answering the question about the 
impact on the patient’s life as answers were regarded as subjective, but these answers were 
noted and analysed.  
Question 18*. Table pre-populated with a list of ten genetic conditions. Answers to this table 
were scored out of 30, with a mark given for correctly identifying whether or not a genetic 
test is available, a mark for correctly identifying whether predictive or carrier testing is 
available and a mark for correctly identifying whether other family members are at risk. The 
section on metabolic testing was removed from the analysis as it was felt that the question 
was ambiguous. It was also decided that, since Down syndrome can, in some circumstances, 
be familial, either answer for “Other family members at risk” would be accepted (Appendix 
C shows a table of correct answers). 
Question 19*. Doctors chose from the following list of options for prenatal diagnosis: family 
history, ultrasound scan, non-invasive prenatal testing, amniocentesis, karyotype, testing 
maternal DNA, testing paternal DNA and other. All seven of these answers were correct and 
a mark out of seven was given depending on how many correct answers were chosen. 
Questions 20 to 23*. Hereditary breast cancer. This section was marked out of four, with 
“both” being the correct answer for the first question, “10%” for the second question, “Yes” 
for the third question and “As someone at higher than population risk” for the fourth 
question.  
Question 26*.  The question on the meaning of “VOUS” was added to the overall knowledge 
score, with one point given for the correct answer: Variant of Unknown Significance.  
Question 27*. The question asking when it is appropriate to test a child under the age of 18 
for a genetic condition gave seven options and doctors could choose as many as they thought 
were accurate. Three answers in this section were correct: “When the child requests a test”, 
“When a child is symptomatic” and “When treatment or management is available that could 
prevent or delay the onset of a genetic condition”. A score out of 3 was added to the final 
knowledge score, but the answers were further analysed to see which incorrect answers 
were chosen as well. 
Answers to the questions marked above with a * were scored and marks were added 
together for an overall score out of 45 for each respondent that answered all questions. 
Ratings on genetic conditions seen in practice were separated from the other knowledge 
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questions as they did not add information to doctors’ overall knowledge score, and the 
number of conditions seen by each doctor varied. This section gave a quantitative score, as 
well as some qualitative information where respondents commented on their answers. 
Answers to questions were also analysed independently to inform future educational 
presentations for doctors.  
2.6.4 Doctors’ knowledge and attitudes about genetic s ervices 
Attitudes and knowledge of doctors about genetic services were analysed using descriptive 
statistics, with individual answers being informed by content analysis of open-ended 
questions. 
2.6.5 Content analysis 
Answers to open-ended questions dispersed throughout the survey instrument were 
categorised into conceptually similar responses using content analysis which is a flexible 
method for analysing text data obtained from open-ended survey questions and other 
sources such as interviews, print media and focus groups. According to Hsieh and Shannon 
(2005:1278) “qualitative content analysis is defined as a research method for the subjective 
interpretation of the content of text data through the systematic classification process of 
coding and identifying themes or patterns”.  Conventional content analysis was used in this 
study due to the limited amount of existing research on doctors’ attitudes to genetics and 
genetic services and how this relates to their use of these services.  This method meant that, 
in most cases, no preconceived categories or theoretical perspectives were imposed on data 
obtained from the respondents. However, genetic counsellor’s roles, as described by 
respondents, fitted into the four categories of skills mentioned by Uhlmann, Schuette & 
Yashar (2009) and this guide was used to categorise responses. 
Similarly, open-ended answers on the value of genetic services and genetic counselling were 
put into themes and then categorised according to respondents’ choice of whether services 
were “Indispensable”, “A luxury”, “Pointless” or “Other”. 
 Initially, all responses were read several times to get an overall sense of the content. The 
responses were then read word by word to extract key concepts from the content, which 
were highlighted. Notes were made of this initial analysis before creating codes describing 
the key concepts. The codes were then grouped into themes (Hsieh & Shannon, 2005).    
Supporting comments from open-ended questions are included under themes in the Results 
section. Many comments were excluded from the Results section for the sake of brevity, but 
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some were used to illustrate themes and all relevant comments are included in Appendix E 
with reference made in the relevant results section. 
2.6.6 Test of association 
Test of association or “goodness of fit” analysis was conducted using a chi-squared (χ²) 
distribution in contingency tables (matrices of counts) to determine which variables were 
significantly associated with patient referral to genetic services by doctors in the past.  The 
χ² test statistic is a function of the differences between observed and expected frequencies 
with a known sampling distribution, and is valid with a sample size of at least 40 (Underhill 
& Bradfield, 2012). 
The Yates’ continuity correction (Y) was used to prevent overestimation of significance when 
at least one cell of the chi-squared data table was smaller than 5, although it has been argued 
that the Yates’ continuity correction overcorrects and is unnecessary even with small sample 
sizes.  A significance value of the chi-square test p > 0.05 implies that the data is normally 
distributed, i.e. that there is no significant difference between observed and expected 
frequencies (Underhill & Bradfield, 2012).  
For the analysis, variables were grouped into above the average and below or equal to the 
average, so years of practice were divided into less than or equal to 24 and greater than 24. 
Hours of undergraduate education were grouped into less than or equal to 5 hours or more 
than 5 hours, and, similarly, hours of genetics education post-graduation were clustered into 
3 hours or less, and more than 3 hours. Overall knowledge was grouped into less than or 
equal to the average score obtained (39%) and more than 39%. The number of conditions 
seen in practice were divided into 3 or less and 4 or more. 
When doing statistical analysis, the acceptable number of respondents depends on the type 
of research study, and depends on the central limit theory, which states that in a sufficiently 
large sample, the distribution of the mean of the samples will be normal. A figure of 30 
respondents is usually sufficient unless the distribution is very skew (Underhill & Bradfield, 
2012) and 10% to 20% of the population is sufficient for a descriptive study (Gay & Diehl, 
1992). The 51 responses obtained in this study were thus considered sufficient for 
associations to be made between referral behaviour of doctors in this sample and other 
characteristics. There were also sufficient responses (36.4%) for a descriptive study of the 
conference delegates, but further research will be needed to extrapolate this to the 
population of general practitioners in South Africa.  
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Where questions were not answered by all respondents, calculations were based on 
numbers of participants responding to each question. 
 
 
 
 
 
  
32 
 
3 RESULTS 
Results from the survey are presented below. 
3.1 Sample demographics  
Fifty one (n=51) responses were obtained from the 140 questionnaires distributed at the 
conference (10 delegates did not accept a questionnaire), a response rate of 36.4%. It was 
not possible to determine reasons for non-response as the only demographics available for 
the conference delegates was the number of males and females. The sample demographics 
are summarised in Table 1. Since not all respondents answered all questions, numbers do 
not always add up to 51. 
3.1.1 Gender 
Overall, 60% of respondents were female and 40% were male. One respondent did not 
answer this question. The conference was attended by 150 delegates, of which 41.3% were 
female. The SAMA database in 2010 listed 65.4% male doctors, so this sample was not 
representative of the population of doctors in South Africa. 
3.1.2 Age, decade of graduation and years in p ractice 
The majority of respondents were aged between 30 and 69, with a drop in the 40-49 age 
group corresponding with a dip in graduation from 1981 to 2000, and 2 respondents in both 
the 20-29 and 70-79 age groups.  
Years in practice ranged between 4 and 50 years, with an average of 24.12 years in practice.  
Fifty respondents classified their field of practice. Most of them (56%) said they were GPs, 
and 26% said they worked in family medicine (Table 1). 
3.1.3 Practice location 
All 51 respondents answered the question on practice location. Several respondents picked 
more than one practice location, hence numbers add up to more than 51. Doctors were 
evenly distributed between the private sector and the public sector at 45.1% and 41.2% 
respectively, with some doctors working in both sectors. 33.3% worked in urban areas and 
11.8% in rural settings.  
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Table 1: Respondents’ demographic characteristics 
Variable Number Percent (%) 
Gender  
    Male 
    Female 
 *Total 
 
20 
30 
50 
 
40 
60 
Age 
    20-29 
    30-39 
    40-49 
    50-59 
    60-69 
    70-79 
*Total 
 
2 
14 
5 
14 
14 
2 
51 
 
3.9 
27.5 
9.8 
27.5 
27.5 
3.9 
Decade of graduation 
    1961-1970 
    1971-1980 
    1981-1990 
    1991-2000 
    2001-2010 
*Total 
 
2 
14 
9 
8 
14 
47 
 
4.3 
29.8 
19.1 
17.0 
29.8 
Qualifications 
    MBChB only 
    MBChB plus one 
    MBChB plus two 
    MBChB plus three 
or more 
*Total 
 
21 
13 
9 
6 
 
49 
 
42.9 
26.5 
18.4 
12.2 
Field of practice 
     General practice or 
general medicine 
     Family medicine 
 /practice /physician 
     Medical officer 
     Primary health care 
     Family medicine 
facilitator 
     Disability grants 
    Academia 
    Not practising 
    Palliative medicine 
*Total 
 
28  
 
 
13 
2 
2  
1  
 
1  
1  
1  
1  
50 
 
56 
 
 
26 
4 
4 
2 
2 
2 
2 
2 
Practice location 
   Private sector 
   Public sector 
   Urban 
   Rural 
   Tertiary hospital 
   Primary care 
   Academic 
   Other  
**Total 
 
23 
21 
17 
6 
1 
20 
3 
7 
98 
 
45.1 
41.2 
33.3 
11.8 
2.0 
39.2 
5.9 
13.7 
*Not all respondents answered all questions, so numbers do not add up to 51. 
** Some respondents gave more than one answer so answers total more than 51 
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Seven (13.7%) chose the option of “Other”. Comments made under other included:  
 no formal practice at the moment;  
 multiple practices;  
 NGO – Khayelitsha;  
 UCT Student Wellness Service;  
 Department of Correctional Services;  
 Ireland (Public/Private).  
3.1.4 Specific fields of interest of respondents 
A wide range of professional interests were described by respondents. Doctors working in in 
the public sector cited areas such as: Occupational exposure to blood / body fluids; Palliative 
medicine; Infectious diseases: TB; HIV/AIDS; Trauma and Preventative care. Many of these 
concerns are commonly raised in public health care in South Africa (Mayosi et al., 2009).   
Doctors in private practice had a wide range of interests, encompassing the specialities of 
Neurology, Psychiatry, Geriatrics, Ophthalmology, Travel medicine, Allergy, Sports and 
Infertility. Several were also interested in diseases of lifestyle, particularly diabetes mellitus 
and hypertension. More general interests cited by private doctors included: Integrated 
medicine; Female health care; Nutrition and Health.  
3.2 Referral patterns of doctors to genetic services 
Doctors were asked whether they had previously referred to genetic services, whether they 
thought they might refer in future, and whether they know how to access genetic services in 
South Africa. Fig. 1 illustrates the doctors’ answers. There was an almost even distribution 
between doctors who had used genetic services (52.9%) and those who had not (47.1%). Of 
those who had not referred to genetic services, one commented that Pathcare had been 
used for testing. 
Almost all (92.2%) respondents thought they would refer to genetic services in the future 
and two of those who said they would not were retired.  
In response to the question on whether or not they knew how to access genetic services, 
49% said “yes” (with two mentioning Groote Schuur and Red Cross Hospitals), 20 (39.2%) 
said “no” (one had accessed through Ampath) and six said “Other”, commenting that they 
were not sure of the referral pathways, would ask at clinics, and were not aware of all 
services.  
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Fig. 1: Respondents’ referral patterns to genetic services 
Although only 24 doctors said they had not previously referred to genetic services, 43 
answered the checkbox question: “If you haven't used genetic services previously, why not?”  
Their replies are summarised in fig. 2 and a full list of comments appears in Appendix E. This 
question was placed towards the end of the questionnaire and it is possible that respondents 
had forgotten their first answer, or that they wanted to comment on their use of genetic 
services. Many respondents commented on their chosen answer even though only the 
option “Other” had a comment box. This helped to explain their choices. Almost half of the 
doctors (44.7%) said that genetic services were “Difficult to access”. This is in close 
agreement with the 39.2% who do not know how to access services (fig. 1). Another third 
(28.9%) said they had not found it necessary to refer to genetic services, and 26.3% gave 
“Other” as a reason for not referring.  
Lack of familiarity with genetics and genetic services was a common theme across the 
respondents’ comments, and indeed across many of the questions, no matter what choice 
they made. Comments under “Difficult to access” included:  
 “??because my knowledge limited”  
Doctors that selected “Not necessary”, commented:  
 “Patients never requested referrals”  
 “Patients already diagnosed when I see them”.  
Comments under Other included:  
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 “Didn’t know I could”  
 “Not sure what they are offering.” 
                 
 
Fig. 2: Doctors’ reasons for not using genetic services previously 
3.3 Doctors’ education in genetics  
Table 2 summarises the amount and form of genetics education received by respondents 
during undergraduate training and since graduation.  
3.3.1 Undergraduate genetic education  
All 51 respondents answered the question “How much genetics education did you receive in 
undergraduate training?” with 50.5% indicating they had less than 10 hours’ of 
undergraduate genetic education. Almost 20%, however, said that they had more than 10 
hours of undergraduate genetic training. Three respondents commented next to their 
answer that they could not remember how much education they had received:  
 “Cannot remember how much, had some lectures”.  
 “Difficult to quantify. Incorporated as a short lecture or part of a lecture in 
each block e.g. O&G (obstetrics and gynaecology), Medicine etc.”  
It is, however, impossible to know whether participants’ answers are accurate when 
questions require recall of events. 
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All respondents answered “How was this education offered?” with some choosing more than 
one option. As expected, since lectures are the most common form of tertiary education, 
lectures were overwhelmingly the most frequently chosen form of education (90.2%). 
Interesting and specific comments under “Other”, indicating the importance of education 
being offered in different forms, were:  
 “Consultations”  
 “Visit to the genetic counselling centre.” 
3.3.2 Postgraduate genetic education 
“How much genetics education have you received since graduation?” was answered by all 
respondents. An almost equal number said they had received no (29.4%) or 0 to 3 hours 
(33.3%) of genetics education since graduation, so in total 62.7% had fewer than 3 hours of 
education in genetics since graduation. Only one respondent implied that she had many 
hours of genetic education, saying under “Other”:  
 “I worked in Genetics full-time and part-time in the 80s.” 
Once again, respondents reported that most of their postgraduate education to date was in 
the form of lectures, with almost half (49%) selecting this option. The attractiveness of 
attending educational activities for continuing professional development (CPD) (also known 
as continuing medical education - CME) points was illustrated by 37.3% saying they had 
earned points for genetics education. The relevance of journals and congresses in self-study 
were mentioned, and one respondent said they had “clinical exposure” to genetics since 
graduation. This shows that a wide range of educational activities are acceptable for 
postgraduate education. 
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Table 2 Genetic education of respondents 
Variable Number Percent (%) ** 
Amount of genetics 
education in 
undergraduate training 
    None 
    1 or 2 hours 
    3 to 5 hours 
    5 to 10 hours 
    >10 hours 
    Don’t know 
    Other  
Total* 
 
 
 
   3 
  10 
  13 
   7 
  10 
   6 
   2 
52 
 
 
 
5.9 
19.6 
25.5 
13.7 
19.6 
11.8 
6.9 
Form of genetics 
education in 
undergraduate training 
    Not applicable 
    Lectures 
    Meetings 
    Self-study 
    Short course 
    Other 
Total* 
 
 
 
   3 
  46 
   4 
   7 
   1 
   5 
66 
 
 
 
5.9 
90.2 
7.8 
13.7 
2.0 
9.8 
Amount of genetics 
education since 
graduation 
    None 
    0 to 3 hours 
    3 to 5 hours 
    >5 hours 
    Other 
Total* 
 
 
 
  15 
  17 
   9 
   7 
   4 
52 
 
 
 
29.4 
33.3 
17.6 
13.7 
7.8 
Form of genetics 
education since 
graduation 
    Not applicable 
    Lectures 
    Meetings 
    CPD points 
    Self-study 
    Short course 
    Other 
Total* 
 
 
 
  14 
  25 
   9 
  19 
  10 
   3 
   4 
84 
 
 
 
27.5 
49.0 
17.6 
37.3 
19.6 
5.9 
7.8 
* Some respondents gave more than one answer so answers total more than 51. 
**Percentage out of number of respondents to each question, not number of answers  
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3.3.3 Doctors’ needs from genetic education  
A variety of answers were obtained to the open-ended question: “What sort of further 
education on genetics, if any, would you like?” These were grouped into 4 themes. Several 
doctors made comments that fitted more than one theme, so numbers do not add up. A full 
list of quotes appears in Appendix E. The four themes were: 
1. Forum for education (n=16, 31.4%) 
2. Topics (n=10, 19.6%) 
3. Resources for self-study (n=10, 19.6%) 
4. Not applicable (n=1, 2.0%) 
                                  Theme 1: Forum for education. Most doctors (n=16, 31.4%) explained 
how and where they would like to receive genetic education. Many doctors felt that there 
was not sufficient opportunity for genetic education, and some realised the importance of 
updating their genetic knowledge through various platforms, including conferences, 
tutorials, short courses, CME activities and refresher courses, e.g. 
 “Education on genetics does not happen often. Congresses and medical 
journals should bring more of this”.  
  “Part-time / distance learning with contact sessions - towards a certificate.” 
  “Short courses, starting with the basics, including information about 
indications for referral and contact details of referral centres.”  
  “Refresher courses which teach about the advances in diagnosis, prognosis 
and management of genetic diseases”  
One respondent remarked that he/she would like more hands-on experience of genetic 
services. 
 “What genetic counsellors do? To sit in on counselling sessions. Common 
genetic conditions - to attend a genetic clinic and see these conditions.” 
            Theme 2: Topics. Ten respondents (19.6%) mentioned that they would like to 
know more about genetics and when it would be useful to their practice and many indicated 
that their understanding of basic concepts in genetics including genetic tests, genetic 
conditions and the function of genetic services was lacking, e.g.  
 “A basic course with presentation of information useful in the GP setting”. 
 “Reminders of genetic conditions to help us pick them up”  
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 “Information about indications for referral and contact details of referral 
centres”.  
A lack of understanding of the role of genetic counsellors was mentioned by two 
respondents, e.g.  
 “What do genetic counsellors do?” 
A number of participants (n=7) wanted help with patient management as they felt that this 
would allow them to improve patient care, e.g.   
 “GP oriented courses to help me better serve my patients and their 
communities”.  
Finally, 3 wanted current knowledge, e.g.  
  “Updates on new developments” . 
                                  Theme 3: Resources for self-study. Ten respondents (19.6%) felt that 
they would like access to materials for self-study, which would be easily available when they 
needed it. Three people mentioned the internet or technology, e.g.  
 “Access to a good website”  
 “Phone apps”.  
Another 3 requested print media, including journal articles, and one said:  
 “Have a booklet in my practice covering "genetics 101". 
                                  Theme 4: Not applicable. One doctor was retired and commented:  
 “Too late!” 
These answers gave insight into how respondents like to learn, as well as what sorts of topics 
in genetics are of interest to them. 
3.4 Knowledge – what doctors know and what they think they know about 
genetics 
Overall, doctors rated their genetic knowledge as very poor, and this was somewhat 
confirmed by their answers to the practical knowledge questions, with an average score of 
39.6% obtained for the 11 questions that were scored, although this may not indicate very 
poor knowledge of genetics.  
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The majority of respondents (n=28, 54.9%) were not confident in their knowledge of genetics 
when measured on a Likert scale. This followed a declining trend, with 14 (29.4%) being 
slightly confident, 3 (5.9%) somewhat confident and only one feeling confident in their 
genetic knowledge. No respondents rated themselves as very confident (fig. 3). 
 
Fig. 3 Respondents’ self-rating of genetic knowledge 
The doctors’ feelings about their knowledge of genetics were further explored in the open-
ended question: “What do you think about your knowledge of genetics?” (Full table of 
comments appears in Appendix E). The resulting answers were rated as: 
1. Very poor 
2. Could be better 
3. Good 
                                 Theme 1: Very poor. The majority of doctors (n=36, 70.6%) felt that they 
did not have enough knowledge to help patients with genetic conditions. As one participant 
said:  
 “I have a basic knowledge of a few conditions and principles of genetics but 
feel that I do not have adequate knowledge to confidently diagnose and 
manage all genetic conditions.”  
Another doctor thought that their paucity of genetic knowledge was unacceptable: 
 “Virtually zero knowledge which is not really acceptable”  
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On a positive note, a few (n=6, 11.8%) thought that although their knowledge was poor,  they 
felt that they could rectify this lack of knowledge with education, and thought that increased 
knowledge might enable them to diagnose more genetic conditions:   
 “I would love to learn and know more. I realise I have many ‘gaps’ BUT usually 
would ask for advice/ help from specialists / colleagues. May diagnose more 
conditions with more awareness of testing / implications / presentation.”  
There were 2 doctors who felt that their knowledge was so poor that it was:  
 “Non-existent”  
 “Woeful.” 
                                  Theme 2: Could be better. Four individuals (7.8%) were reasonably 
confident in their knowledge, but felt that they could still learn:  
 “Could always improve, probably in the context of ongoing developments in 
the field.” 
                                  Theme 3: Good. Only two respondents rated their knowledge as good and 
one attributed this to:  
 “Good teaching in undergraduate at UCT.” 
3.4.1 Knowledge of conditions seen in practice 
This tabulated question asked the doctors to list inherited conditions that they had seen in 
their practices. For each condition they listed, they would then choose whether a genetic 
test is available, the mode of inheritance of the condition, and whether or not it would have 
a significant impact on a patient’s life (Table 3). A total of 45 different conditions were listed 
by 37 (72.5%) respondents. Between 1 and 8 conditions were listed per respondent, with an 
average of 3.62 conditions mentioned per doctor. Knowledge of conditions seen in practice 
was scored on the basis of 1 mark per recognised condition, 1 mark if the correct answer was 
given for genetic test availability, and 1 mark for correct mode of inheritance. This was 
difficult to compare as some respondents only listed 1 condition while others listed several. 
Overall, participants scored an average mark of 70.6% (SD 21.2), with a mode of 66.7% and 
a range between 20% and 100%, which indicates that they have a good knowledge of genetic 
conditions that they have seen in practice.  
Fig. 4 shows the 10 most frequently cited conditions reported as being seen in practice by 
responding doctors. Down syndrome was the most frequently reported condition, followed 
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by cystic fibrosis, breast cancer, sickle cell anaemia, haemophilia, Huntington disease, 
albinism, thalassemia, familial hypercholesterolaemia and Marfan syndrome. The other 35 
conditions mentioned were seen by less than 10% of respondents. 
 
Fig. 4 Ten inherited conditions seen most frequently in practice 
Table 3 is a summary of answers obtained for the ten most commonly seen inherited 
conditions (Appendix E shows a complete table of answers for all 45 conditions). 
Of the 139 answers citing conditions seen in practice, 94.2% (n=130) correctly identified 
conditions with a genetic or congenital component. The other 9 conditions mentioned by 
respondents are not commonly seen in the genetic clinic, e.g. attention deficit disorder, 
asthma, diabetes, hypertension and Stevens Johnson syndrome (these can be seen in the full 
table in Appendix E). Spinal muscular atrophy (SMA) was cited by one doctor, who also 
correctly identified the inheritance of the condition as autosomal recessive, but was not 
aware of the existence of a genetic test for the disorder.  
Similarly, of the potential 115 correct answers for availability of a genetic test, 69.6% (n=80) 
chose correctly. Finally, from 129 answers given for inheritance patterns, 58.1% (n=75) 
selected the correct mode of inheritance. Almost all conditions (except haemophilia and 
thalassemia, which can be lethal) were considered to significantly impact life.  
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Table 3: Knowledge of genetic conditions seen by doctors in practice (conditions listed by 
respondents) 
Name of inherited condition 
cited by doctors as being 
seen in practice 
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Down syndrome 
 
32 28 2 2 1 26 1 27 
 
88 81 
Cystic fibrosis  11 8 2 7    10 73 64 
Breast cancer  
 
 
9 8 3  2  2 6 
 
 
89 33 
Sickle Cell 
Anaemia  
8 6 1 4    7 75 50 
Haemophilia   7 7  2 4   2 
 
100 57 
Huntington disease   6 5 5   1  5 83 83 
Albinism  5 4  3  1 2 
 
 
 
 
4 80 60 
Thalassemia  
 
5 0 1 3    0 0 60 
Familial 
Hypercholestrolaemia 
4 2 2 2  1  3 50 50 
Marfan Syndrome  4 1 3     4 25 75 
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These results indicate that GPs have seen a range of genetic conditions and they have 
increased knowledge about these disorders, although only 58.1% of respondents knew how 
these conditions are inherited, implying that their genetic knowledge, even of familiar 
conditions, could be improved. 
3.4.2 Knowledge and awareness of 10 inherited conditions 
Only 47 of the 51 respondents (92.2%) attempted the table pre-populated with a list of 10 
conditions and not all answers were complete (Table 4). Percentages were calculated based 
on the 47 that filled in the table, although the remaining 4 respondents may not have known 
the conditions at all and thus percentages would have been lower. Correct answers are 
marked with a √ and incorrect answers with a X. The column for “Metabolic testing available” 
was removed from the final analysis as the interpretation was ambiguous (Appendix 5 shows 
the full table). 
All 47 doctors were aware of breast cancer and all but one knew of Down syndrome, as 
expected, as these conditions had been seen in practice by more than 80% of respondents. 
Cystic fibrosis, haemophilia, sickle cell disease and albinism were all known to more than 
70% of the doctors but only cystic fibrosis had been seen by more than 50% of doctors.  Lynch 
syndrome was the least recognised condition, known by only 31.9% of respondents and only 
seen by 8.5%. Thus, awareness of inherited conditions seems to be closely linked to the 
experience of seeing patients with that condition, although more doctors are aware of all 
conditions than had actually seen them in practice. This is in agreement with the previous 
result, where doctors were well informed about conditions they had seen in practice. 
Cognisance of availability of genetic tests was variable. Most respondents (82.6%) knew that 
a genetic test was available for Down syndrome, but only 22.7% knew that there was a 
genetic test for spinal muscular atrophy. Surprisingly, only 59.6% were aware that a genetic 
test is available for a BRCA mutation. The words “inherited breast cancer” were not specified 
in the table and it is acknowledged that this may have caused confusion. 
Analysis of answers on the availability of predictive and carrier tests indicated that doctors 
did not know the difference between these tests as the almost 50/50 split between correct 
(191) and incorrect (189) answers could have been randomly generated. Several respondents 
wrote comments indicating that they thought either predictive or carrier testing implied 
prenatal testing e.g. comments such as “antenatal” or “in utero” under “carrier testing 
available” for Huntington disease and Down syndrome; for cystic fibrosis one respondent 
wrote “antenatal” under “carrier testing available” and under ”predictive testing available” 
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wrote “antenatal screen”. This indicates that doctors have no real understanding of the 
meaning of the terms “predictive” and “carrier” testing. 
Table 4: Knowledge and awareness by doctors of 10 inherited conditions (table pre-
populated with conditions) 
Name  
of condition 
*Know the 
condition 
 
*Seen 
the 
condition 
in 
practice 
Genetic 
test 
available 
Carrier 
testing 
available 
Predictive 
testing 
available 
Other 
family 
members 
at risk 
Breast cancer 
 
 
47(100.0%)  
 
43 
(91.5%) 
√28 
(59.6%) 
X21(44.7%) √19 
(40.4%) 
√32 
(68.1%) 
Down 
syndrome 
 
46 (97.9%) 41 
(87.2%) 
√38 
(82.6%) 
X5 (10.9%) X14 
(30.4%) 
√5 
(10.9%) 
Cystic fibrosis 
 
 
43 (91.5%) 
 
24 
(51.1%) 
√28(65.1%) √15 
(34.9%) 
X9 
(20.9%) 
√17 
(39.5%) 
Haemophilia 
 
 
40 (85.1%) 
 
23 
(48.9%) 
√29 
(72.5%) 
√21 
(52.5%) 
X10 
(25.0%) 
√19 
(47.5%) 
Sickle cell 
disease 
 
36 (76.6%)  
 
18 
(38.3%) 
√19 
(52.8%) 
√14 
(38.9%) 
X4 
(11.1%) 
√17 
(47.2%) 
Albinism 
 
 
35 (74.5%) 
 
21 
(44.7%) 
√9 (25.7%) √6 (17.1%) X4 
(11.4%) 
√9 
(25.7%) 
Huntington 
disease 
 
32 (68.1%) 16 
(34.0%) 
√21 
(65.6%) 
X17 
(53.1%) 
√5 
(15.6%) 
√23 
(71.9%) 
Spinal 
muscular 
atrophy 
 
22 (46.8%) 8  
(17.0%) 
√5 (22.7%) √4 (18.2%) X1(4.5%) √5 
(22.7%) 
Spinocerebellar 
ataxia 
 
16 (34.0%) 6  
(12.8%) 
√4 (25.0%) X1 (6.3%) √0 (0.0%) √4 
(25.0%) 
Lynch 
syndrome 
(hereditary 
non- 
polyposis colon 
cancer) 
 
15 (31.9%) 4 (8.5%) √6 (40.0%) X3 (20.0%) √2 
(13.3%) 
√10 
(66.7%) 
*Percentages for Know the condition and Seen the condition as a proportion of the 47 respondents 
who filled in the table. All other percentages as a proportion of the number of people who knew the 
condition. 
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There was a general lack of awareness that all inherited conditions place family members at 
risk (apart from chromosomal conditions in most cases). No respondents wrote that all the 
conditions (except for Down syndrome) would place other family members at risk. One 
respondent, however, understood translocation forms of Down syndrome – saying “it 
depends” under the column: “Other family members at risk”. One doctor said “maybe” for 
the risk to other family members of inherited breast cancer.  
The results of this question on genetic conditions confirmed the doctors’ self-reported 
comments (section 3.4) that they need basic education on genetic concepts. Pre-populating 
table 4 with a list of conditions may have acted as a reminder to the doctors, as many more 
doctors confirmed seeing all the conditions than had cited them from recall in the previous 
question (table 3). Some doctors may have added these conditions to the previous table 
later.  
3.4.3 Awareness of prenatal d iagnosis of genetic conditions  
The multiple choice question on what is involved in prenatal diagnosis of genetic conditions 
was answered by 50 of the 51 doctors. Fig. 5 shows the percentage of doctors choosing each 
option. All 7 options given were correct, but only 26% (n=13) chose all these possibilities 
(table 5). The most common combination chosen was family history, amniocentesis and 
ultrasound scan, with 88% (n=44) picking at least these three options together. 
Amniocentesis was the most popular choice (n=49, 98%), followed closely by family history 
(n=48, 96%), indicating a good understanding of the importance of family history in detecting 
genetic conditions. Just under 60% of respondents ticked non-invasive prenatal testing, 
meaning knowledge of this new technology is becoming widespread.  
Table 5: Number of correct prenatal test options chose by respondents  
Answers Number  (%) 
7 correct 13 26.0 
6 correct 6 12.0 
5 correct 7 14.0 
4 correct 11 22.0 
3 correct 11 22.0 
2 correct 1 2.0 
1 correct 1 2.0 
Total 50 100 
 
48 
 
 
Fig 5. Percentage respondents choosing each prenatal test option 
3.4.4 Awareness and knowledge of inherited breast cancer  
Four questions were asked about inherited breast cancer:  
1. A multiple choice question on whether maternal or paternal history, or 
neither or both (which is correct) were more important in inherited breast 
cancer. 
2. A multiple choice question asking what percentage of breast cancer is 
inherited and offering the following options: 1%, 5%, 10% (the correct 
answer – Nelson et al., 2014), 15%, 25%, 50%, 100% or “Other”. 
3. A question asking whether a male diagnosed with breast cancer is at risk of 
a BRCA mutation even without family history. Options were “Yes” (which is 
correct), “No” and “Other”. 
4. A multiple choice question on how a patient with family history that tests 
negative for a BRCA mutation should be managed with the choices: “As 
someone at population risk”, “As someone at higher than population risk” 
(correct) and “Other”.  
Respondents demonstrated limited knowledge about inherited breast cancer. Most 
respondents (n=35, 70%) chose maternal history as most important in inherited breast 
cancer, not understanding that, although breast cancer is a disease usually found in women, 
this does not imply that the gene cannot be passed through the paternal line. Only 30% 
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(n=15) of respondents chose the correct answer of both paternal and maternal history being 
important. 
Almost half of the doctors (n=22, 43.1%) chose a number greater than the correct answer of 
10% for the second question: the percentage of breast cancer that is inherited. Most (n=14, 
28.2%) thought that 25% of breast cancer is inherited and 21.7% (n=11) chose the correct 
answer (fig. 6). No one thought that only 1% of breast cancer is inherited. Comments from 
those that selected “Other” (n= 9, 17.4%), were “not sure” or “guessing”. 
 
Fig. 6 Respondents’ perception of percentage of breast cancer that is inherited 
Fifty percent of respondents (n=25) correctly answered the third question. A patient with 
family history that screens negative for a BRCA mutation should be treated “As someone at 
higher than population risk”. This shows understanding that family history alone is a risk 
factor for breast cancer, possibly due to underlying genetic factors that have not yet been 
discovered. “As someone at population risk” was chosen by 39.6% (n=20), with 10.4% (n=5) 
selecting “Other”. Several doctors qualified their answers (either under “Other” or, in one 
case, “As someone at population risk”), commenting: “Depending on other risk factors” and  
“DO NOT KNOW!” One mentioned “Depends on age presentation. If below 40 higher risk”, 
implying an appreciation of the role of a directed family history in the management of a 
patient with a family history of breast cancer 
Thirty (65%) of the 46 respondents that answered the fourth question correctly said that a 
male diagnosed with breast cancer is at risk for an inherited BRCA mutation even without 
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family history. Only 13.0% (n=6) answered “No”, but 21.7% (n=10) chose “Other” and said 
they “did not know”, or were “unsure”. 
3.4.5. Overall knowledge score 
The total number of correct answers for each participant for questions 18, 19, 20, 21, 22, 23, 
26, 27 were scored out of 45.  The average knowledge score per participant was 39.9%, with 
scores ranging between 6.7% and 71.1% and a standard deviation of 15.7%, and 35.6% being 
the mode (most frequent answer). These scores indicate that the participants’ knowledge 
may not be very poor, but still illustrate the lack of depth shown by answers to the various 
questions and highlight the need for more genetic education and awareness programmes for 
GPs. 
3.4.6. Knowledge and attitudes concerning genomics 
DTC genetic testing is new technology that 82.4% (n=42) of the respondents do not yet know 
about. Comments on this innovation in the question “Do you think you might be approached 
to interpret results of a direct-to-consumer test in future?” indicated that participants were 
aware that they need to know more and almost half (n=23, 46%) thought they might be 
approached to interpret these tests in future despite not knowing about them at present, 
showing an understanding that new technology is usually assimilated over time. Nineteen 
doctors (38%) did not expect to have to interpret these tests in future, and 2% said they did 
not know.  The remaining 14% (n=7) of doctors chose “Other” and  made comments such as 
“Possibly when I know more”, “You never can tell!”, “Probably” and “Do not know what it 
is”, again indicating a need for education on this new technology. 
 A chi-squared test showed no relationship between those who know what DTC testing is and 
those who thought they might be approached to interpret results (p=0.134). However, only 
9 people (17.6%) knew about DTC testing, so this association could be skewed. Of the 42 
(82.4%) who didn’t know about DTC testing, 18 (42.9%) said they expected to be asked to 
interpret results in future and another 18 (42.9%) said they did not expect to be asked. Seven 
(77.8%) of the 9 respondents who did know about DTC testing said they expected to be asked 
to interpret results and two (22.2%) said they did not expect to be asked, with one 
commenting “Rare if at all (deep rural area hospital)” and the other saying “Work in the 
public service”, indicating that the doctors feel that this type of testing is unlikely to be 
accessed by rural people or people who use public health care. 
The abbreviation, VOUS, was only recognised by one third of respondents (n=17) as meaning 
“Variant of unknown significance”, more than half (n=29) said they did not know what VOUS 
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means and the remaining 10% chose incorrect answers (fig. 7). This is another indication of 
poor knowledge of genomics as this abbreviation is very commonly used in DTC testing and 
genetics research and indicates: “An alteration in the normal sequence of a gene, the 
significance of which is unclear until further study of the genotype and corresponding 
phenotype in a sufficiently large population” (Pagon, et al. 2015). 
 
Fig. 7 Percentage of respondents choosing different answers for the meaning of VOUS 
Forty five responses were obtained for the open-ended question “What would you do if a 
patient approached you with results from a direct-to-consumer genetic test?” Four themes 
were obtained from content analysis of the responses, some which applied to more than one 
theme, so numbers do not add up to 45. 
The themes were:    
1. Ask for advice / seek information (n=26, 57.8%) 
2. Refer (n=20, 44.4%) 
3. Interpret results (n=12, 26,7% ) 
4. Don’t know (n=4, 8.9%) 
Theme 1: Ask for advice /seek information: The majority of participants (57.8%) thought 
that, with some help from colleagues or genetic services, they would be able to discuss the 
results from a DTC test with a patient. One doctor said: 
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 “I would attempt to contact a colleague at the Genetic services to ask for 
assistance / advice on any further steps to be done / taken to assist the 
patient.”  
Two indicated that they were nervous about interpreting these results, and so would consult 
the internet or colleagues for assistance:   
 “Panic - Need to obtain information therefore go to internet.” 
 “Call for help!!”  
Another 4 felt that the company supplying the tests would be able to explain the results: 
  “Refer back to direct-to-consumer tester.” 
Theme 2: Refer. Twenty respondents (44.4%) felt that they did not have enough 
knowledge or experience to offer their patients a proper consultation on results from a DTC 
test and said they would refer to either colleagues or specialists, or to genetic services:  
 “I would refer them to specialist and genetic services. This information 
should be given to the patient under proper guidance and explanation.”   
 “Depends on what the issue is – Refer the problem. 
Theme 3: Interpret the results. Twelve participants thought they could interpret 
the results themselves without mentioning the need for consulting with specialist 
services or colleagues:  
 “Consider my own clinical assessment of patient. It would help if the 
parameters of the validity of the tests are cited with the results.”   
 “May ask patient to come back for another appointment to get the best 
information to give the patient the best answers”. 
Theme 4: Don’t know. Only four doctors acknowledged that they didn’t know 
what they would do if approached with results from a DTC test:   
 “I have no knowledge at all.” 
Genetic services, which would be the most likely place to find good information on DTC 
testing, were only mentioned by 17 respondents, although only 9 respondents originally said 
they knew about DTC testing. More doctors said that they would seek advice or information 
from colleagues (the most common source of information for doctors according to Bennett 
et al., 2006), the DTC test company or through self-study (often the internet) than would try 
and call genetic services. Even the doctor who said he/she would “panic” followed this by 
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saying he/she would search the internet for information. These answers are interesting as 
the doctors appear to be quite confident when asked what they would do with a DTC test 
query, in contrast to their stated lack of confidence in their genetic knowledge (section 3.4). 
Doctors were then asked whether they think that pharmacogenomics would have an impact 
on prescribing medications in future, in a multiple choice question with answers “Yes”, “No” 
or “Other”. Overall almost 90% (n=45) of the doctors thought pharmacogenomics would 
have an impact on prescribing medications in future, with the remainder saying they did not 
know about pharmacogenomics, remarking: “Don’t know anything about this” and “Not sure 
what it is” (see fig. 8). Nobody chose “No”, again indicating an understanding that new 
technology will impact practice eventually. 
 
Fig. 8 Percentage of respondents who think pharmacogenomics will have an impact on 
prescribing medications in future. 
Thirty nine doctors responded to the open-ended question: “How can we make genomics 
more accessible to clinicians in South Africa? Genomics refers to whole genome science and 
includes genome sequencing that is already available to consumers online.” (A full table of 
responses appears in Appendix E). Responses were similar to those on what sort of education 
doctors would like to receive in future, with lack of awareness and need for more information 
included as major themes.  
Four themes were generated from respondents’ comments: 
1. Raising awareness (n=18, 46.2%) 
2. Education and information (n=18, 46.2%) 
3. Increase accessibility (n=8, 20.5%) 
4. Don’t know (n=5, 12.8%) 
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                          Theme 1: Raising awareness. Five respondents (12.8%) suggested advertising 
and marketing would increase accessibility to genomics – indicating that they think of 
genomics as a commercial entity, possibly due to confusion with DTC testing. Comments 
included:  
 “Advertise widely. Reduce price and make it affordable for man in the 
street.” 
Six participants (15.4%) suggested the internet as an awareness tool:  
 “Internet access promoted by SAMA.”  
Another 5 (12.8%) mentioned raising awareness through other media such as magazines and 
telephonic support. 
                          Theme 2: Education and information. Nine comments (23.1%) cited 
education as the best way of increasing accessibility to genomics, feeling that the subject 
matter is complex: 
 “Educate! Educate! Educate!”  
 “Make subject matter more user friendly.”  
 “Clarify relevance which I understand and which can help me explain to 
patients”. 
Six participants (15.4%) suggested lectures, workshops and CPD activities would increase 
understanding of genomics:  
 “Through this kind of lecturing venue.”  
Other respondents (n=5, 12.8%) commented on the need for more information on genomics:  
 “Give us more information re services + cost + availability - via email / post” 
                          Theme 3: Increase accessibility.  Eight doctors (20.5%) felt there was 
insufficient contact with genetics and genomics: 
 “1. More visibility 2. Contact numbers to be held in surgeries 3. Genetics 
contact”. 
  “Perhaps informing clinicians firstly of this availability and means to access 
it”. 
                          Theme 4: Don’t know. Five people had: 
  NO IDEA”. 
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3.4.7 Knowledge of the ethics of testing children under 18 for genetic 
conditions 
The checkbox question:  “When is it appropriate to refer a child under the age of 18 for a 
genetic test?” (Fig. 9) – had 3 correct answers: “when a child requests a test” (under specific 
circumstances), “when a child is symptomatic” and “when treatment or management is 
available that could prevent or delay the onset of a genetic condition”. The other 4 options: 
“when a second degree relative has a genetic condition”, “when a sibling has a genetic 
condition” “when a parent has a genetic condition” and “when parents request a test” are 
not considered to be appropriate when testing children for genetic conditions that could 
impact their lives physically, emotionally and socially. 
 
Fig. 9 Doctors’ responses to when it is appropriate to test children under the age of 18 for 
a genetic condition 
All respondents answered this question. The most frequently chosen correct answers were 
“when treatment or management is available that could prevent or delay the onset of a 
genetic condition” (n=37, 72.5%) and “when a child is symptomatic” (n=37, 72.5%), but just 
4% (n=2) chose these only two answers and did not choose any incorrect options.  
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The most frequently chosen options overall were “when a sibling has a genetic condition” 
(n= 46, 90.2%), and “when a parent has a genetic condition” (n=43, 84.3%), neither of which 
are correct. 
When analysing which answers were chosen together, 8 out of the 50 respondents (16%) 
chose all 3 correct answers, but they all chose either 3 or all 4 incorrect options as well, 
indicating little real understanding of the ethical issues behind genetic testing of minors.  
There is also a possibility that the question was not properly understood by the doctors. 
3.5 Knowledge and attitudes of doctors concerning genetic services 
3.5.1 Which medical professionals should refer to genetic services?  
All respondents answered this open-ended question and most (n=37, 72.5%) thought that all 
medical professionals should be able to refer to genetic services. This indicates that the 
doctors understood that patients with genetic conditions could be seen in many health care 
settings. Seven groups of medical professionals were recorded from comments about who 
should be able to refer to genetic services. (A full table of comments appears in Appendix E). 
 Group 1: All. Thirty seven respondents (72.5%) thought all medical professionals 
should be able to refer to genetic services:  
 “Any medical professional picking up / suspecting a genetic abnormality / 
condition in any patient. Whether a surgeon, GP, neurologist etc. anyone 
can diagnose a genetic condition”.  
Five (9.8%) remarked that genetic services should be available whenever necessary:  
 “Where there is a need or special case”. 
Group 2: Specialists. Fifteen (29.4%) felt that specialists would probably diagnose 
genetic conditions and refer on to genetic services: 
 “Specialists should be the medical professionals to refer. Only they have all 
the details, full diagnosis. They would also decide about further treatment/ 
prevention/ management”. 
 “Those who diagnose genetic conditions most likely specialists rather than 
GPs”. 
Under this category, the following specialisations were named: Paediatricians (9), 
Gynaecologists/obstetricians (8), Internal medicine physicians (4), Surgeons (2).  
Neonatologists, Neurologists, Oncologists and Psychiatrists were each mentioned once. 
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Group 3: General practitioners. Eighteen (25.3%) respondents thought that GPs 
were particularly likely to see patients with genetic conditions and need to refer them to 
genetic services: 
“GPs especially”. 
Group 4: Nurses. Nurses were also seen as important sources of referral to 
genetic services and were cited 9 times (17.6%):  
 “Nurses in medical practice”  
 “Professional nurses (in discussion with doctors)”. 
Group 5: Institutions. One person mentioned Tygerberg and Groote Schuur 
hospitals. 
 Group 6: Pathology laboratories (1) 
 Group 7: Allied services. One respondent took a broader view of who should refer, 
mentioning:  
 “Psychologists, OTs (occupational therapists) and Physios”.  
3.5.2 What doctors think is the role of genetic counsellors  
Genetic counsellor’s roles were described by all 51 respondents and fitted into the four 
categories of skills (not roles) mentioned by Uhlmann, Schuette & Yashar (2009). These skills 
were used as a guide to categorise responses into 4 themes: 
1. Theme 1: Critical thinking skills (n=38, 74.5%) 
2. Theme 2: Interpersonal, counselling and psychosocial skills (n=30, 58.8%) 
3. Theme 3: Communication skills (n=28, 54.9%) 
4. Theme 4: Professional ethics and values (n=7, 13.7%) 
 Theme 1: Critical thinking skills. Most of the respondents (n=38, 74.5%) felt that 
genetic counsellors are able to critically assess genetic conditions. Thirteen (25.5%) thought 
that genetic counsellors could use this information to assess and communicate risks to 
patients and families of inheriting genetic conditions:  
 “Very important when planning pregnancy where known genetic condition 
is in the family or where genetic condition diagnosed and the family 
members may be affected by latent condition e.g. Huntington's disease”. 
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Several respondents (n=10, 19.6%) remarked that genetic counsellors could use their skills 
to screen and diagnose patients with genetic conditions:  
 “To advise, screen and assist in diagnosis.”  
  “To make the diagnosis”  
Another 11 (21.6%) respondents felt that, by applying their genetic knowledge, genetic 
counsellors could advise and guide patients and families on what to do about genetic 
conditions:  
 “……what to do if a result is positive”  
 “TO ADVISE THE WHOLE FAMILY”  
 “To provide accurate and informative guidance to families with genetic 
diseases”.  
Some respondents made comments which align more closely with the non-directive nature 
of genetic counselling such as:  
 “Someone with genetic knowledge who can advise on likelihood of certain 
outcomes”  
 “To prepare family/patient for test - implications of the results”  
Genetic testing and its’ utility were mentioned by 9 (17.6%) respondents and indicated a 
good understanding of genetic counsellors’ roles:  
 “Explain the test, what positive and negative findings mean, and what one 
may gain by doing the test. To assist with family decision making on basis of 
test”  
               Theme 2: Interpersonal, counselling and psychosocial skills. Interpersonal, 
counselling and psychosocial skills were recognised by more than half (58.8%) of the 
respondents as important functions of genetic counsellors. This role was aptly described by 
one respondent as “walk(ing) the journey” at genetic clinic while another mentioned 
“holding” families’ anxieties.  
Skills involved in counselling, such as providing information, and helping to calm patients 
were mentioned by 18 (35.3%) respondents:  
 “Inform, prepare, support. Not to add anxiety + stress” 
 “Counselling of doctors and patients”  
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 “Someone who addresses all fears and concerns and facts of the specific 
condition with the patient and the rest of the family”. 
Support, help and assistance (for doctors, patients and families) were mentioned by 12 
respondents (23.5%) as skills that genetic counsellors possess:  
 “To help with this complicated issue about which I know nothing”  
 “….to support families with genetic defects”.  
               Theme 3: Communication skills. The communication skills of genetic counsellors 
were mentioned by more than half of the doctors (n=28, 54.9%), with their main role being 
seen as educating and informing patients. The following comment summarises thoughts on 
this skill:  
 “Provides reliable information on the incidences, presentation, prognosis, 
complications, relevant treatment including rehabilitative actions on various 
genetic disorders.”  
Seven doctors (13.7%) also mentioned that genetic counsellors help patients to make 
informed choices and complex decisions about their genetic conditions:  
 “Education (informed choice)”  
 “Counselling the family on management plans + options available for their 
affected child or patient”. 
               Theme 4: Professional ethics and values (13.7%). Finally, eight people commented 
on the professionalism of genetic counsellors: 
 “…specially trained to deal with these complex matters”.  
The role of a genetic counsellor as a team worker who provides optimal care to patients 
along with medical geneticists, genetic nurses, laboratory scientists and specialists was 
recognised by 4 (7.8%) doctors: 
  “To form part of the multidisciplinary team managing a patient /family 
diagnosed with a genetic disease /condition”. 
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Fig 10 is a graphic representation of doctors’ perceptions of the roles of genetic counsellors.                                           
 
Fig. 10 Doctors’ perceptions of genetic counsellors’ roles 
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3.5.3 Doctors’ attitudes towards genetic Services and genetic c ounselling  
This was a two-part question, which first asked doctors to choose whether they felt genetic 
services were “Indispensable”, “A luxury”, “Pointless” or “Other” (with a comment box.) The 
same question was asked specifically for genetic counselling (fig. 11). These questions were 
followed by a question asking the respondents to explain their previous choices.  
All respondents completed the question on genetic services, and some who did not choose 
“Other” added a comment as well. They all saw the value of genetic services and genetic 
counselling. Slightly more said that genetic counselling is “Indispensable” than chose the 
option of “Indispensable” for genetic services (74.5% vs 66.7%), but no one chose the option 
of “Pointless” for either counselling or services. 
 
Fig. 11 Doctors’ perceptions of the value of genetic services and genetic counselling 
Forty seven doctors explained their answers to the previous question and these were divided 
into remarks about genetic services only, comments about genetic counselling only, and 
statements about both genetic services and genetic counselling together.  (For a complete 
table of comments, see Appendix E). Comments were categorised under the 3 themes of 
“Indispensable”, “A luxury” and “Other” as follows:  
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1. Theme 1: Indispensable (Genetic services - n=34, 66.7%)  
                                            (Genetic counselling – n= 38, 74.5%) 
Categories: i. Management (n=16, 34.0%) 
                     ii. Support (n=10, 21.3%) 
                    iii. Knowledge (n=10, 21.3%) 
                    iv. Burden of conditions (n=5, 10.6% ) 
                     v. Complete health service (n=4, 8.5%) 
                    vi. Access (n=3, 6.4%) 
                   vii. Essential (n=2, 4.3%) 
                  viii. Specialist field (n=2, 4.3%) 
                    ix. Resources (n=1, 2.1%) 
 
2. Theme 2: A luxury (Genetic services – n=9, 17.6%) 
                                  (Genetic counselling n=8, 15.7%) 
              Categories: i. Resources (n=6, 12.8%) 
                                  ii. Access (n=4, 8.5%) 
                                 iii. Knowledge (n=1, 2.1%) 
                                 iv. Burden of conditions (n=1, 2.1%) 
 
3. Theme 3: Other (Genetic services “necessary” – n=1, 2.1%) 
                             (Individual answers for genetic services and genetic counselling 
were “relevant”, “useful”, “important” and “needed”) 
              Categories: i. Support (n=2, 4.3%) 
                                  ii. Burden of conditions (n=2, 4.3%) 
                                 iii. Management (n=1, 2.1%) 
                                 iv. Essential (n=1, 2.1%) 
                                  v. Specialist field (n=1, 2.1%) 
                
              Theme 1: Indispensable. Management was seen by most respondents as the reason 
that genetic services and genetic counselling are Indispensable. Screening, testing, diagnosis, 
options, treatment and planning were all included in this category. Genetic counselling was 
seen as “Indispensable” because it helps with managing and adapting to genetic conditions: 
 “… essential to help manage other risk factors.”  
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 “Genetic counselling is crucial to help parents and families deal with rare 
conditions that will have lifelong consequences.”  
Other reasons that both genetic services and counselling were seen as “Indispensable” 
pertaining to management included helping patients to understand why they might want to 
be tested for genetic conditions and what options are available to them: 
 “Patients need to understand the implications of testing - the nature of the 
disease and risk to family.”  
 “…. give them options about prevention, how to deal with the situation etc., 
lifestyle.” 
 “… both diagnosis and potential treatment (physical/psychological) become 
very important.” 
Three respondents (6.4%) who said genetic counselling was “Indispensable” because of the 
role it plays in support made comments such as:  
 “Genetic counselling is crucial to help parents and families deal with rare 
conditions that will have lifelong consequences.”   
The theme of support, especially in providing information, for both patients and their 
families as well as medical practitioners was mentioned by 7 respondents (14.9%) who said 
both services and counselling were “Indispensable”: 
 “Family and patients need lots of support and need to be informed with facts 
to help them deal with illness”  
 “General practitioners need referral facility for support.”  
Ten doctors (21.3%) commented that in-depth knowledge of genetics, including both 
increase in genetic knowledge and lack of genetic knowledge by doctors, made genetic 
services and genetic counselling “Indispensable”:  
 “Genetic services are very important….as more conditions are found to be 
linked to genetic background.”  
 “Genetic services provide DEPTH around the genetic conditions. That 
knowledge is not available/present outside of formal genetic services.”  
 “Recent knowledge growth in genetics is beyond average GPs ability to 
cover.” 
  “New field that is going to influence how we treat patients and influence 
decisions about treatments.”  
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Five GPs (10.6%) noted the increasing burden of genetic conditions as being a reason that 
genetic services are “Indispensable”:  
 “With the current burden of genetic conditions and the risk of increased 
incidence in future of genetic conditions due to lifestyle changes, increased 
age of childbearing and adverse environmental factors, Genetic services will 
become an even more important part of medicine” . 
One felt that the psychological and physical burden of genetic conditions made genetic 
services “Indispensable”.  
 “Genetic conditions have a major impact on wellbeing. Thus both diagnosis 
and potential treatment (physical/psychological) become very important.” 
The importance of genetic services as part of a complete health care service which would 
provide care for everyone was mentioned by 3 respondents (6.4%), although two thought 
that these services were expensive: 
 “An holistic health service needs genetic services.”  
 “Why discriminate patients with genetic disorders just because services are 
EXPENSIVE?”  
 Genetic counselling was also seen as “Indispensable” to a complete health service as it is 
complementary to genetic services by a respondent who said:  
 “If a genetic service is present it has to go hand-in-hand with counselling.” 
Availability of genetic services for everyone was raised by 2 doctors (4.3%) who thought 
genetic services were “Indispensable” because of increased knowledge and the need for 
genetic testing: 
 “With all the advances in the subject and management of genetic conditions, 
all should have access to these services.”  
One doctor who thought that genetic counselling was “Indispensable” because of the options 
of genetic testing and counselling for genetic conditions commented:  
 “It’s important for patients to have access to counselling and testing, doesn't 
matter the condition.”  
Two participants, who said services and counselling are “Indispensable” simply commented 
that genetic services and counselling are essential:  
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 “Common sense tells me this is an essential service.”  
Two respondents noted that genetics is a: 
 “Specialised field and very important.” 
              Theme 2: A luxury. Genetics is perceived as important in a comprehensive health 
service, but many of those answering “A luxury” drew attention to the lack of resources, the 
cost of genetic services  and the first/third world divide, e.g. under genetic services, one 
doctor said:   
 “Unfortunately in state sector where time with patients is so pressured and 
budgets are constrained, it is a luxury. Even in private, the cost to many 
patients is prohibitive”.  
Four comments (8.5%) related to a belief that rural areas and poor people lack access to 
good primary health care due to resource and time limitations and that this should be 
prioritised over tertiary services such as genetics:   
 “In a 3rd world setting where basic medical care is appalling, is it relevant. In 
the first world e.g. Ireland, I see lots of genetic conditions - basic health needs 
are met therefore more appropriate.”  
 “Indispensable (in an ideal world), a luxury (in this world): In a country where 
people still have no running water, genetic services are a luxury!” 
Comments about difficulty accessing counselling and services in the public sector were made 
by 2 respondents who chose “A luxury” in each category. Supporting comments for 
counselling were:  
 “Difficult to access genetic services for majority of the patient population”  
 “It seems to be something available in private services and as someone 
working in the public sector, I don't know the roles of genetic counsellors or 
how to access them.”  
 “In 3rd World countries only a fraction of the population have access to the 
above.” 
Further statements from respondents who thought services were “A luxury” because of 
difficulty accessing them in the private sector included:  
 “Generally, as far as I am aware, accessing services is difficult and seems 
unavailable in private sector - expensive if it is”  
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One respondent, who saw genetic services as “A luxury” (but “eventually indispensable”) 
again emphasised the need for increased education and awareness of genetics and genetic 
services:  
 “When I know more about this then I would utilise it???”  
One respondent said that genetic services are “A Luxury” but nevertheless recognised the 
impact of these services on the burden of genetic conditions because:  
 “Genetic services are poorly accessed especially in rural areas, yet are 
indispensable due to the number/prevalence of genetic-related diseases”. 
             Theme 3: Other. One person said genetic services were “necessary”, because of: 
“psychosocial support”.  
Another respondent said services and counselling were “Relevant” in supporting medical 
professionals as these services:  
 “…..reduce the load from other health care practitioners”. 
An additional respondent said genetic services and counselling are “relevant” to lowering 
the burden of disease as:  
 “Various healthcare practitioners can be trained to deliver genetic services, 
but to have specialised Genetic Services centre will significantly lower the 
burden of genetic disorders…..”  
A different participant noted that genetic services and counselling are “important” in 
reducing the effect of genetic conditions because:  
 “Genetic abnormalities have great impact on patients and families.” 
Management was also seen as significant by one respondent who said genetic services and 
counselling were “useful”:  
 “… Option of genetic services needs to be available to patients for current 
and future decisions on health care.” 
 One said that genetic services and counselling were “needed”:  
 “REALLY needed”. 
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3.5.4 Doctors’ attitudes and needs concerning genetic services  
Doctors were asked two multiple choice questions about whether they would like improved 
access to genetic services (fig. 12) and, if so, what form this access should take (fig.3). This 
was followed by an open-ended question asking what the doctors need from genetic services 
in South Africa (see Appendix E for a full list of comments). 
 
 
Fig. 12 Doctors’ responses to whether or not they would like improved access to genetic 
services 
 
The theme of increased education in genetics was the most popular choice of what form of 
improved access to genetics doctors would like (fig. 13). Improved support via the internet 
or telephonically was also mentioned. One person asked for specialist visits to community 
health clinics. 
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Thirty one responses were obtained for the open-ended questions asking what doctors need 
from genetic services in South Africa. The answers were analysed and sorted into 6 themes 
as follows:  
1. Theme 1: Referral (n=15, 48.4%) 
2. Theme 2: Advice (n=11, 35.5%) 
3. Theme 3: Access (n=7, 22.6%) 
4. Theme 4: Information (n=6, 19.4%) 
5. Theme 5: Nothing (n=4, 12.9%) 
6. Theme 6: Don’t know (n=1, 3.2%) 
                      Theme 1: Referral. Almost half of the respondents (n=15, 48.4%) mentioned 
referral as their major requirement from genetic services, as they did not know how, when 
or where to refer patients: 
 “Primary care. So I want to be able to refer to a service that can counsel and 
clinically manage if need be.”  
 “Improved referral pathways.”  
 “Referral criteria??At risk patients!!” 
Three (9.7%) pointed out the need for assistance with assessment and diagnosis:  
 “To assist with support in diagnosis and management of patients with 
suspected /confirmed genetic conditions.”  
Another three (9.7%) respondents wanted genetic counselling for their patients:  
 “Genetic counselling after diagnosis for patients and family members.” 
                      Theme 2: Advice. A further third (n=11) felt that they needed advice on genetic 
conditions from experts who would be able to help them with management and referrals to 
support services:  
 “To provide comprehensive knowledge on the disease, support, suggestions 
on management and to provide a network of support services.”   
Three wanted telephonic advice so that they could have immediate access to genetic 
services:  
 “A helpline such as that offered by Dept. of Pharmacology would be great- 
one could email or call for advice.” 
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                      Theme 3: Access. Seven doctors (22.6%) did not know how to access genetic 
services at all and requested contact information: 
 “Where are you? How do I contact you?”  
                      Theme 4: Information on progress in genetics and how to recognise genetic 
conditions was mentioned by 6 participants (19.4%): 
 “Communication on genetic developments” 
 “What we can do to pick up families or patients with genetic problems”. 
                      Theme 5: Nothing. Four respondents said they did not need anything from 
genetic services in South Africa:  
 “So far I did not need any help from genetic services”.  
Of these four doctors, one does not work in the country and two are retired, so their lack of 
need for genetic services in South Africa is understandable. 
                      Theme 6: Don’t know. One person did not know what they needed from genetic 
services.  
3.6 Influence of conference genetics session on respondents’ answers 
Only eight responses were obtained for this question, but the genetics session was held on 
the last morning of the conference and many of the questionnaires had been returned 
already. However, the doctors’ lack of knowledge and the importance of raising awareness 
were the recurring themes from these answers too. 
Both of the respondents who said their answers had not changed said this was due to the 
complexity of the information and the need for more education. One respondent felt that 
the subject matter was too complex:  
 “NO - would need to listen to lectures several times over! Simple minded GP 
:-) (too complicated).” 
Three participants said their answers had changed because their awareness had been raised 
by the genetics session:   
•”Yes - a subject that I have never explored or been subject to till Angelina raised the 
issue!”  
•”Awareness +++”  
•”Yes. Created awareness.” 
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Another three explained that their knowledge was increased by the genetics session, and 
one listed what he/she had learnt during the conference:   
•”Yes. The explanation surrounding developments is inspiring/highlights the ever-
increasing role of genetics in medical practice.”  
•”YES BETTER UNDERSTANDING AND KNOWLEDGE”  
•”1. Role of CONFIRMING diagnosis - multi factors involved! 
   2. Costs involved. 
   3. 3 parent embryo (ovum donor) 
   4. Non-invasive prenatal testing 
   5. Pharmacogenomics 
 6. Role of research (schizophrenia)”. 
 
3.7 Factors influencing previous referral to genetic services by doctors 
Chi-squared (χ²) tests of association were performed to obtain an indication of predictors 
for referral to genetic services by comparing various aspects with previous referral to 
services. Factors were assumed to be significant at p<0.05, which indicates that there is more 
than 95% probability that the distribution of interest was not due to chance (table 7). 
Only three factors were significant in determining whether or not doctors had previously 
referred to genetics. The most important feature (p=0.001) was that doctors who have had 
more than 3 hours of postgraduate genetic education are significantly more likely to have 
referred to genetic services. Two other factors significantly impacting previous referral to 
genetic services are, not unexpectedly, knowledge of how to access genetic services 
(p=0.009) and more than 5 hours of undergraduate genetic education (p=0.037). A fourth 
factor, whether or not the doctor had extra qualifications (which may relate to the amount 
of postgraduate education), was significant to a lesser degree (p=0.063, i.e. p<0.1). 
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Table 7 Associations between predictors for previous referral to genetic services. 
Significance highlighted in yellow (p<0.05) or green (p<0.1). 
Factor   χ² Significance 
level 
(p) 
Significance 
level  
adjusted for 
observations 
with 
n<5 (Yates 
 coefficient Y) 
Knowledge of 
how to access 
services 
6.76 0.009  
Gender 0.12 0.729  
Years in practise 
(≤24 vs >24) 
0.01 0.907  
Public vs private 
practice 
0.38 0.537  
Urban vs rural 2.37 0.123 0.288 
Tertiary vs 
primary care 
0.79 0.375 0.882 
Undergraduate  
education (≤5h vs 
>5h) 
4.36 0.037  
Postgraduate 
education (≤3h vs 
>3h) 
10.31 0.001 0.004 
Knowledge scale 
(self-rated) 
(1 vs 2 to 4) 
1.52 0.218  
Knowledge % 
(≤39% vs >39%) 
1.90 0.168  
Genetic services 
indispensable vs 
luxury 
0.05 0.817 0.870 
Genetic counselling 
indispensable vs 
luxury 
0.97 0.325 0.566 
Need for 
improved 
access 
0.6109 0.434 0.680 
MBChB only vs 
MBChB plus 
other 
qualifications 
3.47 0.063  
Number of 
conditions seen 
in practice (<3 vs >3) 
0.04 0.842  
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4 DISCUSSION 
In this study, 51 doctors attending a Family Practitioners’ Conference in Cape Town 
completed a survey assessing their knowledge and perceived knowledge of genetics, 
exposure to genetic conditions and education, perceptions of genetics, genetic education 
and genetic services and referral patterns to genetic services, both in the past and in the 
future. This discussion will include findings related to the major research questions, study 
limitations, practice implications, research recommendations and conclusions. 
4.1 Sample demographics 
A broad range of GPs attended the conference, with a wide diversity of age, years in practice, 
interests and education level, making this a relatively good sample approximating the 
population of GPs in South Africa. However, the 40:60 male: female ratio of survey 
participants was opposite to that of the conference delegates (58.7:41.3). This female gender 
response bias has also been noted in a review on response bias for paediatricians’ surveys 
and is particularly relevant in small samples (Cull et al., 2005). On the other hand, the 1:3 
ratio of doctors working in rural vs private practice agrees with the ratio in the SAMA 
database. 
Of note was the reduced number of participants in the 40 to 49 year old age group. This may 
be due to large numbers of doctors leaving South Africa in the 1990s shortly after they 
graduated, or because the doctors are in their peak earning years and thus do not have time 
to attend conferences, or it may have been an artefact due to doctors of this age not being 
motivated to fill in the survey. 
A second point of interest was that there were no respondents that graduated after 2010. 
This may be due to the nature of internship and community service, as these doctors are not 
yet established in their own practices and are unable to take time off for conferences. 
4.2 Referral to genetic services by doctors 
The findings indicate that the doctors are aware of the need for genetic services, with almost 
all (92.2%) indicating they will refer in future, although only slightly over half (52.9%) have 
referred previously. While few studies have been done on referral to genetic services, these 
numbers are similar to those found by Claybrook et al. (2010), who found that slightly over 
half (58%) of surveyed oncologists in Indiana had referred patients to colorectal cancer 
genetic services previously, but 98% thought they would refer in future. Whereas 83% of the 
oncologists in Indiana knew how to access genetic services, in the current study, a large 
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number of respondents (39.2%) are not aware of how to access genetic services. Lack of 
awareness of how to access genetic services was, as expected, positively associated 
(p=0.009) with the number of doctors who have not referred previously (47.1%).  
The lack of sufficient knowledge about genetics and genetic services was a recurring theme 
from the survey results. Some participants said that they had no knowledge of what genetic 
services were offering, where they were or even that they could access services, most felt 
that their knowledge of genetics was very poor and several said that they did not know what 
the referral guidelines were for genetic services. This raises the question of whether the lack 
of posts for genetic professionals, and consequently, the lack of sufficient genetic services in 
South Africa, has caused reduced awareness by other health professionals of their 
availability. Alternatively, the insufficient number of genetic services could be caused by the 
lack of awareness of doctors who are thus not driving the development of these services. 
Among the third of doctors who said that they had not previously found it necessary to refer 
to genetic services, only 2 mentioned that they were retired or not dealing directly with 
patients and one said that patients had not requested a referral, indicating that the doctor 
felt it was not their responsibility to decide when to refer a patient to genetic services. 
According to the National Society of Genetic Counsellors (NSGC) in America, about 50% of 
genetic counselling clients are self-referred (Riesgraf et al., 2014), implying that doctors do 
not always recognise when a client should be referred to genetic services and the system of 
referral to state services, via tertiary institutions, may not be optimal at this point for patient 
needs.  
Other papers by Delikurt et al. (2015) and Claybrook et al. (2010) established similar reasons 
for doctors not referring to genetic services, including lack of knowledge on where and why 
to refer patients. Mikat-Stevens, Larson & Tarini (2014) classified these barriers into themes 
including knowledge and skills, healthcare systems and scientific evidence, as well as lack of 
time (two doctors in this study ticked “Too busy”).  Guidelines on where and when to refer 
patients to genetic services might help to increase awareness among doctors of these 
services, resulting in more appropriate use and improved care for patients with genetic 
conditions.  
4.3 Doctors’ genetic education  
The wide range of educational qualifications, fields of interest and practice locations indicate 
that a broad range of doctors responded to the survey. 
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Most respondents recalled having received some undergraduate education, with the 
majority of this education being in the form of lectures, although a few said that they had 
done self-study and seen genetic consultations during undergraduate training. More than 
half of the respondents remembered less than 5 hours of training in genetics, with only 
13.7% recalling 5 to 10 hours of training. Currently, MBChB students at the University of Cape 
Town (UCT) receive 20 hours of genetic education over their 6 year degree (pers. comm., J. 
Greenberg, 2015). However, the surveyed doctors had been in practice for an average of 
24.1 years and had attended diverse universities, so they would have had different 
experiences. This concurs with the GenTEE report (Nippert et al., 2013) which commented 
that medical doctors receive “limited” undergraduate teaching, and may reflect the 
perception that genetics is not often useful in patient management as a relatively limited 
number of patients require genetic services. However, with 1 in 15 patients being affected 
by congenital disorders (Malherbe, Christianson & Aldous, 2015) and since patients with 
genetic conditions require lifelong management and their families may also be affected, the 
overall burden of conditions can be relatively high, especially when the conditions require 
regular medical follow-ups by local doctors. Furthermore, as more and more genetic tests 
become available, genetics is going to become increasingly important in medical practice and 
doctors in many disciplines and specialities will need the background to understand when to 
test patients for conditions and how to interpret the results from the tests (Goldsmith et al., 
2013). 
A third of doctors had not received any education related to genetics since graduation, and 
another third had less than 3 hours of post graduate genetic education. Most of this 
education was through lectures or CPD activities. 
In common with studies done in Britain and Columbia (Burke et al., 2009, Rodas-Perez et al., 
2015), almost all of the participants wanted more genetic education, recognising that their 
knowledge of genetics was inadequate and suggesting conferences, online courses, lectures 
and workshops as environments for educational activities. Over 70% of doctors in the 
present study felt that they do not even have a basic grasp of topics in genetics and expressed 
a need for education on basic genetic terminology, what genetic services offer, how and 
when to refer patients to genetic services, common genetic conditions, screening for 
conditions, management of conditions and what tests are available. Some wanted to know 
what genetic counsellors do and others requested simple, easily accessible information. 
Finally, three were interested in new developments in the field. These answers indicate an 
interest in genetics and a willingness to learn more about the subject, and provide a 
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framework for future conference presentations and other educational initiatives.  Much of 
the information that was requested was reflected in the answers to the knowledge section 
(below).  
Other studies also found that doctors were very interested in more education on topics 
including genetic testing and genetic services, as well as tools such as algorithms to guide 
genetic referrals (Claybrook et al., 2010; Freedman et al., 2003), which were reflected in 
doctors’ answers to what they need from genetic services in South Africa. 
Doctors in this study indicated that they would like basic education that would help them to 
identify and manage patients who need referral to genetic services, as well as access to web 
pages and other resources which they could refer to for information whenever necessary. 
Well-structured genetic education programmes for both undergraduates and for post-
graduate medical training would help to meet the need for more knowledge of genetics and 
genetic services. 
4.4 Doctors’ knowledge of genetics 
The mean knowledge score obtained after adding up answers to several of the knowledge 
based questions was 39.9%, with a range between 6.7% and 71.1%. This low mean score was 
reflective of over 70% of the respondents recognising that that their genetic knowledge is 
very poor or could be better. However, since many of the participants scored over 39.9%, 
this could indicate that their overall knowledge of genetics is better than they think, although 
it may still be insufficient for their patients’ needs.  More education in genetics would help 
to improve the knowledge of participants. This self-reported lack of genetic knowledge was 
similar to that reported in other studies worldwide (Klitzman et al., 2013; Aalfs et al., 2003).  
4.4.1 Conditions seen in practice  
Despite the self-reported lack of genetic knowledge, doctors had a reasonable grasp of 
conditions that they had seen themselves in practice. This indicates that they are willing to 
engage with genetic conditions when their patients are affected. Common conditions such 
as attention deficit disorder, asthma, diabetes and hypertension are not commonly seen in 
the genetic clinic. Respondents citing these conditions may have recognised that all 
conditions have an element of genetic predisposition, and may have misunderstood the 
question, or they may have thought that the disorders have a purely genetic cause. Although 
these conditions are generally thought to be multifactorial in aetiology, the answers do 
indicate an understanding of the value of family history as hypertension, particularly, is 
known to have a hereditary component. Stevens Johnson syndrome, which is a cluster of 
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symptoms caused by an allergic reaction to medication, may have been cited because of the 
word “syndrome” indicating that the respondent did not realise that, while a syndrome is a 
collection of symptoms occurring together, it does not necessarily have a genetic cause.  
As expected, the most commonly seen condition in practice was Down syndrome (seen by 
over 80% of the respondents) as it occurs in about 1 in every 525 live births (Kromberg, Sizer 
& Christianson, 2013). Doctors also had a good understanding of the chromosomal nature of 
the condition with almost 90% of them answering this question correctly. Thirty percent of 
doctors had seen cystic fibrosis, which has a reported incidence of 1 in 3000 among White 
South Africans (Kromberg, Sizer & Christianson, 2013).  Almost two thirds of these doctors 
knew that cystic fibrosis is inherited as an autosomal recessive condition.  One quarter of 
respondents mentioned breast cancer, which is a condition seen in 1 in 10 women in South 
Africa, although only up to 10% of all breast cancer cases are inherited (Nelson et al., 2014). 
This awareness of breast cancer as an inherited disease could be due to the commonly cited 
“Angelina effect” which has raised awareness of inherited breast cancer among the public 
via the popular media (Raphael et al., 2015). Sickle cell anaemia, seen by just over 20% of 
doctors in the study, occurs at a rate of less than 1 in 10 000 in Black immigrants (Kromberg, 
Sizer & Christianson, 2013), but the severity of the disease and the increasing immigrant 
population in South Africa, as well as the fact that sickle cell anaemia is often one of the first 
conditions studied (at secondary and tertiary level) may also have raised awareness among 
practitioners. Half of the respondents correctly identified the autosomal recessive pattern of 
inheritance of sickle cell anaemia.  Conditions such as Huntington disease, haemophilia, 
thalassemia and albinism had been seen by between 13 and 20% of doctors and correct 
answers on their inheritance patterns varied from 57% to 83%.  Spinal muscular atrophy 
(SMA), although a very severe condition that is found in 1 in 2000 blacks (Kromberg, Sizer & 
Christianson, 2013) was only cited by one doctor, who also correctly identified the 
inheritance of the condition as autosomal recessive, but was not aware of the existence of a 
genetic test for the disorder. Albinism is present in 1 in 3900 Blacks (Kromberg, Sizer & 
Christianson, 2013) and was seen by five doctors. Albinism is a very easily recognisable 
disorder in dark-skinned races and this may contribute to recall of the condition.  
The relatively high numbers of doctors seeing cystic fibrosis, which is more common in White 
patients, and the low numbers of doctors mentioning SMA and albinism (more commonly 
present in Black patients) could be related to the racial profile of the patients seen by doctors 
(particularly in private practice) but this was not assessed, nor were conference delegates 
racially profiled.  
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One doctor saw foetal alcohol spectrum disorder (FASD), which is the most common 
congenital disorder seen in South Africa, having  the highest prevalence of all countries and  
being seen in up to 9% of children (May et al., 2013) in some areas of South Africa. FASD is 
commonly recognised among communities of mixed ancestry who live and work on farms 
and so patients with this condition may not be seen by doctors in private or urban settings, 
who made up nearly half of the respondents. Three respondents mentioned spina bifida 
which is another relatively common congenital disorder, occurring in up to 1 in 200 live births 
in South Africa (Fieggen & Stewart, 2014). These disorders are congenital conditions (i.e. they 
are present at birth) and affected children are often seen in genetic clinics. Similarly to the 
situation with FASD, the social profiles of patients seen by doctors may have been a factor in 
the low numbers reported by doctors as the burden of neural tube defects has been reduced 
by folic acid supplementation and, furthermore, patients receiving more antenatal care may 
be more likely to terminate a pregnancy where a foetus is found to have spina bifida.  
It was interesting that all conditions, except for haemophilia and thalassemia, were seen as 
having a significant impact on patients’ lives by most respondents. This implies that doctors 
seeing these conditions in general practice may be seeing patients with milder forms and 
thus may not be aware that both conditions can be lethal and need very frequent follow-ups 
at haematology clinics. Alternatively, their patients may be well managed and go directly to 
tertiary centres when they develop severe symptoms rather than reporting to their GP. If 
these conditions are considered to be serious, however, the doctors may not be referring 
other family members appropriately to genetic services for risk counselling. Wertz and 
Knoppers (2002) (cited by Wonkam, Njamnshi & Angwafo, 2006), found, however, that even 
experienced genetics professionals do not always agree on the relative severity of conditions 
and it would thus be unreasonable to expect the GPs in this study to rate conditions with 
confidence. 
4.4.2 Knowledge and awareness of 10 inherited conditions   
The results of this question on a list of 10 genetic conditions provided in the survey confirmed 
the doctors’ self-reported comments (section 4.3) that they need basic education on genetic 
concepts, as answers to the questions indicated that they have little in-depth knowledge of 
the conditions that they recognised. In particular, their understanding of commonly used 
genetic terminology such as “carrier testing” and “predictive testing” was very poor. 
Although 6 of the 10 conditions (Down syndrome, haemophilia, breast cancer, cystic fibrosis, 
albinism and sickle cell anaemia) were recognised by 75% or more respondents, analysis of 
answers on the availability of predictive and carrier tests indicated that doctors did not know 
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the difference between these tests, and several seemed to think that these tests were mainly 
done on pregnancies, thinking that the word ”predictive” meant the test would predict 
whether the foetus would carry the gene (when these tests are commonly done to predict 
whether at risk adults carry a dominant gene for a late onset condition) and, similarly, that a 
“carrier” test means that a foetus “carries” a mutated gene (or a whole chromosome) when 
this test is usually performed on an adult at risk of carrying a mutated gene for an autosomal 
or X-linked recessive condition. This implies that education on basic genetic terminology 
should be improved at all levels. Awareness of basic genetic terminology would give doctors 
better understanding of genetic testing and when to order genetic tests appropriately, i.e. a 
predictive test for an autosomal dominant late onset condition and a carrier test for a couple 
at risk of having a child with an autosomal recessive condition.  
The doctors had a good basic understanding of the practicalities of prenatal testing, but their 
answers to this question (pre-populated knowledge table) indicate that they would not know 
when to use the various techniques available, or what they would need to test in a family 
with a genetic condition. 
The general lack of awareness that all of the listed genetic conditions (apart from 
chromosomal conditions) place family members at risk also implies a lack of basic 
understanding of genetics and mechanisms of inheritance which could easily be rectified by 
improved education and awareness programmes. Likewise, educating the doctors on these 
basic concepts could raise their awareness of when to refer to genetic services. 
4.4.3 Knowledge of the ethics of testing children under 18 for genetic 
conditions   
The lack of knowledge of the meaning of carrier and predictive tests is reflected in the 
respondents’ answers about testing minors for genetic conditions. 
No one answered this question correctly, indicating little real understanding of the ethical 
issues behind genetic testing of minors (or that the question was difficult to understand). 
Doctors’ basic understanding was similar to what they would do with a non-genetic 
condition, i.e.  
1. 72.5% chose to test if the child is symptomatic and there is treatment available 
(these are correct for genetic conditions as well),  
2. Test if a sibling (90.2%) or parent (84.3%) has a condition (in the case of an infectious 
disease, a child could be at risk of developing the condition). Over 90% of 
respondents thought it was appropriate to test a child for a genetic condition if a 
79 
 
sibling is affected, showing that, when prompted, respondents do recognise that all 
genetic conditions place family members at risk in contrast to the answers given in 
4.4.2 (above).  
These answers would at first appear logical, as they imply an understanding that if a 
condition is present in the family, the children are at risk of inheriting that disorder. However, 
the responses do not take into account the ethical principles of beneficence, autonomy, 
justice and non-maleficence for the child. The American Society of Human Genetics (ASHG) 
has taken the position that, unless medical intervention is available, children (usually above 
the age of 18) should be allowed to make their own decisions about whether and when to 
be tested for genetic conditions when they are old enough to make considered judgements 
with full information and understanding of the implications of results from genetic tests 
(Botkin et al., 2015). Genetic counselling would usually be recommended for informed 
decision making. 
Only 15.7% of doctors recognised that a child under the age of 18 has a right to request a 
genetic test (under certain circumstances). This is another area in which doctors need 
education, specifically because genetic testing is different from other medical testing as the 
consequences of testing are lifelong and have implications for future decisions on 
childbearing and, in some cases, life choices. The right for a child not to know their genetic 
status, or to decide for themselves when they want to know, should be protected. The ethics 
of genetic testing will become increasingly important as more tests and DTC testing become 
available, and proper policies will need to be implemented to prevent harm being done to 
the public through inappropriate use of genetic tests (Skirton, 2015). 
4.4.4 Awareness and knowledge of inherited breast cancer  
Despite the awareness of inherited breast cancer generated by media exposure since 
Angelina Jolie disclosed her BRCA status to the media, doctors had limited understanding of 
the mechanisms of inheritance of the BRCA gene, with few understanding that breast cancer 
can be inherited through both paternal and maternal lines. The “Angelina effect”, first 
mentioned in Time magazine in 2013 (Borzekowski et al., 2013) is credited with raising 
awareness of inherited breast cancer and BRCA testing among the public and this increased 
consciousness could cause doctors to assume that more than 10% of breast cancer is 
inherited. In the current study, 19.6% of doctors chose 10%, but 25.5% thought that 25% of 
breast cancer is hereditary and 5.9% chose 50% as the correct answer.  A study done in the 
USA, prior to the disclosure of Angelina Jolie’s status, also found that doctors inaccurately 
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estimated risk for BRCA1/2, mutations and thus referred too many low risk and too few high 
risk patients to genetic services (Trivers et al., 2011). Consequently it seems that doctors are 
superficially aware of the BRCA genes and their tendency to cause inherited breast cancer, 
but they do not have in-depth knowledge of the risks it confers, or how it is inherited.  
Education programmes with genetic referral guidelines and information about risk 
assessment models for inherited breast cancer (e.g. Manchester, Boadicea) would be 
valuable for doctors working with families who may be at risk for inherited cancers (Nelson 
et al., 2014) 
4.4.5 Doctors’ knowledge and attitudes concerning genomics  
Over 80% of respondents did not know about DTC testing, which is higher than the 65% 
mentioned in a review article by Goldsmith et al. (2013). However, unlike the doctors 
mentioned in this systematic review, where 85% did not feel qualified to interpret the results 
of a DTC test, only 10% of doctors in the current study said they did not know what they 
would do if approached to interpret a DTC test result.  Almost 27% said they would interpret 
the results themselves, while the rest would either refer or gather information before 
discussing the results with a patient. This indicates that the doctors may be assuming their 
existing skills in dealing with new phenomena may be adequate for DTC testing as well. 
Similar responses were obtained in 1999 by Kumar & Gantley, prior to the existence of DTC 
tests, who found that GPs felt that they would be able to integrate genetic technology into 
their work with little adaptation, and the results from this study may simply reflect lack of 
familiarity with this new technology. However, in the current study, this confidence in their 
ability to manage DTC testing is not present in doctors’ feelings on their knowledge of other 
genetic issues and may be related to the lack of understanding about what DTC tests offer 
and how easily accessible they are to the public. 
Currently, reporting on the results of DTC testing is unregulated and the lack of basic genetics 
knowledge displayed by physicians means that doctors may “mishandle, misinterpret, and 
misadvise these patients on what is one of the most important pieces of medical information 
they will ever receive” (Matloff & Caplan, 2008, cited in Harris, Kelly & Wyatt, 2013).  
South Africa’s relative isolation from the larger markets of Europe and America may have 
shielded the doctors from this technology which is becoming increasingly popular elsewhere, 
but DTC testing is now being advertised in popular media in South Africa too and GPs may 
be faced with requests from patients to order or interpret tests soon. Despite their 
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unexpected confidence in working with genomics, respondents felt that awareness of 
genomics needed to be raised through marketing, education, information and CME activities.  
Ninety percent of respondents to this study believed that genetic profiles might influence 
pharmaceutical therapy, similarly to 98% of physicians in a study by Stanek et al. (2012). This 
indicates an awareness of the importance of genetics for medicine in the future, although 
pharmacogenomics tests for medications such as warfarin, tamoxifen and some anti-
depressants are available but not yet widely used by physicians (Klitzman et al., 2013).  
In common with studies done in Argentina (Bidondo et al., 2015), there was a perception 
that genomics is not relevant to rural practice or people using public health care. This is 
probably true for now, as most patients using these services are from lower socioeconomic 
groups and would not be able to afford these tests. However, as one respondent noted: “You 
never can tell.” 
Answers to these questions again highlight the need for more comprehensive education of 
GPs, especially those in the private sector, who may, in future, be approached to interpret 
or request DTC tests. The field of pharmacogenomics is rapidly developing and will be 
available to GPs soon. Genetic services will not be able to manage large numbers of private 
patients with queries, so laboratories offering DTC tests, as well as pharmaceutical 
companies, may need to employ genetic counsellors to help GPs and other medical 
professionals with interpreting results from tests and helping to explain how a patient’s 
genetic profile could affect their medication regime.  
4.5 Doctors’ knowledge and attitudes concerning genetic services 
4.5.1 Which medical professionals should refer to genetic services?  
Most of the doctors (72.5%) said that all medical practitioners should be able to refer to 
genetic services, which was inclusive of the other categories mentioned, i.e. specialists, GPs, 
nurses, institutions and pathology laboratories. This reflects the understanding that genetic 
conditions can be recognised in any health care setting, from primary care through to tertiary 
and quaternary institutions, e.g. a community nurse working in a rural setting could diagnose 
a new born baby with Down syndrome, and an oncologist in a tertiary hospital could identify 
a family with a strong history of early onset cancer.  
A few (29.4%) felt that specialists were more likely to diagnose genetic conditions than other 
doctors and so they should be the ones to refer. While this may be true in some cases, e.g. a 
cardiac surgeon may be more likely than a GP to detect that a cardiac condition in a patient 
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is hereditary, if more GPs understood the indications for referrals, more of them might be 
comfortable with referring directly to genetic services in certain instances, e.g. when a child 
is healthy but dysmorphic, or when a patient is worried about a family history of a condition 
but is not symptomatic.  
Basic guidelines on when it is appropriate to refer to genetic services would help GPs to be 
more confident in referring in future, as “Recognizing signals that are potentially indicative 
of a hereditary component of a disease” was rated the highest need for genetic education of 
GPs by Houwink et al. (2012), since a lack of knowledge can lead to poor recognition of 
genetic problems and a reduction the quality of patient care. 
4.5.2 Roles of genetic counsellors  
Respondents recognised that genetic counsellors possess many skills valuable to the medical 
profession. Doctors commonly saw genetic counsellors as being skilled in critical thinking, 
including being able to critically evaluate conditions to accurately assess risks for future 
pregnancies, and whether or not genetic testing would be an option for a patient. Their 
specialised training was also recognised, as was their role in supporting both doctors and 
patients with genetic concerns. Communication skills, which are the crux of all genetic 
counselling interactions, were mentioned by more than half of the doctors, with the main 
role being seen as educating and informing patients. Communication skills included 
facilitating patients’ decision making through informed choice, which is aligned with genetic 
counsellors’ roles (McAllister et al., 2015). 
However, the need for more information concerning what genetic counsellors do in practice 
was emphasised by the mention that genetic counsellors screen, diagnose conditions and 
advise patients. While genetic counsellors may be involved in screening patients who might 
need genetic services, this is more frequently done by medical doctors. Genetic counsellors 
may add information in diagnosing genetic conditions but they are usually confirmed by 
medical geneticists (i.e. medical doctors that specialise in genetics), specialists or GPs. Finally, 
genetic counsellors do not offer advice, but, using information, communication and 
supporting skills, help people to make their own decisions about managing genetic issues in 
their lives (McAllister et al., 2015).   
4.5.3 Doctors’ attitudes towards genetic services and genetic counselling  
In common with previous studies (Burke et al., 2009; Wonkam, Njamnshi & Angwafo, 2006), 
all respondents realised the value of genetic services and genetic counselling. Slightly more 
(74.5%) said that genetic counselling is Indispensable than said that genetic services are 
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Indispensable (66.7%), but no one chose the option of “Pointless” for either counselling or 
services. One said: “An holistic health service needs genetic services.” A comment on genetic 
counselling was that it is part of a complete genetic service: “If a genetic service is present it 
has to go hand-in-hand with counselling.” These findings are in contrast to the assumptions 
of the GenTEE report (Nippert et al., 2013) that most doctors in South Africa “do not give due 
importance to genetic counselling” due to lack of genetic education.   
As with genomics, there was a perception by some respondents that rural areas have more 
important needs than genetic services and that these services are very expensive. Tan & 
Fitzgerald (2014) also mentioned the perceived high cost of genetic services as a barrier to 
referrals in Australia. Similarly, the perception that medical genetics is a service only for 
highly developed countries is mentioned by Bidondo et al. (2015) in a study on genetic 
services in Argentina, and this perception should be corrected, as one respondent noted: 
“Why discriminate (against) patients with genetic disorders just because services are 
EXPENSIVE?” Other comments such as: “A necessary luxury”, “Genetic services are poorly 
accessed especially in rural areas, yet are indispensable due to the number/prevalence of 
genetic-related diseases” indicate support for genetic services despite the lack of resources 
in South Africa. As mentioned in the first part of this study, almost 40% of respondents did 
not know how to access genetic services, so they are probably unaware of the availability of 
services in the main centres as well as the regular outreach programmes to community 
health clinics and hospitals in rural areas. Raising awareness of the accessibility of genetic 
services in the state might change perceptions that in South Africa genetic services are only 
for wealthy, private patients. Furthermore, there are no medical geneticists and only a few 
genetic counsellors working in the private sector, so services may in fact be more readily 
accessible by state patients. 
The burden of genetic conditions was also recognised as a reason for genetic services to be 
indispensable, in agreement with the GenTee report (Nippert et al., 2013), with one 
respondent commenting: “With the current burden of genetic conditions and the risk of 
increased incidence in future of genetic conditions due to lifestyle changes, increased age of 
childbearing and adverse environmental factors, genetic services will become an even more 
important part of medicine.” 
Once again, the overwhelming theme from this question is that, while doctors recognise the 
need for genetic services, they were not sure how and when to access these services. 
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4.5.4 Doctors’ needs from genetic services in South  Africa 
Doctors identified their major need from genetic services as how, where and when to refer 
patients, implying that doctors do not feel confident about referring patients to genetic 
services appropriately. This concurs with the GenTEE report’s assumption that lack of genetic 
education means that physicians in the GenTEE countries “do not recognize the genetic basis 
of diseases of their patients, (and) do not know how to refer to genetic services” (Nippert et 
al., 2013). This also reflects the continuing theme of lack of knowledge of genetics and 
genetic services by doctors. 
4.6 Influence of the conference genetics session on respondents’ answers 
Although only 8 doctors answered this question, they were mostly enthusiastic about the 
increase in awareness and knowledge that the conference genetics session had created, and 
their answers indicated the value of including genetics sessions in conferences such as this 
one. An earlier study by Vogel (2011) also indicated that attending a conference about 
genetics and genetic testing was instrumental in raising awareness of genetics among a 
group of doctors.  
It may have been interesting to ask whether simply completing this questionnaire had 
changed how the doctors thought about genetics and genetic services. This would have 
addressed a minor aim of the study, which was to raise awareness of genetics among 
participants.  
4.7 Factors influencing previous referrals to genetic services 
Four factors were significant in determining whether or not doctors had previously referred 
to genetics:  
i. more than 3 hours of post-graduate genetic education  
ii. knowledge of how to access genetic services 
iii. more than 5 hours of undergraduate education  
iv. extra qualifications apart from MBChB (less significant) 
These factors correlate with the barriers to referral to genetic services mentioned by other 
authors (Baars, Henneman & ten Kate, 2005, Claybrook et al., 2010,  Delikurt et al., 2015; 
Kromberg, Sizer & Christianson, 2013, Marathe et al., 2015, Mikat-Stevens, Larson & Tarini, 
2014, Rodas-Perez et al., 2015, Tan & Fitzgerald, 2014): lack of awareness of patient risk 
factors, lack of knowledge of genetics and genetic conditions and lack of awareness of 
genetic services, all of which could be addressed by more education.  
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Education seems to raise awareness of genetics and genetic services, regardless of any other 
demographic factors. More education implies greater familiarity with subject matter and, 
therefore, increased likelihood of recognising the need for genetic referrals. More post 
graduate education also indicates more interest in the subject matter and doctors with more 
qualifications were also more likely to have referred to genetic services. This could also be 
due to increased education being associated with more time at tertiary institutions where 
genetic services are based. The final, and obvious, association is that doctors who know 
where to access genetic services are more likely to have referred to them. This could be 
related to the fact that they have had to find genetic services previously, having recognised 
a need for a patient, or that they knew where services were and so were more likely to use 
them.  
4.8 Study strengths and limitations 
This study has a small sample of 51, however, despite the small sample size, respondents’ 
backgrounds and demographics varied widely. The low response rate could reflect 
disinterest in the topic or unwillingness to complete the survey. According to Asch, 
Jedzriewski & Christakis (1997) low response rates do not necessarily increase bias, but in 
this case, selection bias may have occurred because participants had a greater interest in 
genetics and genetic services. If this is the case, it strengthens the need for improved genetic 
education for clinicians as those with less interest would probably have even less knowledge 
of genetics. However, further studies with more respondents are important to validate the 
answers obtained in this survey. 
The study included more women (60%) than men, compared with 65.4% male doctors in the 
SAMA report of 2010.  Further studies with more participants and, possibly, including focus 
groups and face-to-face interviews are needed to verify information and conclusions made 
in this study. 
The study covered a broad range of topics and each of these could be individually studied in 
greater depth. 
The response rate of 36.4% was lower than the reported survey response rate of physicians 
of between 50 and 59% (Asch, Jedzriewski & Christakis, 1997), but this could be explained by 
the fact that two other surveys were distributed at the conference and time was limited for 
completing surveys. The paper survey was also quite bulky and respondents may have 
thought it would take too long to complete. 
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The conference was held in Cape Town, which has well-developed genetic services at Groote 
Schuur Hospital, Red Cross War Memorial Children’s Hospital and at Tygerberg Hospital, and 
the delegates may have had more exposure to genetic services than other doctors in South 
Africa. However, doctors attended the conference from all over South Africa and the 
demographics questions did not include practice location beyond asking whether it was rural 
or urban.  
Failure to identify all concepts may have resulted in conclusions that do not accurately 
represent the data. The addition of open-ended questions means that the doctors could 
more accurately express their thoughts and thus the conclusions may be more 
representative than what would have been learnt from closed-ended questions only.  
Limitations affecting findings and their generalisability include the fact that the doctors were 
all at a conference, which may indicate greater interest in CME and updating knowledge 
relative to the overall population. There is, however, no way of knowing whether the 
answers obtained from respondents differ substantially from those that would have been 
obtained from non-respondents. Furthermore, many of the questions required recall and it 
is impossible to determine accuracy of answers given from memory. 
The assessment of intention to use genetic services in future may not generalise to actual 
uptake of services.  
4.9 Future implications 
Despite the preliminary nature of this study, the findings have implications for interventions 
with doctors. The self-reported willingness to use genetic services and the desire to learn 
more about genetic conditions and services suggest the benefits of developing educational 
initiatives targeted towards increasing medical doctors’ awareness of genetics and when and 
how to refer patients to genetic services. 
The results also highlight the importance of awareness initiatives so that doctors understand 
where to find information on genetic services and where to obtain advice on conditions that 
they may see in practice, as there are several websites with this information, as well as 
telephonic advice available in Cape Town, Johannesburg, Bloemfontein and KwaZulu-Natal. 
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5 RESEARCH RECOMMENDATIONS 
More research with larger and more diverse groups of medical practitioners (including 
specialists and allied services) is needed to confirm the findings of this research, as the 
sample was small and a larger sample with more representatives could lead to different 
conclusions. 
Deeper insight could be obtained by further developing many of the questions in the survey.  
Research into how many patients doctors have referred to genetic services would be 
valuable. It would also be of interest would also be whether to determine the 
appropriateness of these referrals. 
Studies are necessary to further understand the role of significant predictors in determining 
doctors’ willingness to refer to genetic services. 
Qualitative studies, including in-depth interviews with doctors, would provide additional 
elaboration of why/how the factors identified in this study are important. 
A study on patient needs from genetic services in South Africa, including how patients 
accessed these services, would add clarity to whether patient referrals are appropriate to 
their requirements.  
Further studies on educational topics for genetics training in South Africa, including experts’ 
views on what should be taught, is needed to develop genetics training programmes in 
medical schools and for CME for practising doctors. 
6 CONCLUSIONS 
To my knowledge, this is the first study in South Africa to investigate knowledge and attitudes 
of general practitioners to genetics and genetic services. A variety of questions were asked, 
and answers were obtained to all of them. This study shows that the use of genetic services 
could improve by, in particular, increasing genetic education for doctors in order to help 
them to recognise how, when and where to access genetic services for their patients. The 
doctors are willing to learn more about genetics and this could be achieved through several 
channels, including seminars and talks for CPD points, journal articles and internet sites. 
Participants also understand the value of genetic services as being essential as they do not 
know enough about genetics to manage patients appropriately. This study has helped to 
define two of the four pre-requisites for development of genetics literacy (Gaff et al., 2007, 
cited in de Abrew, Dissanayake & Korf, 2014): 1) recognition of the need; and 2) defining the 
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knowledge and skills required. The third and fourth pre-requisites: developing and 
implementing education programmes and evaluating these programmes, are beyond the 
scope of this study. 
Importantly, this study has determined some indications as to what can be done to make 
genetic services more appropriate to doctors’ needs. Of special interest is fundamental 
education, for instance on basic terminology in genetics, in directed family history-taking for 
genetic conditions such as inherited cancers, and in recognising dysmorphology in young 
children and when this would warrant referral to genetic services. Furthermore, information 
on where to find genetic services and what they can offer for patients is also needed. Annual 
updates on new developments in genetics are important too. The topics mentioned by Burke 
et al. (2009) for undergraduate medical students were also mentioned by GPs inthis study. 
These topics are:  
   i) the ability to identify patients with genetic conditions, with understanding of 
inheritance patterns and basic genetics; 
ii) the ability to manage patients with genetic conditions; 
iii) the ability to appropriately refer patients with genetic conditions; 
iv) the ability to access information on genetics 
v) the ability to understand the uses and limitations of different genetic tests, and 
ethical issues associated with genetic testing; 
vi) the ability to discuss genetic information with patients.  
The development of guidelines for referral to genetic services is also aligned with the doctors’ 
perceived needs. Results from the study indicate that the presence of genetic services does 
not imply that doctors will automatically make use of them, but that other factors, 
particularly the amount of education that doctors have had and whether or not they know 
how to access these services, influence referral to genetic services. The services need to be 
easily integrated into the doctors’ practices and should have a positive influence on patient 
care. Lack of skills and knowledge in genetics was one of the most commonly cited reasons 
for not using genetic services and this could also be addressed through education.  
Additional research is needed to understand whether educational interventions will play a 
role in referring patients to genetic services, but the generally positive attitudes of GPs 
towards genetics and genetic services shown in this study indicate that, with increased 
knowledge, GPs will be more likely to refer patients appropriately to genetic services.  
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Increasing the awareness of genetics and genetic services in South Africa among GPs could 
also influence the Department of Health to implement the policies and frameworks that are 
already in place for genetic services, thus improving care for patients and families who are 
affected by genetic conditions. 
The major findings of this study confirm the findings in other countries by Afroze & Jehan 
(2014), Mikat-Stevens, Larson & Tarini (2014), Tan & Fitzgerald (2014), Delikurt et al. (2015) 
and Rodas-Perez et al. (2015) that doctors feel that they do not know enough about genetics 
and genetic services, and that more education in genetics is the most important factor 
influencing previous referral to genetic services.  
In the words of Nelson Mandela: “Education is the most powerful weapon which you can use 
to change the world” (Baggaley et al., 2013). 
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APPENDIX A: Information Sheet and Informed Consent 
QUESTIONNAIRE: An Investigation into the knowledge and attitudes of 
General Practitioners to Genomics, Genetics and Genetic Counselling 
Survey Information 
You are invited to take part in a survey investigating doctors' knowledge of genetics and their 
attitudes to genetic services in South Africa. This is part of my research for a mini-dissertation 
for a MSc (Genetic Counselling) at UCT. 
The survey is designed to take less than 20 min to answer 40 questions. You do not have to 
answer all the questions but it would be very useful for data analysis if you could answer as 
many questions as possible. Please answer using your working knowledge. There are no right 
or wrong answers as we are interested in your exposure to genetics and your experiences in 
practice. 
The results of this survey will be used to gain insight into how GPs use genetic services in 
South Africa, and how they would like to see them develop in the future. The responses will 
also be used to generate CPD courses in Genetics that are aligned to GPs' needs. A report on 
the answers will be made to all participants if requested. 
All participants who complete the survey will be entered into a lucky draw for a two night 
stay in a one-bedroom apartment in Century City, valued at up to R3000. 
(http://www.myleisuregroup.com/property/Majorca-219/968). 
CONFIDENTIALITY The information obtained will be used in a student's dissertation, in 
congress presentations and for publication without revealing your identity. 
Contact details: Researcher:  Gillian Dusterwald 
                                               Tel: 082 684 5857 
                                               Email: gilldust@gmail.com 
                       Supervisor: Dr Tina Wessels 
                                          Tel: 021 406 6698 
                                          Email: tina.wessels@uct.ac.za 
 
All identifiers will be removed from the competed questionnaire. PLEASE ANSWER 
QUESTIONS AS FULLY AS POSSIBLE 
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Informed Consent 
INFORMED CONSENT 
I, __________________________________________________, (full name) consent 
to participate in the survey titled: An Investigation into the knowledge and attitudes 
of General Practitioners to Genomics, Genetics and Genetic Counselling. 
I understand that I do not have to answer all questions in the survey. 
_____________________________________________________ (Signature) 
_________________________________ (Date) 
 
I would prefer an electronic version (please provide email address):  
 
 
PARTICIPATION IN LUCKY DRAW 
This will be removed and kept separately from the questionnaire and destroyed after 
the draw. 
Name:  
 
Email address:  
 
Telephone number: 
 
Would you like feedback on the results of the study? 
□ Yes 
□ No 
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APPENDIX B The Questionnaire 
QUESTIONNAIRE 
1. Have you ever referred a patient to genetic services? 
□ Yes 
□ No 
 
 
2. Do you think you will refer patients to genetic services in future? 
□ Yes 
□ No 
□ Other : 
 
 
3. Do you know how to access genetic services in South Africa? 
□ Yes 
□ No 
□ Other:    
 
DEMOGRAPHICS  
4. Field of practise 
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5. Age (years) 
□ 20 to 29 
□ 30 to 39 
□ 40 to 49 
□ 50 to 59 
□ 60 to 69 
□ 70 to 79 
□ Other   
6. Gender 
□ Male 
□ Female 
7. When did you qualify? 
 
 
 
8. What qualifications do you hold? 
 
 
 
9. How many years have you worked as a doctor? 
 
 
 
10. Do you have a specific field of interest? If so, what? 
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11. Where is your practice located? 
Fill in as many as apply 
□ Private sector 
□ Public sector 
□ Urban 
□ Rural 
□ Tertiary hospital 
□ Primary care 
□ Academic 
□ Not applicable 
□ Other:  
 
EDUCATION AND KNOWLEDGE 
12. How much genetics education did you receive in undergraduate training? 
□ None 
□ One or two hours 
□ Three to five hours 
□ Five to ten hours 
□ More than ten hours 
□ Don’t know 
□ Other:  
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13. What form did the education take? (Choose as many as apply) 
□ Not applicable 
□ Lectures 
□ Meetings 
□ Self-study 
□ Short course 
□ Other:  
 
14. How much genetics education have you received since graduation? 
□ None 
□ 0 to 3 hours 
□ 3 to 5 hours 
□ More than 5 hours 
□ Other:  
 
15. What form has this education taken? (Choose as many as apply) 
□ Not applicable 
□ Lectures 
□ Meetings 
□ CPD points 
□ Self-study 
□ Short course 
□ Other:  
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16. On a scale of 1 to 5, how confident are you in your knowledge of genetics? 
1- not confident, 2- slightly confident, 3- somewhat confident, 4- confident, 5- very 
confident 
17. Please fill in the table, listing genetic conditions that you have seen in your practice. 
Tick for yes, leave blank for no,? for don’t know. An example has been listed in the first 
row. 
 
  
Name of inherited 
condition 
Genetic test 
available  
Form of inheritance 
Significant 
impact on life 
Autosomal 
dominant 
Autosomal 
recessive 
X-linked Chromosomal Other  ? 
Turner’s syndrome √    √    
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18.  Please fill in the following table, listing specific inherited conditions and what you know 
about them. Tick for yes, leave blank for no, ? for don’t know. Comments in “other”. An 
example has been listed in the first row. 
Name of 
condition 
Know the 
condition 
Seen the 
condition 
in 
practice 
Metabolic 
test 
available 
Genetic 
test 
available 
Carrier 
testing 
available 
Predictive 
testing 
available 
Other 
family 
members 
at risk 
Other 
Turners 
syndrome 
 
√ √  √     
Huntington 
Disease 
 
        
Down 
Syndrome 
 
        
Haemophilia 
 
 
        
Spinal 
Muscular 
Atrophy 
        
Spinocere-
bellar Ataxia 
 
        
Breast 
cancer 
 
 
        
Lynch 
syndrome 
(hereditary 
non- 
polyposis 
colon 
cancer) 
 
        
Cystic 
fibrosis 
 
 
        
Albinism 
 
 
        
Sickle cell 
disease 
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19. Prenatal diagnosis of genetic conditions involves: 
Tick as many as apply 
□ Family history 
□ Ultrasound scan  
□ Non-invasive prenatal testing 
□ Amniocentesis 
□ Karyotype 
□ Testing maternal DNA 
□ Testing paternal DNA 
□ Other:  
 
20. In inherited breast cancer, which is more important: 
□ Maternal history 
□ Paternal history 
□ Neither 
□ Both 
21. Approximately what percentage of breast cancer is inherited? 
□ 1% 
□ 5% 
□ 10% 
□ 15% 
□ 25% 
□ 50% 
□ 100% 
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□ Other:  
 
22. Is a male diagnosed with breast cancer at risk for an inherited mutation even 
without family history? 
□ Yes 
□ No 
□ Other:  
 
23. If a patient with family history screens negative for a BrCa mutation, how should 
she be managed? 
□ As someone at population risk 
□ As someone at higher than population risk 
□ Other: 
 
 
24. Do you know about direct-to-consumer genetic testing? 
□ Yes 
□ No 
□ Other:  
 
25. Do you think you may be approached to interpret results of a direct-to-
consumer genetic test in future? 
□ Yes 
□ No 
 
 
 
 
107 
 
□ Other:  
 
 
26. What does the term “VOUS” indicate in a direct-to consumer genetic test 
result? 
□ Various outstanding samples 
□ Variable or unknown status 
□ Variant of unknown significance 
□ Variety of undetected SNPs 
27. When is it appropriate to refer a child under the age of 18 for a genetic test? 
Choose as many as necessary 
□ When parents request a test 
□ When the child requests the test 
□ When a child is symptomatic 
□ When a parent has a genetic condition 
□ When a sibling has a genetic condition 
□ When a second degree relative has a genetic condition 
□ When treatment or management is available that could prevent or delay the 
onset of a genetic condition 
□ None of the above 
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GENETIC SERVICES 
Please take time to think about these questions and answer as fully as possible. Your 
responses will help us to develop education programmes for medical professionals. 
28. Which medical professionals should refer to genetic services? 
 
 
 
 
 
 
29. What, in your view, is the role of a genetic counsellor? 
 
 
30. Are genetic services: 
□ Indispensable 
□ A luxury 
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□ Pointless 
□ Other:  
 
31. Is genetic counselling: 
□ Indispensable 
□ A luxury 
□ Pointless 
□ Other:  
 
32. Please explain your answers to 30 and 31 above: 
 
 
 
 
 
 
33. What do you think about your knowledge of genetics? 
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34. What sort of further education on genetics, if any, would you like? 
 
35. Would you like improved access to genetic services? 
□ Yes 
□ No 
□ Access is sufficient 
□ Other:  
 
35a. If your answer to the above is “yes”, what form should this improved access 
take? 
□ More visibility 
□ Telephonic support 
□ Internet support 
□ Increased education (e.g. for CPD points) 
□ More services 
□ Other  
 
 
 
 
 
 
 
111 
 
36. What needs do you have from genetic services in South Africa? 
 
37. What would you do if a patient approached you with results from a direct-to-
consumer genetic test? 
 
38. How can we make genomics more accessible to clinicians in South Africa? 
Genomics refers to whole genome science and includes genome sequencing that is  
already available to consumers online. 
 
39. Do you think that pharmacogenomics will have an impact on prescribing 
medications in the future? 
□ Yes 
□ No 
□ Other:   
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40. If you haven’t used genetic services previously, why not? 
□ Not necessary 
□ Too busy 
□ Forget 
□ Difficult to access 
□ Other:  
 
If this questionnaire is completed after the genetics session, have your answers 
changed because of this session? If so, which questions and why? 
 
 
PLEASE LEAVE COMPLETED QUESTIONNAIRES IN 
MARKED BOX AT DOOR 
 
 
 
  
 
 
THANK YOU FOR YOUR 
PARTICIPATION 
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APPENDIX C Completed table of correct answers for listed inherited 
conditions 
18.  Please fill in the following table, listing specific inherited conditions and what you know 
about them. Tick for yes, leave blank for no,? for don’t know. Comments in “other”. An 
example has been listed in the first row. 
Name of 
condition 
Know the 
condition 
Seen the 
condition 
in 
practice 
Metabolic 
test 
available 
Genetic 
test 
available 
Carrier 
testing 
available 
Predictive 
testing 
available 
Other family 
members at 
risk 
Other 
Turners 
syndrome 
 
√ √  √     
Huntington’s 
Disease 
 
   √  √ √  
Down 
Syndrome 
 
   √   Sometimes  
Haemophilia 
 
 
  √ √ √  √  
Spinal 
Muscular 
Atrophy 
   √ √  √  
Spinocerebellar 
Ataxia 
 
   √  √ √  
Breast cancer 
 
 
   √  √ √  
Lynch 
syndrome 
(hereditary 
non- 
polyposis colon 
cancer) 
 
   √  √ √  
Cystic fibrosis 
 
 
  √ √ √  √  
Albinism 
 
 
   √ √  √  
Sickle cell 
disease 
 
   √ √  √  
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APPENDIX D Table of doctors’ qualifications 
Qualification MBChB.or 
equivalent 
(%) 
MBChB or 
equivalent 
plus 1 other 
qualification 
no. (%) 
MBChB plus 2 
other 
qualifications 
no. (%) 
MBChB plus 3 
or more other 
qualifications 
no. (%) 
Totals 
 21 (42.9) 13 (26.5) 9 (18.4) 6 (12.2) 49  
Dip Child Health   2  3 5 
(10.2) 
M Fam Med  1 2 2 5 
(10.2) 
Dip 
Anaesthetics 
  1 3 4 (8.2) 
Fellow of 
College of 
Family 
Physicians 
 1 2 1 4 (8.2) 
Dip Fam Med  2 1 1 4 (8.2) 
Dip Pall Med  1 1 1 3 (6.1) 
Dip Obstets  1 1  2 (4.1) 
MSc   1 1 2 (4.1) 
MCPCPZ  2   2 (4.1) 
M Maternal and 
Child Health 
 1   1 (2.0) 
HIV/AIDS 
management 
dipl 
   1 1 (2.0) 
Dip Primary 
Emergency Care 
  1  1 (2.0) 
MP Ax Med   1  1 (2.0) 
BSc Nutrition    1 1 (2.0) 
Exec MBA  1   1 (2.0) 
PG Dip Business 
Management 
  1  1 (2.0) 
PDD    1 1 (2.0) 
Mem Royal 
College of 
General 
Practitioners 
 1   1 (2.0) 
DCh   1 1 2 (4.1) 
MFHomeopathy    1 1 (2.0) 
COACH Conflict 
coaching 
international 
   1 1 (2.0) 
MFGP   1  1 (2.0) 
Certificate in 
Travel Health 
  1  1 (2.0) 
Mem College of 
Family 
Physicians 
 1   1 (2.0) 
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NBA   1  1 (2.0) 
BVetSc  1   1 (2.0) 
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APPENDIX E Complete tables of comments 
Reasons for not previously using genetic services 
Option Numbers (%) *Comments 
Difficult to access 17 (44.7) ?? because my 
knowledge limited. 
 
Thus indirect referrals. 
 
Expensive.  
 
Not necessary 11 (28.9) I did not need them. I am 
unemployed for a while 
already. If there were cases I 
would refer patients first to the 
specialists to avoid 
misinformation. 
 
Patients already diagnosed 
when I see them. 
 
Not relevant in my practice - 
only do disability grant 
applications. But have friends / 
contacts who ask me for advice 
and direction. 
 
Work overseas, when in S.A. 
work in day hospitals. ?relevant 
when std of care is so poor. 
 
Not recognised a need. 
 
Patients never requested 
referral. 
 
Other 10 (26.3) Didn’t know I could. 
 
No knowledge. 
 
First must refer to specialist – 
HOSPITAL PUBLIC. 
 
Not sure what they are 
offering. 
 
I found my colleagues were not 
aware of services. 
 
Forget 3 (7.9) Dealing with subeconomic 
patients, so reliant on state 
referrals. 
 
 Ignorance of non-mainstream 
awareness of possibilities. 
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Too busy 2 (5.3)  
 
 
What doctors want from further genetic education 
Theme and Category No. of 
responses* 
Illustrative examples 
Theme 1: Forum for education 
     Category :Conferences 
 
      
 
 
 
    
                         
                         
 
 
  
Lectures 
             
              
            Seminars to public                       
            hospitals 
            Outreach tutorials 
                       Short courses 
     
 
 
 
    
                        
                    CME 
     
    
 
                       
                      
                  Refresher courses 
     
 
    
                     Counselling  
                     sessions 
    
16 
    
   6 
 
     
 
 
 
     
    
 
 
 
5 
        
         
        1 
        
       1 
    3 
     
 
 
 
   
    
 3    
 
     
    
    
     
     2 
     
 
     
   1     
 
 
•annual UCT GP conference 
•Education on genetics does not 
happen often. Congresses and 
medical journals should bring more of 
this. 
•Also a section (maybe morning or 
afternoon, 2 - 3 lectures) at a 
conference like this. 
•Part of regular lecture / conference. 
Been absent in the PAST. 
 
•Small group study lectures  
•REGULAR LECTURES 
•Workshops 
•Part-time / distance learning with 
contact sessions - towards a 
certificate 
 
•Short courses, starting with the 
basics, including information about 
indications for referral and contact 
details of referral centres. 
 
 
 
•Seminars at CME events 
•Ongoing CME lectures at eg 
Constantiaberg and Kingsbury 
hospitals - already have CME 
programs in place. 
 
•Refresher courses on genetics. 
•Refresher courses which teach about 
the advances in diagnosis, prognosis 
and management of genetic diseases. 
 
•What genetic counsellors do? To sit 
in on counselling sessions. Common 
genetic conditions - to attend a genetic 
clinic and see these conditions. 
 
Theme 2: Topics 
       Basics 
          
 
10 
    8 
         
 
 
• Going back to basics 
• A basic course with presentation of 
information useful in the GP setting. 
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     Services 
 
          
          
       
 
      Tests available 
 
         
      Genetic conditions 
    
 
 
 
       
 
     Referral guidelines 
     
 
    
 
      
     Genetic counselling 
     
     
 
   
      
     Screening 
     
      
      
    Management 
     
 
 
     
 
      New developments 
 
         
 
        
      
       2 
 
 
        
        
 
      5 
 
         
        5 
 
 
 
 
         
 
     5 
 
 
     
 
          
     2 
 
 
 
 
      
       3 
 
        
       
      7 
 
 
 
      
  
     3 
•Basic and new developments and 
testing 
•Basic information about 
TERMINOLOGY used in Genetics 
 
•what genetics clinics offer. 
•Basic services available 
•Genetics in primary health care 
• what is available, where and when to 
use 
 
• Info re tests available 
• New tests and how easy they are to 
do. 
  
• Common genetic conditions 
• Reminders of genetic conditions to 
help us pick them up 
• Prioritized to important common 
conditions /problems 
 
• Referral guidelines 
• Need to know what is available, 
where and when to use / refer 
• information about indications for 
referral and contact details of referral 
centres 
 
• To acquire knowledge to be able to 
provide further genetic counselling to 
patients in the community (particularly 
after they've been discharged from the 
clinic) 
•What genetic counsellors do? 
 
• Clinically orientated screening  
•Assistance in early detection and 
screening 
 
•GP oriented courses to help me 
better serve my patients and their 
communities 
• what interventions are available to 
minimise morbidity 
 
• What new developments there are.  
•.Updates on new developments 
 
 
Theme 3: Resources for self-
study 
      Internet/technology 
       
 
 
      Print media 
       
 
 
10 
     
   7 
     
 
 
    3 
     
 
 
 
 
• Short online course 
• Access to a good website 
• Email 
• Phone apps? 
 
• Have a booklet in my practice 
covering "genetics 101" 
• Advice sheets 
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           • Journal articles about what genetics 
clinics offer. 
Theme 4: Not applicable 
      Retired 
1 
    1 
 
•Too late! 
                
*Note Some responses were complex and therefore classified multiple times into themes and/or 
categories, so numbers do not add up  
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                  Self-reported thoughts on genetics knowledge* 
Theme and category Number of 
responses 
Illustrative examples 
Theme 1: Very poor 
   Little 
knowledge 
    
 
 
 
 
 
 
 
    
    
 
 
 
 
 
 
    
 
 
 
     
       
 
Need 
education 
    
    
     
 
 
 
 
 
   Non-
existent 
    
36 
   29 
    
 
 
 
 
 
 
 
    
         
 
 
 
 
 
 
      
 
 
 
      
         
 
 
      6 
 
   
      
 
 
 
 
   
       
2 
 
    
 
• Virtually zero knowledge which is not really 
acceptable. 
•My knowledge is very little - definitely 
sub-optimal! 
•Very little! I'd like to know more. 
• My personal knowledge is very 
limited. 
• My knowledge is very little. I  
personally don't know much besides 
breast cancer, bowel cancer, which was 
found with neighbours and family 
members. 
• Poor - inadequate 
•MUCH too little knowledge 
•Way inadequate 
• Very sketchy 
•Very, very marginal 
• Not sufficient at present 
• lots of gaps 
• I have a basic knowledge of a few 
conditions and principles of genetics but 
feel that I do not have adequate 
knowledge to confidently diagnose and 
manage all genetic conditions 
 
• Poor. Needs updating 
• Nil. Need education 
• I need to know a lot more. 
•I would love to learn and know more. I 
realise I have many "gaps" BUT usually 
would ask for advice/ help from 
specialists / colleagues. May diagnose 
more conditions with more awareness 
of testing / implications / presentation. 
 
• Non-existent. Woeful! 
 
Theme 2: Could be 
better 
4 • Could always improve, probably in the context 
of ongoing developments in the field. 
• Middle of the range 
 
Theme 3: Good 2 • Fair to good 
• Good teaching in undergraduate at UCT. 
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Complete list of conditions seen in practice 
Name of 
inherited 
condition  
No. 
citing 
conditi
on 
Genetic 
test• 
√availa
ble (no. 
of 
respons
es)  
Mode of inheritance/ (no. of 
respondents)/ √correct mode of 
inheritance 
Significan
t impact 
on life 
(no. of 
responde
nts) 
%correct  
A
D 
AR XL Chromos
omal 
Oth
erˠ 
 
Testing/inheri
tance 
 
Achondroplasia  1 √ √     Y (1) 
 
 
 
0/0 
Albinism 
 
5 √(4)  √(
3) 
 (1) (2) 
 
 
 
 
Y(4) 80/60 
*Asthma 1      √(i) 
 
 
 
Y(1) - 
*Attention 
deficit disorder 
 
1      √(i)1 
 
 
 
 
Y(1) -/100 
Barth 
Syndrome  
 
1 (1)   √(
1) 
  
 
 
 
 
Y(1) 0/100 
Breast cancer 
(BRCA)       
 
 
9 √(8) √(
3) 
 (2)  (2) 
 
 
 
 
Y(6) 89/33 
Cleft lip/palate  3  √    √(i)2 Y(2) -/67 
Cystic fibrosis  11 √(8) (2) √(
7) 
   Y(10) 73/64 
*Diabetes 3 (1)     √(i)3 Y(3) -/100 
Down 
syndrome 
32 √(28) (2) (2) (1) √(26) (1) Y(27) 88/81 
Duchenne’s 
muscular 
dystrophy  
1 √   √   Y(1) 0/0 
Epiphyseal 
dysplasia  
1 √ √ √     0/0 
Factor V Leiden  1 √(1) √      100/0 
Familial 
hypercholestrol
aemia 
4 √(2) (2) √(
2) 
 (1)  Y(3) 50/50 
Familial 
adenomatous 
polyposis  
2 √(1) √(
2) 
(1)    Y(2) 50/100 
Fanconi’s 
anaemia  
1 √  √ √  (1) Y(1) 0/0 
Foetal alcohol 
syndrome  
1 (1)     √(i)1 Y(1) 0/100 
Haemophilia  7 √(7)  (2) √(
4) 
  Y(2) 100/57 
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Huntington’s 
Disease  
6 √(5) √(
5) 
  (1)  Y(5) 83/83 
Hypertension 1  (1)    √ (i) Y(1)  
          
Name of 
inherited 
condition  
No. 
citing 
conditi
on 
Genetic 
test• 
√availa
ble (no. 
of 
respons
es)  
Mode of inheritance/ (no. of 
respondents)/ √correct mode of 
inheritance 
Significan
t impact 
on life 
(no. of 
responde
nts) 
%correct  
A
D 
AR XL Chromos
omal 
Oth
erˠ 
 
Testing/inheri
tance 
Klinefelter’s 
syndrome  
2 √(2)  (2) (1) √   100/0 
Marfan’s 
Syndrome  
4 √(1) √(
3) 
    Y(4) 25/75 
Metabolic 
syndrome  
1      √ (i) Y(1) - 
Muscular 
dystrophy  
1 √(1) (1)  √    100/0 
Myotonic 
dystrophy  
1 √ √ (1)  (1)  Y(1) 0/0 
Neurofibromat
osis  
1 √(1) √(
1) 
    Y(1) 100/100 
*Pancreatic 
cancer  
1 (1)      Y(1) - 
*Pierre Robin 
Sequence  
1 (1)    (1)  Y(1) - 
Porphyria  1 √ √(
1) 
     0/100 
Prader-Willi 
Syndrome  
1 √(1)    √(1)  Y(1) 100/100 
Recessive 
disorders  
2       Y(2)  
Retinitis 
pigmentosa  
2 √ √(
1) 
√(
1) 
√ 1 √ (ii) Y(2) 0/100 
Schizencephaly  1      √ (i) Y(1)  
Schizophrenia  1      √ 
(i)(2) 
Y(2) 0/100 
Sickle Cell 
Anaemia  
8 √(6) (1) √(
4) 
   Y(7) 75/50 
Spina bifida  3 (2)     √(i)1 Y(3) - 
Spinal muscular 
atrophy  
1 √  √(
1) 
   Y(1) -/100 
Spinocerebellar 
ataxia   
2 √      Y(2) 0/0 
*Stevens-
Johnson 
Syndrome  
1  (1)    √ (i)  - 
Sturge-Weber 
syndrome  
1  (1)     Y(1) - 
Thalassemia  5 √ (1) √(
3) 
    0/60 
Triple X 1 √    √   0/0 
Tuberous 
sclerosis  
1 √ √(
1) 
    Y(1) 0/100 
Turners 
Syndrome 
2 √(2)    √(2)  Y(2) 100/100 
Von 
Willebrand’s 
disease  
1 √(1) √ √ √    100/0 
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*not commonly seen in genetic clinics. While all conditions are to some extent genetic, only those that are seen 
in genetic clinics are accepted as “correct” answers here  
• genetic tests said to be available if they are mentioned on Gene reviews.  
ˠ i) multifactorial, ii) mitochondrial  
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Knowledge and awareness by doctors of 10 inherited conditions. √ correct answer 
X incorrect answer 
Name of 
condition 
*Know 
the 
condition 
 
*Seen the 
condition 
in 
practice 
Metabolic 
test 
available 
Genetic 
test 
available 
Carrier 
testing 
available 
Predictive 
testing 
available 
Other 
family 
members 
at risk 
Huntington’s 
Disease 
 
32 
(68.1%) 
16 
(34.0%) 
X1 (3.1%) √ 21 
(65.6%) 
X 17 
(53.1%) 
√ 5 
(15.6%) 
√23 
(71.9%) 
Down Syndrome 
 
46 
(97.9%) 
41 
(87.2%) 
X1(2.2%) √38 
(82.6%) 
X5 
(10.9%) 
X14 
(30.4%) 
√ in 
certain 
circum-
stances 
5 (10.9%) 
Haemophilia 
 
 
40 
(85.1%) 
 
23 
(48.9%) 
5 (12.5%) √29 
(72.5%) 
√21 
(52.5%) 
X10 
(25.0%) 
√19 
(47.5%) 
Spinal Muscular 
Atrophy 
 
22 
(46.8%) 
8  
(17.0%) 
1 (4.5%) √5 
(22.7%) 
√4 
(18.2%) 
X1(4.5%) √5 
(22.7%) 
Spinocerebellar 
Ataxia 
 
16 
(34.0%) 
6  
(12.8%) 
0 (0.0%) √4 
(25.0%) 
X1 
(6.3%) 
√0 (0.0%) √4 
(25.0%) 
Breast cancer 
 
 
47 
(100.0%)  
 
43 
(91.5%) 
2 (4.3%) √28 
(59.6%) 
X21 
(44.7%) 
√19 
(40.4%) 
√32 
(68.1%) 
Lynch syndrome 
(hereditary non-
polyposis colon 
cancer) 
 
15 
(31.9%) 
4  
(8.5%) 
0 (0.0%) √6 
(40.0%) 
X3 
(20.0%) 
√2 
(13.3%) 
√10 
(66.7%) 
Cystic fibrosis 
 
 
43 
(91.5%) 
 
24 
(51.1%) 
13 (30.2%) √28 
(65.1%) 
√15 
(34.9%) 
X9 
(20.9%) 
√17 
(39.5%) 
Albinism 
 
 
35 
(74.5%) 
 
21 
(44.7%) 
1 (2.9%) √9 
(25.7%) 
√6 
(17.1%) 
X4 
(11.4%) 
√9 
(25.7%) 
Sickle cell disease 
 
36 
(76.6%)  
 
18 
(38.3%) 
5 (13.9%) √19 
(52.8%) 
√14 
(38.9%) 
X4 
(11.1%) 
√17 
(47.2%) 
*Percentages for Know the condition and Seen the condition as a proportion of the 47 
respondents who filled in the table. All other percentages as a proportion of the number of 
people who knew the condition. 
 
 
125 
 
What doctors would do if a patient approached them with results from a direct-to-
consumer genetic test 
Themes and Categories Number of responses* Illustrative examples † 
Theme 1: Refer 
     
 Refer to 
colleagues/specialists ‡ 
     
 
     
 
 
 
 
    
Refer to genetic services 
20 
 
4 
 
 
 
 
 
 
 
 
8 
 
 
 
 
 
 
 
 
 
 
•Refer to a more 
knowledgeable colleague.  
•Depending on condition 
would refer if confirmation 
needed and intervention 
warranted (eg BrCa) 
•Currently would probably 
refer them to a specialist  
 
•Refer to a genetic 
counsellor 
•Will probably refer to a 
Genetic unit 
•I would refer them to 
specialist and genetic 
services. This information 
should be given to the 
patient under proper 
guidance and explanation.  
•1. Liaise with genetic 
counselling services 2. 
Ensure that patient undergo 
aforementioned (counselling 
service) 3. Explain the 
importance of discussion of 
condition with a specialist 
service (i.e. face-to-face)  
 
Theme 2: Ask for 
advice/seek information 
      
    Genetic services 
      
     
  
 
 
 
 
 
 
 
 
 
 
 
     Direct to consumer test 
     company 
 
 
 
 
 
26 
 
 
     9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     4 
 
 
 
 
 
 
•Call for help!!  
•Phone an expert 
 
•Seek assistance from the 
genetic services in SA 
•Call a genetic expert to 
assist with interpretation. 
•Phone genetics clinic at 
GSH and ask for advice. 
•needs advice and support 
from SA gen. services 
•I would attempt to contact a 
colleague at the Genetic 
services to ask for 
assistance / advice on my 
further steps to be done / 
taken to assist the patient.  
 
•First check the reliability of 
the company doing the test 
•Refer back to direct to 
consumer genetic tester 
•Most likely call the lab that 
did the test and speak to a 
consultant 
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     Colleague 
 
 
 
      
     Self-study 
 
 
 
 
     6 
 
 
 
      
    6 
•Phone the company who 
did the test for help. Look up 
on internet? 
 
•Ask advice from colleague 
with training 
•I would ask a colleague if 
they have heard of it? 
 
•? learn more on the 
condition. 
•I would research the results 
to learn how to help them 
interpret the results 
•Get onto www! 
•To research on internet and 
also can phone a tertiary 
level hospital to help me 
understand and to explain to 
the patient. 
•Panic - Need to obtain 
information therefore go to 
internet. 
 
Theme 3 Interpret results 12 •Help the patient to interpret 
the results. 
•Consider my own clinical 
assessment of patient. It 
would help if the parameters 
of the validity of the tests are 
cited with the results. 
•I would research the results 
to learn how to help them 
interpret the results 
•May ask patient to come 
back for another 
appointment to get the best 
information to give the 
patient the best answers. 
•Interpret them. 
•Try to figure out the result. 
•Provide support until info 
obtained, then counsel. 
 
Theme 4 Don’t know  4 •I have no idea!  
•? 
•Don't know. Depends on 
what the issue is. - Refer the 
problem. I have no 
knowledge at all. 
 
*Note Some responses were complex and therefore classified multiple times into themes 
and/or categories, so numbers do not add up 
†only a few illustrative comments are quoted here. A full list appears in Appendix 5.2   
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Themes, categories and examples of responses on how to make genomics more 
accessible to clinicians in South Africa.  
Themes and Categories Number of 
responses* 
Illustrative 
examples† 
Theme 1: Raising 
awareness 
 Advertising and 
marketing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
 
 
 
 
     Internet  
 
 
 
 
 
      
     
 
    Other media 
18 
 
    5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
 
 
 
 
 
     6 
 
 
 
 
 
 
      
 
 5 
 
 
•Advertise widely. 
Reduce price and 
make it affordable 
for man in the street 
•more marketing of 
Medicine + of 
science (as whole) 
to the people with 
resources. 
•More visibility 
•Direct marketing of 
information? Reps? 
•Advertise online 
services 
•There could be 
more awareness 
and information. 
•One can always 
check the internet, 
but medical 
professionals 
should know where 
exactly to look for 
information. 
 
•Internet access 
promoted by SAMA 
•On-line 
•Website – 
interactive. 
•Internet support 
•website  + apps? 
 
•Magazines – CPD 
•Telephonic 
support 
•Advice sheets 
 
 
Theme 2: 
Education/information 
     Lectures, 
workshops, CPD  
 activities 
 
 
 
 
      
 
     Information 
 
 
 
18 
     6 
 
 
 
 
 
      
 
 
   5 
 
 
 
 
•Through CPD 
activities 
•Through this kind 
of lecturing venue. 
•Write articles in 
SAMJ esp •CME 
section of SAMJ 
 
•Give us more 
information re 
services + cost + 
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        Education 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
     
 
 
 
 
 
 
 
 
   9 
availability - via 
email / post 
•Perhaps informing 
clinicians firstly of 
this availability and 
means to access it. 
•Clarify relevance 
which I understand 
and which can help 
me explain to 
patients. 
•medical 
professionals 
should know where 
exactly to look for 
information. 
•Provide 
information to 
health care 
providers, who can 
pass it on to the 
patients. 
 
•Teach us to 
interpret the results 
and reassure 
patients if no 
problems with 
results. 
•-educate! educate! 
educate! - make 
subject matter more 
user friendly!!! 
•provide training on 
the rational use of 
these genomics 
and safe use as 
well as how to 
assist / advise 
patients they 
referred to it with 
queries / 
interpretation 
thereof. 
•Provide a short 
course and market 
it well. 
 
Theme 3: Increase 
accessibility 
8 •I was not aware 
that it is available to 
consumers online. 
•Need to know 
where to access 
information. 
•Easy 
approachability 
•1.More visibility 2. 
Contact numbers to 
be held in surgeries 
3. Genetics contact 
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•Perhaps informing 
clinicians firstly of 
this availability and 
means to access it. 
•Make it accessible 
as a routine blood 
test. 
•Make them 
practical 
 
Theme 4: Don’t know 5 NO IDEA 
I'm not sure. 
I don't know 
 
*Some responses were complex and therefore classified multiple times into themes and/or categories, so 
numbers do not add up 
†only a few illustrative comments are quoted here. A full list appears in Appendix 5.2   
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Medical professionals who should refer to genetic services 
Medical professional Number of 
responses* (%) 
Illustrative comments† 
Theme 1 Specialists 
        Paediatricians 
        Neonatalogist 
        Gynaecologists/                         
obstetricians 
        Internal medicine 
physicians 
        Neurologists 
        Surgeons  
       Oncologists 
       Psychiatrists 
15 (29.4) 
     9 (17.6) 
     1 (2.0) 
     8 (15.7) 
      
     4 (7.8) 
      
     1 (2.0) 
     2 (3.9) 
     1 (2.0) 
     1 (2.0) 
•Specialist should be the medical 
professionals to refer. Only they have 
all the details, full diagnosis. They 
would also decide about further 
treatment/ prevention/ management. 
 
•Those who diagnose genetic 
conditions most likely specialists rather 
than GPs. 
 
Theme 2 All 
   
 
 
 
 
 
 
 
              
 
     
    Needs basis 
    37 (72.5) 
 
 
 
 
 
 
 
 
  
 
    
 5 (9.8) 
 
 
 
 
 
 
 
 
•All should be able to. 
•Concerned medical professionals of 
the whole spectrum. 
•All health professionals should be 
aware and refer. 
•Any medical professional picking up / 
suspecting a genetic abnormality / 
condition in any patient. Whether a 
surgeon, GP, neurologist etc. anyone 
can diagnose a genetic condition. 
 
•Where is the need or special case. 
•Anyone to assist with diagnosis - 
provided understand what services 
offer and where appropriate. 
•All doctors suspecting a genetic 
condition or where counselling is 
needed 
 
Theme 3 General 
Practitioners 
18 (35.2) •GPs especially 
Theme 4 Nurses  9 (17.6) •Nurse practitioners 
•Nurses in medical practice 
•Registered nurses  
•Professional nurses (in discussion with 
doctors) 
 
Theme 4 Institutions  1 (2.0) •GSH (Groote Schuur Hospital) 
•TBH (Tygerberg Hospital) 
 
Theme 5 Laboratories 1 (2.0) •Pathology lab 
Theme 6 Allied services  1 (2.0) •Psychologists, OTs (occupational 
therapists) and Physios 
*Some responses were complex and therefore classified multiple times into themes and/or categories, so 
numbers do not add up †only a few illustrative comments are quoted here. A full list appears in Appendix 5.2   
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Doctors’ responses to roles of genetic counsellors 
Themes Numbers (%)* Illustrative examples† 
Theme 1 Critical thinking 
skills 
    Risk assessment 
       
       
         Patients 
         
 
 
        Families/ pregnancy 
        planning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Advice and guidance 
   
 
 
 
 
   
    
              
             Patients 
             Families/ 
pregnancy planning 
 
 
 
 
 
 
38 (74.5) 
 
    13 (25.5) 
   
  
        4 (7.8) 
 
 
 
        10 (19.6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    11 (21.6) 
   
 
 
 
 
   
   
         
         3 (5.9) 
         7 (13.7) 
     
 
 
 
 
 
 
 
 
•Assess risk of genetic 
condition. 
 
•Explaining the risk of genetic 
conditions to families and for 
people who have the 
condition already. 
•…recurrence of cases in a 
family. 
•To inform parents of risks of 
inheriting conditions. 
•Chances of children 
inheriting the disease. Other 
family members at risk. 
•…risk of passing deformity / 
carrier gene to offspring. 
•Very important when 
planning pregnancy where 
known genetic condition is in 
the family or where genetic 
condition diagnosed and the 
family members may be 
affected by latent condition 
eg Huntington's disease. 
•… educate them on 
prognosis, management 
options and future risk. 
 
•Someone with genetic 
knowledge who can advise on 
likelihood of certain 
outcomes. 
•….suggestions on 
management. 
•…..advising about choices 
•…..direct further 
management 
•……what to do if a result is 
positive. Counsel patient (and 
family) post-test and plan 
way forward. 
•TO ADVISE THE WHOLE 
FAMILY  
•To provide accurate and 
informative guidance to 
families with genetic 
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    Genetic testing 
 
      
              
             Patients 
             Families 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Diagnosis and screening 
 
 
 
      
 
             
             Patients 
             Families 
 
 
 
 
 
 
 
 
 
    9 (17.6) 
 
      
 
4 (7.8)  
      
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     5 (9.8) 
 
 
 
 
 
         
        8 (15.7) 
        2 (3.9) 
      
 
 
 
 
 
diseases. 
•To prepare family/pt for test 
- implications of the results. 
•Advice about if they should 
or should not do the test in 
the first place. 
•…advise re planning for 
children. 
 
•Very important and 
essential prior to any genetic 
testing 
 
•Counsel patient (and family) 
post-test. 
•…..counsel patients, test 
those possibly affected. 
•Explain the test, what 
positive and negative findings 
mean, and what one may gain 
by doing the test. To assist  
ith family decision making on 
basis of test. 
•To prepare family/patient 
for test - implications of the 
results. 
•To help the patient and 
family understand the 
implications of testing and 
the implications of results.  
 
•To make the diagnosis. 
•…guide for suitable 
screening in genetic 
conditions. 
•To advise, screen and assist 
in diagnosis.  
 
•Counsel parents and 
patients on possible diagnosis 
of genetic condition.  
•Very important in terms of 
communicating with and  
ʺholdingʺ families' anxieties 
and formulating a diagnostic 
plan. 
 
Theme 2 Interpersonal, 
counselling and 
psychosocial skills 
      
30 (58.8) 
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     Counselling 
  
 
 
 
 
 
 
 
       
 
 
        Doctors 
       
       
        Patients 
        Families 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Support, help and 
assistance  
      
 
 
        Doctors 
      
 
 
 
 
        Patients 
     
  
 
18 (35.3) 
 
  
 
 
 
 
 
 
   
 
 
        1 (2.0) 
  
 
        8 (15.7) 
        7 (13.7) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    12 (23.5) 
 
 
 
 
        2 (3.9) 
 
 
 
 
 
        4 (7.8) 
 
 
 
•Counselling for genetic 
conditions 
•Explain and counsel genetic 
conditions 
•Inform, prepare, support. 
Not to add anxiety + stress 
•To understand the nature of 
the disease. 
•Discuss the problem with 
the disorder as to outcome, 
future treatment 
 
•Counselling of doctors and 
patients  
 
•Counsel patient (and family)  
•Assist patient and/or family 
to ʺwalk the journeyʺ whilst 
attending genetic clinic. 
•To discuss with parents or 
patient the risks and 
management of genetic 
disorders. 
•Someone who addresses all 
fears and concerns and facts 
of the specific condition with 
the patient and the rest of the 
family. 
•Very important in terms of 
communicating with and 
ʺholdingʺ families' anxieties 
and formulating a diagnostic 
plan. 
•Counselling individuals, 
couples and families. 
 
•To help in management of 
burden 
•Long-term support 
•Offer support (emotionally) 
 
•To offer support patient and 
doctor.  
•To help with this 
complicated issue about 
which I know nothing. 
 
•This assists with the social 
and financial welfare of the 
patient. 
•To support high risk patients 
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        Families 
 
 
        2 (3.9) 
 
 
 
•….to support families with 
genetic defects. 
•expert knowledge to assist 
families. 
 
Theme 3 Communication 
skills 
    
   Education and 
information 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
        Patients 
    
 
       
        Families 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Options, informed 
 choice, decision making 
 
28 (54.9) 
 
 
    21 (41.2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        7 (13.7) 
 
 
 
        8 (15.7) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 (13.7) 
 
 
 
 
 
•Provides reliable 
information on the 
incidences, presentation, 
prognosis, complications, 
relevant treatment including 
rehabilitative actions on 
various genetic disorders. 
•To supply information and 
guide for suitable screening in 
genetic conditions and 
possible (uncertain) genetic 
inheritance. 
•Very important - to explain 
process and what is about. 
•To provide comprehensive 
knowledge. 
 
•Provide information which is 
understandable by the 
patients. 
 
•educate patient about 
condition. 
•He/she needs to explain to 
the family/patient the 
possibilities/complications of 
a disease, preventive 
measurements like 
contraception/recurrence of 
cases in a family. 
•To educate patient and 
family. 
•Profile and needs of genetic 
condition. Effects on rest of 
family. 
•Explain the condition AND 
its mode of transmission to 
family. 
 
•Someone with genetic 
knowledge who can advise on 
likelihood of certain 
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        Patients 
        
 
        Families 
 
 
 
 
 
        2 (3.9) 
 
 
        4 (7.8) 
 
 
 
 
 
 
 
outcomes. 
•Treatment options / 
interventions 
•Education (informed choice) 
•Inform patient. Discuss 
possible outcomes. 
 
•Counselling the family on 
management plans + options 
available for their affected 
child or patient. 
•To assist with family 
decision making on basis of 
test. 
 
 
Theme 4 Professional 
Ethics and Values 
 
   Network, 
multidisciplinary team 
 
        Patients 
        Family 
 
 
 
 
 
 
 
    Professional 
4 (13.7) 
 
 
    4 (7.8) 
 
 
        1(2.0) 
        2 (3.9) 
 
 
 
 
 
 
 
    4 (5.9) 
 
 
 
•… provide a network of 
support services 
 
•To form part of the 
multidisciplinary team 
managing a patient/family 
diagnosed with a genetic 
disease/condition. 
•…network with allied 
professionals to support 
families with genetic defects.  
 
•…..specially trained to deal 
with these complex matters 
•Professionals 
•Expert knowledge to assist 
families 
 
*Some responses were complex and therefore classified multiple times into themes and/or categories, so 
numbers do not add up 
†only a few illustrative comments are quoted here. A full list appears in Appendix 5.2   
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Themes pertaining to answers around value of genetic services 
Themes * Number (%) † Illustrative quotes‡ 
Theme 1 Complete health 
service 
        Indispensable 
 
3 (6.4)  
•An holistic health  
service needs genetic 
services. 
•Why discriminate patients 
with genetic disorders just  
because services are 
EXPENSIVE?  
•A necessary luxury. 
 
Theme 2 Resources  
     Luxury 
2.1  
•Unfortunately in state sector 
where time with patients is so 
pressured and budgets are 
constrained, it is a luxury. 
Even in private, the cost to 
many patients is prohibitive 
Theme 3 Support 
     Necessary 
2.1  
•…especially with 
psychosocial support 
Theme 4 Knowledge - 
increasing 
     Indispensable 
2.1  
•Genetic services are very 
important and as more 
conditions are found to be 
linked to genetic 
background eg. Breast 
cancer 
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Themes pertaining to answers around value of genetic counselling 
Themes Number (%) Illustrative quotes 
Theme 3 Support 
   Indispensable 
6.4  
•Psychosocial support. 
•Genetic counselling is 
crucial to help parents and 
families deal with rare 
conditions that will have 
lifelong consequences. 
Theme 5 Management 
    Indispensable 
6.4  
•… essential to help manage 
other risk factors. 
•…. vital - patients need full 
information and 
instructions. 
•… helps prepare parents in 
the event of a child with 
potential medical/ social/ 
physical difficulties 
 
Theme 6 Access 
    Indispensable 
 
 
 
    
  Luxury 
6.4 
    2.1 
 
 
 
 
    4.3 
 
•It’s important for patients 
to have access to counselling 
and testing, doesn't matter 
the condition. 
 
•Difficult to access genetic 
services for majority of the 
patient population. 
•It seems to be something 
available in private services 
and as someone working in 
the public sector, I don't 
know the roles of genetic 
counsellors or how to access 
them. 
 
Theme 7 Information 
    Indispensable 2.1 
 
•…. patients need full 
information and 
instructions. 
Theme 1 Complete health 
service  
    Indispensable 
2.1  
•If a genetic service is 
present it has to go hand in 
hand with counselling. 
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Themes pertaining to answers around value of both genetic services and genetic 
counselling 
Themes Numbers (%) Illustrative quotes 
Theme 5 Management - 
of conditions 
(screening, testing,  
diagnosis, options, 
treatment, planning) – 
patient centred 
    Indispensable 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
    Useful 
29.8 
 
 
 
 
    13 (27.1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       1 (2.1) 
 
 
 
 
 
•Diagnosis needs to be made. 
•Interventions available in certain 
conditions. Ultimately family can 
decide / plan re having children. 
•…. to enable planning of 
pregnancy or antenatal diagnosis. 
•Patients need to understand the 
implications of testing - the nature 
of the disease and risk to family. 
•Helps to screen diagnosis. 
•Treatment and prevention. 
•Family and patients need lots of 
support and need to be informed 
with facts to help them deal with 
illness. 
•Needs for diagnosis - how to 
TREAT OR CURE without diagnosis 
How to prevent either. 
•…. give them options about 
prevention, how to deal with the 
situation etc., lifestyle. 
•… both diagnosis and potential 
treatment (physical 
/psychological) become very 
important. 
 
•… Useful: Option of genetic 
services needs to be available to 
patients for current and future 
decisions on health care. 
 
Theme 4 Knowledge - 
increasing and lack of 
     Indispensable 
 
 
 
 
 
 
 
 
19.2  
 
     17.0 
 
 
 
 
 
 
 
 
 
 
•Essential, as knowledge is 
generally lacking (concerning 
health care providers). 
•… all the advances in the subject 
and management of genetic 
conditions. 
•Genetic services provided DEPTH 
around the genetic conditions. 
That knowledge is not 
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  Luxury 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    2.1 
available/present outside of 
formal genetic services. 
•Recent knowledge growth in 
genetics is beyond average GPs 
ability to cover.  
•Not enough is known about 
genetics in the general population 
and clearly medical practitioners 
do not know enough about the 
subject matter. 
•New field that is going to 
influence how we treat patients 
and influence decisions about 
treatments.  
 
•…. (eventually indispensable): 
When I know more about this 
then I would utilise it??? 
Theme 3 Support - effect 
of condition on patient 
and family/ support for 
GPs 
     Indispensable  
 
 
 
 
 
 
 
 
        
    Relevant 
 
14.9 
 
 
      12.8 
 
 
 
 
 
 
 
 
 
        2.1 
 
 
 
•Reassure patients. 
•Family and patients need lots of 
support and need to be informed 
with facts to help them deal with 
illness. 
•General practitioners need 
referral facility for support. 
•They can improve the situation 
for the family of a patient. 
 
•…..reduce the load from other 
health care practitioners. 
Theme 2 Resources 
    Indispensable 
     
    Luxury 
12.8 
   2.1 
 
    8.5 
 
•Expensive 
 
•In a 3rd world setting where 
basic medical care is appalling, is it 
relevant. In the first world eg 
Ireland, I see lots of genetic 
conditions - basic health needs are 
met therefore more appropriate. 
•In 3rd World countries only a 
fraction of the population have 
access to the above. 
•Genetic services are poorly 
accessed especially in rural areas, 
yet are indispensable due to the 
number/prevalence of genetic-
related diseases. 
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•Indispensable (in an ideal world), 
a luxury (in this world): In a 
country where people still have no 
running water, genetic services 
are a luxury! 
 
Theme 8 Burden of 
conditions 
     Indispensable 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
     Luxury 
 
 
 
 
     
    Relevant 
 
 
 
 
 
 
 
   
   Important 
10.6 
 
    4.3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    2.1 
 
 
 
 
   2.1 
 
 
 
 
 
   
  
 
2.1 
 
 
•With the current burden of 
genetic conditions and the risk of 
increased incidence in future of 
genetic conditions due to lifestyle 
changes, increased age of 
childbearing and adverse 
environmental factors, Genetic 
services will become an even 
more important part of medicine. 
•Genetic conditions have a major 
impact on wellbeing. Thus both 
diagnosis and potential 
treatment(physical/psychological) 
become very important 
 
•Genetic services are poorly 
accessed especially in rural areas, 
yet are indispensable due to the 
number/prevalence of genetic-
related diseases. 
 
•Various healthcare practitioners 
can be trained to deliver genetic 
services, but to have specialised 
Genetic Services centre will 
significantly lower the burden of 
genetic disorders, as well as 
reduce the load from other health 
care practitioners.  
 
•Genetic abnormalities have great 
impact on patients and families 
Theme 9 Essential 
    Indispensable 
 
 
 
 
 
 
 
 
 
10.6 
    8.5 
 
 
 
 
 
 
 
 
 
 
•Common sense tells me this is an 
essential service. 
•Should be done on all prenatal 
patients and breast / colon cancer 
family members.  
•Services should be made known 
to all even unsuspecting (or) at 
that time uninterested 
prospective parents. 
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  Needed 
 
 
 
 
 
    2.1 
•Essential as genetic testing and 
counselling not only has 
implications for the individual 
being tested but also for family 
members.  
 
•REALLY needed. 
Theme 6 Access 
    Indispensable 
 
 
 
 
 
 
 
     Luxury 
    8.5 
    4.3 
 
 
 
 
 
 
 
    4.3 
 
•Increasing access to genetic 
testing - imperative for patients to 
know. 
•With all the advances in the 
subject and management of 
genetic conditions, all should have 
access to these services. 
 
•Generally, as far as I am aware, 
accessing services is difficult and 
seems unavailable in private 
sector - expensive if it is. 
•In 3rd World countries only a 
fraction of the population have 
access to the above. 
 
Theme 10 Specialist field 
     Indispensable 
 
 
     Relevant 
6.4 
    4.3 
 
 
    2.1 
 
•Specialised field and very 
important. 
 
•Various healthcare practitioners 
can be trained to deliver genetic 
services, but to have specialised 
Genetic Services centre will 
significantly lower the burden of 
genetic disorders, as well as 
reduce the load from other health 
care practitioners. 
 
*Where themes are repeated, the first number allocated is used 
†Some responses were complex and therefore classified multiple times into themes and/or categories, so 
numbers do not add up 
‡only a few illustrative comments are quoted here. A full list appears in Appendix 5.2   
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Themes describing doctors’ perceived needs from genetic services in South Africa 
Themes Number (%)* Illustrative examples† 
Theme 1: Referral 
 
   
 
 
 
 
  
 
 
 
 
 
 
 
    
      
Assessment/diagnosis 
 
 
 
   
      
 
 
      
 
   
  Counselling 
48.4 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
     9.7 
 
 
 
 
 
 
 
     
 
    
    9.7 
•Genetic referral centres.  
•Tertiary/University 
hospitals. 
•Primary care. So I want to 
be able to refer to a service 
that can counsel and 
clinically manage if need be. 
•Improved referral pathways. 
•Down's syndrome; cystic 
fibrosis, Huntington's and 
colon polyposis all needs 
referral for investigation and 
also to help with counselling. 
•Guidance in treatment and 
referral to specific units. 
•Referral criteria??@risk 
patients!! 
 
•Confirmation of diagnosis 
•Screening patients when 
applicable 
•To assist with support in 
diagnosis and management 
of patients with suspected / 
confirmed genetic 
conditions. 
•To consult / assess patients 
with suspected genetic 
conditions. 
 
•Genetic counselling after 
diagnosis for patients and 
family members. 
 
Theme 2: Advice 
 
 
 
       
 
 
 
 
 
 
 
 
 
 
      
 
 
    Telephonic 
35.5 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
      
    9.7 
 
 
 
 
•To provide comprehensive 
knowledge on the disease, 
support, suggestions on 
management and to provide 
a network of support 
services. 
•Guiding me to important, 
valuable management and 
counselling. 
•How to manage and treat 
genetic diseases. 
•Advice re - whom to screen, 
how to screen, when to 
screen patients. 
•Guidance in treatment and 
referral to specific units. 
•Advice about referral. 
 
•Telephonic advice. 
•Telephonic support. 
•A helpline such as that 
offered by Dept of 
Pharmacology would be 
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great - one could email or call 
for advice. 
 
Theme 3: Access 22.6 •More visibility. 
•Access details. 
•Easier access.  
•Education to know 
availability. 
•Do not live in SA, but often 
we need access via 
laboratories such as Lancet. 
•Where are you? How do I 
contact you? 
 
Theme 4: Information 19.4 •Information. Not much else. 
•Basic information. 
•Increased education (e.g. 
for CPD points). 
•Communication on genetic 
developments. 
•What we can do to pick up 
families or patients with 
genetic problems. 
•More information and 
training. 
 
Theme 5: Nothing 12.9 •So far I did not need any 
help from genetic services.  
•None. Was never an issue 
which I had to deal with. 
 
Theme 6: Don’t know  3.2 •Don’t know 
*Some responses were complex and therefore classified multiple times into themes and/or categories, so 
numbers do not add up 
†only a few illustrative comments are quoted here. A full list appears in Appendix 5.2   
 
 
 
